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C. Summary 
 
This Ph.D Thesis describes the first total syntheses of penifulvin A, B and C and synthetic efforts 
towards the total synthesis of providencin. 
Penifulvins are sesquiterpenoids that represent an unprecedented dioxa[5.5.5.6]fenestrane structure 
type. Amongst all five members of this family, penifulvin A is biologically the most interesting one. It 
displays a very potent antiinsectan activity especially against the fall armyworm Spodoptera 
frugiperda, which is the mayor pest of corn on the North- and South-American continent and in China. 
So far no SAR data are available and a short, flexible and stereoselective synthesis of this compound is 
strongly required.  
The syntheses are based on their biosynthetic relationship to silphinene and mimic the possible 
biosynthetic pathway. The key step for the formation of the carbon-skeleton is the meta-
photocycloaddition of an alkene with a benzene ring. The application of this key step to penifulvins B 
and C disclosed a new scope of this reaction, which is the stereoselective introduction of a quaternary 
carbon atom depending on the double bond geometry. 
Providencin is a highly oxygenated diterpene belonging to the huge family of furanocembranoids. It 
exhibits an unprecedented hexacyclic structure containing a cyclobutane ring – a structure element that 
is very scarce in nature. Providencin shows modest anti cancer activity and up to date no total 
synthesis was achieved.  
The synthetic studies to providencin conducted here, describe two approaches with different 
macrocyclization strategies, one being a Horner-Wadsworth –Emmons reaction and the latter a ring-
closing metathesis reaction. The closure of this macrocycle is the most challenging part in this 
synthesis as the ring is extremely strained. Both synthetic studies take advantage of Wipf’s furan 
cyclization and start from bicyclo[3.2.0]heptenone, which is commercially available, and brings with it 
the cyclobutane ring. A versatile chiral resolution for this compound is presented here. Additionally 
model studies on the functionalization of the cyclobutane ring have been carried out. 
D. Zusammenfassung 
Die vorliegende Doktorarbeit beschreibt die erste Totalsynthese von Penifulvin A, B und C, und 
synthetische Studien zur Totalsynthese von Providencin 
Penifulvine sind Sesquiterpene mit einem neuartigen Dioxa[5.5.5.6]fenestrane Strukturtyp. Unter den 
fünf Mitgliedern dieses Strukturtyps ist Penifulvin biologisch der interessanteste Naturstoff. Es sehr 
gute insektizide Eigenschaften besonders gegen Spodoptera frugiperda. Dabei handelt es sich um 
einen der Hauptschädlinge der Landwirtschaft am gesamten amerikanischen ontinent und in China. 
Bis jetzt sind noch keine SAR Daten von Penifulvin A verfügba. Aufgrund dieser biologischen 
Wirksamkeit ist besonders für Penifulvin A ein schneller, flexibler und stereoselektiver Zugang 
erforderlich. 
Die durchgeführten Synthesen basieren auf der biogenetischen Verwandtschaft der Penifulvine zu 
Silphinen. Dabei wurde ein möglicher biosynthetischer Zugang nachgestellt. 
Um das Kohlenstoffgerüst aufzubauen wird eine meta-Photocycloaddition zwischen einem Olefin und 
einem Benzen Ring verwendet. Die Anwendung dieser Reaktion auf Penifulvin B und C hat gezeigt, 
dass auch bei Verwendung einer dreifach-substituierten Doppelbindung das beim neu entstandenen 
quartärnaren Kohlenstoffzentrum die Konfiguration mit der Doppelbindungsgeometrie korreliert. 
Providencin ist ein hochoxygeniertes Diterpen, welches der Furanocembranolid Familie angehört. Es 
besitzt eine komplexe hexacyklische Struktur mit einem Cyclobutan Ring – einem sehr 
seltenenStrukturelement bei Naturstoffen. Providencin zeigt Anticancer Eigenschaften, wenn auch mit 
mässiger Aktivität. Bis heute wurde noch keine Totalsynthese erfolgreich zu Ende geführt. 
Die hier durchgeführten synthetischen Studien von Providencin beinhalten zwei Strategien zur 
Makrozyklisierung. Die erste ist die Horner-Wadsworth-Emmons reaktion und die zweite ist eine 
ringschliessende Metathese Reaktion. Diese Makrozyklisierung stellt die synthetische 
Hauptherausforderung dar, da der Ring sehr hohe Ringspannung aufweist. Beide Zugänge verwenden 
die Wipfsche Furansynthese, und beginnen bei dem käuflichen Bicyclo[3.2.0]heptenon. Dadurch wird 
der Cyclobutan Ring mitgebracht, mit dem Nachteil dass das Material optisch aktiv gemacht werden 
muss. Wir haben für dieses Problem eine enzymatische kinetische Racematspaltung entwickelt die 
schnell und in grossen Mengen optisch aktives Material (98%ee) zugänglich macht. Zusätzlich wurden 
noch Modellstudien zur Funktionalisierung des Cyclobutan Rings durchgeführt. 
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1. Providencin: Synthetic Studies on Macrocyclization Reactions 
1.1 Introduction 
Providencin 1 (0.012% dry weight) has been isolated by Rodriguez et al. in 2003 from the seaplume 
Pseudopterogorgia kallos (Bielschowsky, 1918), collected in the Southwestern Carribean Sea near 
Providencia Island.1 (Figure 1)2 
 
Figure 1 
The highly oxygenated hexacyclic structure of 1 is based on a previously undescribed 
bicyclo[12.2.0]hexadecane ring system, and was established through spectroscopic analysis and X-ray 
crystallographic analysis. Providencin was shown to exhibit in vitro anticancer activity against human 
breast (MCF7), lung (NCI-H460) and CNS (SF-268) cancer cell lines. So far there is no detailed 
biological data available and no total synthesis of this compound was achieved. Furthermore the 
absolute configuration of the molecule is unknown. All this together, the low abundance, the 
unprecedented carbon-skeleton, the high oxidation state, the complex hexacyclic structure, the lack of 
biological data and the unknown absolute configuration make it an utmost attractive target for total 
synthesis – the sheer beauty of the molecular architecture notwithstanding.  
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1.2 Biogenetic Origin of Providencin- the Furanocembranoid Family 
Providencin is a highly oxygenated diterpene that belongs to the family of furanocembranoides 23. 
Due to their rich functionalization and diverse biological activities furanocembranoides have received 
enormous attention over the past few years.  
 
Figure 2 
Structurally, these secondary metabolites feature a 14-membered carbocyclic framework with varying 
degrees of oxygenation, into which a substituted furan ring and a butenolide subunit are embedded. 
Two other structural families the pseudopteranes 3 and the gersolanes 4 can be biosynthetically 
delineated from the furanocembranoids (figure 2). Both exhibit a 12-membered macrocycle gained by 
skeletal rearrangement of the furanocembranoid carbon-framework. They are therefore called 
“rearranged furanocembranoids”. They too exhibit a furan ring and a butenolide moiety.  
The biosynthesis of furanocembranoids starts with a cationic macrocyclization of geranylgeranyl-
pyrophosphate 5, leading to intermediate carbenium ion 6 which upon proton loss gives the natural 
product neo-cembrene 74. Further selective oxidations introduce the furan ring, the butenolide moiety 
and the specific oxidation pattern of the particular furanocembranoid congener (rubifolide 8 shown in 
scheme 1).  
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Scheme 1 
The skeletal rearrangement of furanocembranoids leading to pseudopteranes and gersolides is 
considered to be a photochemical reaction. This assumption is further substantiated by experiments 
performed by Rodriguez and co-workers5. Irradiation of bipinnatin J 9 in acetonitrile for one hour gave 
a mixture of products 10:11:12 in a 120:1:6 ratio. The major pseudopterane framework results from a 
suprafacial photochemically allowed 1,3-allyl-shift. Thereby C9-C10-bond is homolytically cleaved 
and C10 reacts with C7 and thus performs the ring contraction (scheme 2). Concomitant 
rearrangement of the π-system gives Kallolide A 10. The minor gersolide framework results from an 
antarafacial photochemically allowed 1,2-shift, giving rise to a bi-radical which recombines by 
forming the cyclopropane ring. Pinnatin C 12 is formed due to traces of singlet oxygen present during 
the reaction. 
Scheme 2 
It is noteworthy that the configuration of the benzylic alcohol is inverted during the formation of the 
gersolane pinnatin A 11.  
The vast number of structures belonging to these families arises from selective oxidations most likely 
performed by P450 cytochrome monooxygenases, albeit not much is known about these specific 
enzymes. Despite this large diversity almost all structures share a common oxidation pattern: a) The 
Methyl group on the furan ring can be oxidized up to a carboxylic acid functional group. b) C-2 is 
sometimes hydroxylated. c) C-13 position is very often hydroxylated and acetylated. d) The butenolide 
moiety is in some cases epoxidized. e) The Δ7,8-double bond can be oxidized, sometimes leading to 
consecutive transannular reactions. f) Oxidation of the furan ring occurs, and leads to a variety of 
structurally complex congeners. Almost all furanocembranoids, pseudopterolides and gersolides have 
exclusively been isolated from marine habitats, thereof mainly gorgonian octocorals. It is therefore 
very likely that they are biogenetically closely related, moreover that they represent different 
“oxidation stages” en route. Some prominent members are depicted in figure 3. For instance 
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bipinnatin J 9 and bipinnatin E 15 were isolated from Pseudopterogorgia bipinnata6. 9 serves as a key 
compound for speculations about biosynthetic diversification of this family, whereas bipinnatin E 15 is 
considered to be the direct precursor of Providencin (see chapter 1.4). Rubifolide 8 and pukalide 18 
were isolated from the nudibranch Tochuina tetraquetra7. Coralloidolide 13 stems from Alcyonium 
coralloides8. Lophotoxin is a potent neurotoxic agent. It irreversibly inhibits the nicotinic 
acetylcholine receptor, thereby acting as a neuromuscular toxin. It was isolated from several 
lophogorgia species and extensive biological testings have been done with it91011. Deoxylophotoxin 17 
differs from 14 only by the epoxide functionality on the butenolide and was isolated from lophogorgia 
peruana12.  
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Figure 3 
Higher oxidized congeners are shown in figure 4. Very often the furan ring is oxidatively cleaved, 
leading to new transannular ring formations in the case of bipinnatolide E13 24 and corallodiolide B14 
27. Pinnatin C 12, kallolide C15 28, gersemolide 2915, rubifol16 24, bipinnatolide J 2513 and 
lophodione17 26 exhibit a 1,4-diketone as a result of the oxidative furan cleavage. 
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Figure 4 
 
1.3 Proposed Biosynthetic Relations on Furanocembranoid Derivatives  
Biosynthetic considerations become ever more important in total synthesis. The sheer beauty, elegance 
and ease with which nature puts together enormously complex structures, has inspired many chemists 
and the lessons acquired thereby, always lead to new insights and discoveries in organic synthesis. 
Albeit structurally very different from furanocembranoids in figures 3 and 4, furanocembranoid 
derivatives (figure 5) are closely related to them. Strong evidence provides the source of isolation. Just 
like other furanocembranoids, compounds in figure 5 have all been isolated from gorgonian 
octocorals.  
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Figure 5 
The key to the breathtaking structural variety in furanocembranoids in terms of biosynthesis is the 
furan ring, as it encompasses a rich spectrum of oxidation chemistry. The new functionality generated 
in these oxidations, discloses possibilities for C-C-bond formations in situ. The cascades triggered 
thereby lead to highly complex polycyclic structures, named furanocembranoid derivatives to which 
providencin 1 belongs. This characteristic nature of furanocembranoids has prompted many 
biosynthetic proposals and culminated in a biomimetic total synthesis of intricarene which is discussed 
in chapter 1.5.5. 
Trauner et al. have put foreward several biosynthetic hypotheses between furanocembranoids and their 
derivatives18. For example plumarellide19 verillin20 and bielschowskysin21 can be obtained via very 
elegant cascades from rubifolide 8 as outlined in scheme 3. In the case of plumarellide 40, rubifolide 8 
is oxidized at the methyl group of the furan ring to give an allylic alcohol. Additionally a conjugated 
double bond to the butenolide is introduced yielding compound 42. The cascade starts with an 
epoxidation of the benzylic double bond. The epoxide is opened by the furan ring leading to 
compound 43. The reaction sequence terminates with a transannular Diels Alder reaction giving 
plumarellide. The natural products mandapamate22 31, isomandapamate23 32 and 
bishomoisomandapamate23 33 represent diastereomers of plumarellide 40 and are supposed to be 
obtained through the same cascade. The different relative stereochemistry arises from the epoxidation 
and the diastereofaciality of the Diels Alder reaction. 
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Scheme 3 
The proposed route to verillin 38 involves the synthesis of the higher oxidized precursor 44. Again 
epoxidation of the benzylic double bond induces the cascade, but this time a transannular 1,4-addition 
with acetal formation leads to verillin 38. The carbon-skeleton of bielschowskysin 37 is thought to be 
obtained via a transannular [2+2]-cycloaddition of 47, which again comes from the opening of the 
benzylic epoxide by the furan ring. This last proposal for the generation of bielschowskysin caused us 
some doubts, as it discounts the fact that bielschowskysin 37 and providencin 1 were both isolated 
from (Pseudopterogorgia kallos). According to literature proposals bielschowskysin is generated from 
rubifolide 8, which was isolated from different organisms Gersemia rubiformis and from the 
nudibranch Tochuina tetraquerta. As both 37 and 1 were isolated from the same specimen, we think 
that a common precursor for bielschowskysin and providencin leads to both natural products as 
depicted in scheme 4. Therby bipinnatin G serves as a biogenetic precursor. It is epoxidized at the 
benzylic double bond leading to compound 48, which can be either transformed to providencin, or 
opening of the benzylic epoxide in scheme 4 facilitates the transannular [2+2]-cycloaddition cascade 
yielding 50. This undergoes a Baeyer-Villiger type oxidation leading to bielschowskysin. 
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Scheme 4 
At first glance intricarene 36 doesn’t seem to have structurally anything in common with 
furanocembranoids. But after a detailed analysis it can elegantly be deduced from bipinnatin J 9 
(scheme 5)24. This domino reaction starts with an Achmatowicz type oxidation of the furan ring giving 
compound 52. Dehydratisation yields oxopyrylium 53, which undergoes a transannular [5+2]-
cycloaddition with the butenolide moiety, and thus yields intricarene 36. Just recently bipinnatin N25 
57 a new exponent of bipinnatins has been isolated. The structure of this congener is especially 
interesting as it strongly supports the propsed intricarene biosynthesis. We think nature makes 57 in 
the same way as intricarene 36 but starting from 54 (scheme 5). The E-double bond of 54 prevents a 
transannular [5+2]-cycloaddition reaction. Epoxidation of the trisubstituted double bond then gives 57 
(scheme 5). 
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Scheme 5 
Havellockate26 41 is obtained from a rearrangement of the isomandapamate skeleton, and 
rameswaralide26 34 stems from the mandapamate skeleton (for details see ref 18).  
 
1.4 Biosynthetic Proposal for Providencin 
The biosynthetic proposal in literature presumes bipinnatin E 15 is the direct predecessor of 
providencin18 1. It contains a Norrish type II reaction that should form the cyclobutane ring, as shown 
in scheme 6.  
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Scheme 6 
Although there is some experimental evidence for this transformation that was done by Pattenden et 
al. on a test system,27 (discussed in chapter 1.5.8) there exists a second probable pathway nature can 
take.  
Our proposal for the biosynthesis of the cyclobutane involves a homoallyl-cation-cyclization starting 
from bipinnatin F. The resulting cyclobutylidene ring is hydroxylated in an allylic oxidation reaction, 
giving rise to providencin 1 (scheme 6).  
 
1.5 Previous Synthetic Works on Members of the Furanocembranolide Family. 
Not surprisingly in view of the highly demanding architecture of the furanocembranoides relatively 
few target molecules have been synthesized so far.  
1.5.1 Paquette’s Total Synthesis of Gorgiacerone28 21 
Gorgiacerone29 was one of the first structures of this family to be synthesized by Paquette et al. in 
1992. The strategic bond connections are the Lewis acid catalyzed addition of allylstannane 63 to 
aldehyde 64, which brings in the carbon atoms required for the butenolide moiety. The second 
strategic bond connection is Nozaki Hiyama Kishi reaction used as a macrocyclization 69 → 21 
(scheme 7). Paquette and co-workers started the synthesis by condensing glyceraldehydes 60a to 
thiophenyl-acetylacetonate 61 under acidic conditions. Dehydratisation gave a thio-furyl alcohol, 
which was oxidized in a Swern oxidation, yielding 54% of aldehyde 62.  
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Scheme 7 
Scheme 7 Paquette’s synthesis of gorgiacerone. Reagents and conditions: (a) neat; (b) HOAc, H2O, EtOH, 80°C, 60%; (c) (COCl)2, DMSO, 
CH2Cl2, -60°C, NEt3, 90%; (d) 2-propenylmagnesium bromide, Et2O, THF, -30°C; (e) Ac2O, DMAP, pyridine, CH2Cl2; (f) Me2AlSnBu3, 
Pd(PPh3)4, THF, -78°C to rt, 64% over three steps; (g) BF3 OEt2, 64, -78°C; (h) CSA, PhH, Δ, 67%; (i) KHMDS (2eq.), THF, -78°C, PhSeCl 
(2 eq.), 74%; (j) AgClO4, PhH, H2O; (k) NaIO4, NaHCO3, MeOH, H2O, THF, 90% over two steps; (l) NaBH4, MeOH; (m) MsCl, NEt3; (n) 
LiBr, THF, 99% over three steps; (o) Pd(PPh3)4, PhH, 68, Δ, 75%; (p) diphenylphosphinoethane*2Br2, CH2Cl2, 0°C o rt, 65%; (q) 40%-HF-
pyridine, CH3CN, 68%; (r) PDC, CH2Cl2, 0°C, 46%; (s) CrCl2 (20 eq. 4Å MS THF, 20%; (t) (COCl)2, DMSO, CH2Cl2, -60°C, NEt3, 91%.  
Addition of isopropenylmagnesium bromide and subsequent acetylation with acetic anhydride gave an 
allylic acetate which upon treatment with palladium tetrakistriphenylphosphine and dimethyl 
aluminium tributylstannane yields allyl-stannane 63 with 64% yield. This stannane was added to 
aldehyde 64 with borontrifluoride etherate at -78°C. Camphorsulphonic acid formed the butyrolactone 
(67%), which was converted to butenolide 66 via the introduction of a phenylselenyl group in α-
position to the lactone, and a consecutive oxidative elimination reaction (66% over four steps). 
Compound 66 was converted to benzyl bromide 67 in a three step sequence and after sp2-sp3-coupling 
with vinyl stannane 68 the TBDPS-group was removed with 40% HF-pyridine to give 69 (33% yield). 
Alcohol 69 was oxidized to the corresponding aldehyde with pyridinium dichromate and submitted to 
a Nozaki-Hiyama-Kishi coupling, leading to the desired macrocycle in 9% yield. Oxidation of the so 
generated alcohol gave gorgiacerone 21.  
1.5.2 Paquette’s Total Synthesis of Acerosolide30 16 
Acerosolide31 16 was the second furanocembranoid to be completed by Paquette et al. one year later in 
1993 (scheme 8). The synthesis started from the same allylstannane 63 that they had used in the 
gorgiacerone synthesis. Stannane 63 and aldehyde 64 were treated with stannous tetrachloride in 
tetrahydrofuran at -78°C, establishing the benzylic trisubstituted E-double bond in 55% yield. The 
butenolide moiety and the benzylic aldehyde were introduced analogously to the gorgiacerone 
synthesis yielding 50% of 71. After converting this aldehyde to bromide 72 in 95%, a sp2-sp3-coupling 
with vinyl stannane 68 led to alcohol 73 after TBDPS-deprotection (28%yield). Oxidation to the 
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aldehyde and Nozaki-Hiyama-Kishi macrocyclization gave the corresponding alcohol, which was 
oxidized to give acerosolide in 2% yield over the last three steps.  
 
Scheme 8 
Scheme 8 Paquette’s synthesis of acerosolide. Reagents and conditions: (a) SnCl4, THF, -78°C, 64, 55%; (b) CSA, PhH, Δ, 90%; (c) 
KHMDS (2eq.), THF, -78°C, PhSeCl (2 eq.); (d) AgClO4, PhH, H2O; (e) NaIO4, NaHCO3; (f) NaBH4, MeOH, -20°C, 50%; (g) NBS, DMS, 
CH2Cl2,95%; (h) Pd(PPh3)4, 68, CHCl3, Δ,65%; (i) diphenylphosphinoethane*2Br2, CH2Cl2, 0°C o rt, 65%; (j) aq. HF-pyridine, CH3CN, 
68%; (k) PDC, CH2Cl2, 0°C, 46%; (l) CrCl2 (20 eq. 4Å MS THF, 20%; (m) PDC, 4Å MS, DMF, 0°C, 25%.  
1.5.3 Marshall’s Kallolide32 B 19 Total Synthesis 
The Marshall group has succeeded in the total syntheses of rubifolide33 8, deoxypukalide34, kallolide 
A35 10 and B 19. Marshall’s group developed new furan and butenolide syntheses from allenes and 
silver salts, and applied the 2,3-Wittig-ring-contraction of cyclic allylic propargyl ethers to form the 
macrocyclic ring of furancembranoides. As an illustration the synthesis of kallolide B 19 is shown in 
Scheme 9. Thus, the furan ring in intermediate 77 was generated from allenyl ketone 76 and silver 
nitrate. After conversion into ether 78 a [2,3]-Wittig-Still ring-contraction furnished 79, which was 
converted into allene ester 80 and isomerized to 81. Reaction with silver nitrate closed the butenolide 
ring to give the natural product. 
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Scheme 9 
Scheme 9Marshall’s synthesis of kallolide B. Reagents and conditions: (a) 1-bromo-2-butyne, SnCl2, NaI, DMPU; (b) (COCl)2, DMSO, 
CH2Cl2, -60°C, NEt3; (c) AgNO3, acetone; (d) DIBAL-H, PhCH3, -78°C; (e) CBr4, PPh3, NEt3, CH2Cl2; (f) n-BuLi, THF, -78°C, (CHO)n, -
78°C to rt; (g) sec-BuLi, DMF, -78°C; (h) (CF3CH2O)2P(O)CH(Me)CO2Et, KHMDS, 18-c-6, THF, -78°C; (i) MsCl, LiCl, 2,6-lutidine, 
DMF; (j) DIBAL-H, CH2Cl2, -78°C (k) NaH, 18-c-6, PhCH3, Δ; (l) n-BuLi, THF, -78°C (m) MsCl, NEt3, -78°C; (n) Pd2dba3, PPh3, 2,6-
lutidine, 2-(trimethylsilyl)ethanol, CO, THF; (o) PPh3, CH3CN, 55°C; (p) TBAF,DMF, THF; (q) AgNO3, acetone. 
 
1.5.4 Pattenden’s Total Synthesis of Bis-deoxylophotoxin36 94 
In their synthesis of bis-deoxy-lophotoxin 94 Pattenden et al first tried to prepare a 1,4-diketone via a 
free radical cyclization of phenylselenyl ester 82. However, free radical 83 did not form 84 as desired, 
but underwent addition to the butenolide double bond instead (scheme 10).  
 
Scheme 10 
The approach to bis-deoxylophotoxin starts with the addition of trimethylsilylacetylene to (R)-
epichlorhydrine (scheme 11). Removal of the TMS-group was followed by carbometallation with 
iodine quench, leading to the vinyl iodide functionality. Under basic conditions the chlorhydrine was 
converted to the epoxide which was opened by ethoxyacetylene giving 86 in 19% yield. 
Ethoxyacetylene 86 was hydrolyzed under acidic conditions and converted to the γ-lactone upon 
heating in chloroform. Treatment of the lactone with LiHMDS and phenyl-selenyl bromide gave 87 in 
59% yield. The synthesis of the furan fragment starts with a stereoselective alkylation of 88 with 89 
followed by superhydride reduction to cleave off the auxiliary. The alcohol generated thereby was 
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tosylated and the ester at the furan was reduced to the alcohol 90 (yield 37 %). Subsequent TBS-
protection, C1-chain elongation with reduction of the nitrile to the alcohol, and stannylation of the 
furan ring, gave after reoxidation to the aldehyde compound 91 in 29% yield. Aldolreaction of this 
aldehyde with 87 and oxidative elimination to the butenolide led to 92 in 74% yield. Stille coupling 
with compound 92 and acetylation of the alcohol gave macrocycle 93 in 11% yield. Deprotection of 
the TBS-group and oxidation to the aldehyde eventually yielded 47% of bis-deoxylophotoxin 94. 
 
Scheme 11 
Scheme 11 Pattenden’s synthesis of bis-deoxylophotoxin. Reagents and conditions: (a) trimethylsilylacetylene, n-BuLi, BF3, -78°C (b) 
TBAF, HCl, THF, 42% over two steps; (c) Me3Al, ZrCp2Cl2, CH2Cl2, 3 days, I2, THF, -30°C to rt, 60%; (d) NaOH, Et2O, 84%; (e) 1-
ethoxyacetylene, n-BuLi, BF3; (f) p-TsOH, EtOH, 2h, then CHCl3, reflux 14h, 82% over two steps; (g) LiHMDS, THF, then PhSeBr, -
78°C,72%; (h) NaHMDS, THF, -78°C, then 89, 65%; (i) Super Hydride, PhCH3, -78°C, 80%; (j) TsCl, NEt3, DMAP, 75%; (k) DIBAL-H, 
CH2Cl2, -78°C, 95%; (l) n-Bu4CN, DMSO, 60°C, 90%; (m) TSCl, NEt3, DMAP, 91%; (n) DIBAL-H, PhCH3, -78°C to rt, 85%; (o) NaBH4, 
MeOH, 0°C, 70%; (p), n-BuLi, TMEDA, n-BuLi then Me3SnCl, 0°C to rt, 80%; (q) TPAP, NMO, 4Å MS, CH2Cl2, 75%; (r) 87, LiHMDS, -
78°C, then 91, 93%; (s) H2O2, CH2Cl2-pyridine, 0°C; (t) AsPh3, Pd2dba3, 40°C, 20% over two steps; (u) Ac2O, NEt3, DMAP, 54%; (v) CSA, 
MeOH-CH2Cl2, 0°C, 78%; (w) Dess-Martin periodinane, CH2Cl2, 0°C, 61%. 
1.5.5 Trauner’s Total Synthesis of Bipinnatin J37 9 
Syntheses of bipinnatin J 9 have been reported by Trauner, Pattenden38 and Rawal39. Trauner’s 
synthesis (scheme 12) starts from known vinyl iodide 95. Conversion to 96 is straight forward and 
proceeds with 85% yield. Deprotection of the TES group and ruthenium catalyzed retro-ene-reaction 
gave butenolide 97 (52% yield). This was elaborated to allylic alcohol 98 by a reduction/oxidation 
sequence. Stille coupling with furylaldehyde 99 gave 100 in 92 % yield. Allylic alcohol was 
transformed to the corresponding bromide and then the macrocycle was closed in a Nozaki-Hiyama-
Kishi allylation to give bipinnatin J 9 in 63% yield. Rubifolide 8 was then obtained from 9 by a 
hydrosilylation reaction (99% yield). Isoepilophodione 101 was obtained by treating 8 with meta-
chlorobenzoic acid. Additionally Trauner et al. have shown that intricarene 36 can be obtained from 9 
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by a transannular [5+2] cycloaddition, as it was hypothesized for its biosynthesis. For this purpose 
bipinnatin J was treated with meta-chlorobenzoic acid in an Achmatowicz type reaction to give 
compound 102, which upon dehydratisation underwent transannular [5+2]-cycloaddition to give 
intricarene in 21% yield.  
 
Scheme 12 
Scheme 12 Trauner’s synthesis of bipinnatin J. Reagents and conditions: (a) Dess-martin periodinane, CH2Cl2, 0°C. (b) 
trimethylsilylacetylene, n-BuLi, THF, -78°C; (c) Dess-martin periodinane, CH2Cl2, 0°C. (d) (S)-Alpine borane, THF, 55% over four steps; 
(e) K2CO3, MeOH; (f) TESOTf, 2,6-lutidine, THF; (g) LiHMDS, ClCO2Et, THF, -78°C to -50°C; (h) aq. HF-pyridine, 85% over four steps; 
(i) RuCp(MeCN)3PF6, allyl alcohol, CSA, THF-acetone, 52%; (j) Ph3P=(Me)CO2Et, CH2Cl2, 84%; (k) DIBAL-H, , CH2Cl2, PhCH3, -78°C; 
(l) PDC, , CH2Cl2, 0°C to rt  (m) NaBH4, MeOH, 70% over three steps; (n) Pd(PPh3)4, 99, CuI, CsF, DMF, 92%; (o) NBS, PPh3, , CH2Cl2, -
5°C, 87%; (p) CrCl2(10 eq.) 4Å MS, THF, 72%; (q) TFA, HSiEt3, , CH2Cl2, 0°C, 99%; (r) m-CPBA, , CH2Cl2, 0°C, 88%; (s) m-CPBA, , 
CH2Cl2, 0°C; (t) Ac2O, pyridine, DMAP, CH2Cl2, 81% over two steps; (u) TMP, DMSO, 140°C, 26%. 
1.5.6 Rawal’s Total Synthesis of Bipinnatin J39 9 
Rawal’s synthesis of bipinnatin J 9 starts from olefin 103 (scheme 13). Alkylation of γ-butyrolactone 
and allylic oxidation with selenium dioxide with subsequent MOM-protection gave 104 in 44% yield. 
The γ-butyrolactone moiety was transformed to butenolide 105. This was deprotonated and alkylated 
with copound 106 leading to 107 in 60% yield. Negishi coupling of vinyl iodide with furan 108 and 
MOM-deprotection gave 109 in 81% yield. For the completion of the synthesis Rawal et al. performed 
the same endgame as Trauner’ group, with a Nozaki-Hiyama-Kishi reaction for the formation of the 
macrocycle. 
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Scheme 13 
Scheme 13 Rawal’s synthesis of bipinnatin J. Reagents and conditions: (a) SeO2, t-BuOOH, CH2Cl2, 67%; (b) MOMCl, i-Pr2EtN, CH2Cl2, 
0°C to rt, 92%; (c) NaI, acetone, 100%; (d) LDA, γ-butyrolactone, HMPA, THF, -78°C, 72%; (e) LDA, PhSeCl, THF, HMPA, -78°C, 66%; 
(f) aq. H2O2, THF, 0°C to rt, 82%; (g) LDA, TBSCl, THF, -78°C, 100%; (h) AgO2CCF3, 106, CH2Cl2, -40°C to rt, 60%; (i) PdCl2(dppf), 108, 
THF, 0°C to rt, 100%; (j) PPTS, t-BuOH, 90°C, 81%. 
1.5.7 Pattenden’s Total Synthesis of Bipinnatin J38 9 
Pattenden et al. also published a bipinnatin J and a biomimetic intricarene total synthesis (scheme 14). 
Pattenden too used a Nozaki-Hiyama-Kishi allylation for macrocyclization. To build up the carbon 
skeleton of bipinnatin J he started from glycidol. Epoxide 111 was obtained via standard reactions in 
31% yield. This epoxide is opened by α-seleno-ester obtained from 112 to give 113 in 60% yield. 
Lactonization and oxidative elimination, followed by TBS-deprotection led to butenolide 114 in 62 
%yield. The completion of the synthesis was achieved via Trauner’s endgame. Intricarene was 
obtained by oxidizing bipinnatin J with vanadium acetoacetate. Dehydratisation with acetic anydride 
and heating gave then the natural product in 3% yield over three steps. 
 
Scheme 14 
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Scheme 14 Pattenden’s synthesis of bipinnatin J. Reagents and conditions: (a) trimethylsilylacetylene, n-BuLi, BF3, -78°C to -30°C, 97%; (b) 
K2CO3, MeOH, 92%; (c) Me3Al, ZrCp2Cl2, CH2Cl2, 3 days, I2, THF, -30°C to rt; (d) TsCl, pyridine, 48% over two steps; (e) K2CO3, MeOH, 
73%; (f) TBSCl, imidazole, DMF, 0°C,; (g) LDA, TMSCl, PhSeBr, THF, -78°C to rt; (h) NaHMDS, THF, -78°C, then 111, BF3 OEt2, -78°C 
to rt, 60%; (i) p-TsOH, CH2Cl2; (j) H2O2, THF, 0°C; (k) PPTS, CH2Cl2, 62% over three steps; (l) VO(acac)2, t-BuOOH, CH2Cl2, -20°C; (m) 
Ac2O, NEt3, DMAP, CH2Cl2, 30% over two steps; (n) DBU, CH3CN, Δ, 10%. 
1.5.8 Biosynthetic Studies on Bielschowskysin and Providencin 
To probe the proposed biosyntheses of providencin and bielschowskysin, two model experiments for 
forming the cyclobutane rings for both molecules have been reported recently (scheme 15). Pattenden 
published a bio-inspired photocyclization of aldehyde27 115 to the methylene-cyclobutanol moiety of 
providencin 116, however with incorrect configuration of the secondary alcohol. Sulikowski et al. 
investigated a photo-[2+2]-cycloaddition of the bis-butenolide 117 (E/Z-mixture), which gave the 
highly strained bielschowskysin fragment 118 with  5:1-stereoselectivity40.  
 
Scheme 15 
From the completed  total syntheses it can be concluded that cyclizations of furancembranolide seco-
precursors having both the furan and the butenolide rings do work under Nozaki-Hiyama-Kishi 
conditions. Stille cyclizations onto the furan ring are encumbered by high ring strain. Marshall avoids 
this strain by using a ring contraction and forming the butenolide after macrocyclic ring closure. 
 
1.6 Retrosynthetic Analysis of Providencin based on its Structural Features. 
Providencin 1 is a highly oxygenated member of the furanocembranoid family. It has an 
unprecedented [12.2.0] hexadecane system. It exhibits a hexacyclic structure with a furan ring, a 
butenolide moiety two epoxides, a cyclobutane ring and a 13-membered macrocycle. The ring strain in 
the macrocycle is very high making the molecule very rigid. There are two other main indications for 
the ring strain. Firstly the benzylic epoxide in the X-ray is orientated such, that the foregoing double 
bond is out of plane with the furan. In this way no conjugation can occur, and only the outer face of 
the double bond is accessible for epoxidation. Second, the butenolide moiety is captivated 
perpendicular to the furan ring thereby being conformationally locked. In this way only one face of the 
double bond accessible for epoxidation (figure 6). These two points were very important for the 
retrosynthetic analysis. It suggests to introduce both epoxides in the last steps as the ring geometry 
will control the stereoselectivity of both epoxidations, and hence introduce four of the overall nine 
stereogenic centers of providencin in the last two steps of providencin.  
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Figure 6 
Another synthetically very challenging part of the molecule displays the cyclobutane ring. It is 
tetrasubstituted with three stereogenic centers and an exocyclic double bond. A cyclobutane ring as 
structure element is scarce in natural products. Examinating existing cyclobutane ring syntheses, we 
therefore had to realize that they were unsuitable for the application to our target molecule. Further we 
were aware that due to the complexity of providencin we were going to face a long and laborious 
synthesis, leaving us behind with the requirement of large quantities of material. Therefore we decided 
to start with the commercially available bicycle 119. A short structure comparison of this bicycle with 
providencin makes the versatility and the synthetic problems by using it evident (figure 7). The 
versatility of 119 lies in the availability of large quantities. The cyclopentene ring can be easily 
cleaved by ozonolysis, resulting in the formation of two adjacent substituents on the cyclobutane with 
different chain lengths. These two chains (at C1 and C2) have a cis-relationship. To get the correct 
trans-relationship, the configuration at C2 is inverted by capitalizing from the thermodynamically 
favored trans-substitution pattern at the cyclobutane ring via enolization. The drawback by using 119, 
is the need for a hydroxylation at C17. For this purpose an allylic oxidation with selenium dioxide was 
envisaged. 
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Figure 7 
1.6.1 Retrosynthetic Analysis I 
Our first retrosynthetic analysis used a Horner-Wadsworth-Emmons reaction as macrocyclization 
reaction (scheme 16). We chose this reaction because of its huge driving force, and so hoped to 
overcome the ring strain thereby. In retrosynthetic view the first transformation would be the allylic 
oxidation followed by two epoxidations leading to 120. The butenolide should be generated by CO-
insertion into vinyl iodide 121. The latter would be generated from the corresponding enone which 
would be derived in the macrocyclization giving open chain precursor 122. For the synthesis of the 
furan ring we wanted to take advantage of Wipf’s palladium catalyzed furan synthesis starting from 
propargylic β-ketoester. This would be generated by alkylation of β-ketoester 124 with iodide 123. 
 
Scheme 16 
1.6.2 Retrosynthetic Analysis II 
The second retrosynthesis involves a ring closing metathesis reaction as macrocyclization (scheme 
17). The first retrosynthetic steps are as above an allylic oxidation and bis-epoxidation to give 120. 
Then ring closing metathesis should lead to open chain precursor 125. This is constructed via an aldol 
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reaction to attach the butenolide, leading to fragments 123 and 124. Again Wipf’s furan synthesis 
would be used leading to the same β-ketoester 124 as in the former approach.  
 
Scheme 17 
1.7 Unpublished Work – A Model Study on Allylic Oxidations of Cyclobutene-ringsystems 
To the best of our knowledge allylic oxidations with exocyclic cyclobutenes are completely unknown. 
To probe the allylic oxidation of the cyclobutene ring we did some model experiments (scheme 18). 
The first model system 128 contained the exocyclic double bond and the two chains for further CC-
bond formation in a cis-relationship. Allylic oxidation proceeded smoothly albeit with moderate 52% 
yield.  
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Scheme 18 
Scheme 18 Synthesis of the modelsystem 133 for allylic oxidation: Reagents and conditions: (a) see Appendix 1; (b) EtOAc, IBX (3 eq.), Δ, 
94% (c) K2CO3, MeOH, rt, 97%; (d) α-bromo methylacetate, Zn, THF, Δ, 95%; (e) EtOAc, IBX (3 eq.), Δ, 90%; (f) THF, NaH, 124, then 
131, rt, 85%; (g) THF, Pd(OAc)2, dppf, K2CO3, Δ, 72%; (h) 1,1,1,3,3,3-hefafluoroisopropanol, CH2Cl2, MeOH, 89%; (i) TBAF, THF, 88%; 
(j) TBSCl, imidazole, DMF, 76%; (k) IBX, DMSO, 92% (l) PPh3MeBr, KOtBu, 88% (m) t-BuOOH, SeO2, CH2Cl2, 42%.  
As the real system would contain the two substituents at the cyclobutane ring not in a cis- but a trans-
relationship we decided to synthesize a more similar model system with the correct relative 
stereochemistry. For this purpose alcohol 130 was converted to furan 133 as shown in scheme 18. 
When we executed the allylic oxidation on this system, to our surprise not the desired compound 134 
was formed, but the tertiary alcohol 135 instead. It seems therefore that the allylic oxidation is regio-
sensitive to the stereochemistry at C2. The model system has one major drawback. It lacks the 
macrocycle with the butenolide being perpendicular to the furan. We conclude from the X-ray 
structure (figure 8) that this butenolide moiety will reverse the regiochemistry of the allylic oxidation, 
driving the reagent back from the tertiary position, and thus form the desired secondary alcohol. 
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Figure 8 
1.8 Experimental of the Model Study on Allylic Oxidations 
See Appendix 1 
1.9 Published Work – Synthetic Studies towards the Total Synthesis of Providencin 
See Appendix 2 
1. Gaich, Tanja; Arion, Vladimir; Mulzer, Johann. Synthesis of the cyclobutane moiety of 
providencin. Heterocycles  (2007), 855-862. 
2. Schweizer, Eliane; Gaich, Tanja; Brecker, Lothar; Mulzer, Johann.  Synthetic studies 
towards the total synthesis of providencin. Synthesis  (2007), (24), 3807-3814. 
3. Gaich, Tanja; Weinstabl, Harald; Mulzer, Johann. Synthetic efforts towards the complex 
diterpene Providencin. Synthesis (2009), ASAP. 
1.10 Experimental - Synthetic Studies towards the Total Synthesis of Providencin 
See Appendix 3 
1.11 Conclusion 
In conclusion we have developed 2 synthetic routes to providencin 1. The major synthetic challenge in 
the total synthesis of this natural product is the highly strained macrocycle. We were able to work out 
two different macrocyclizations, the first one being a Horner-Wadsworth-Emmons reaction (scheme 
16), and the second one being a metathesis reaction (scheme 17).  
Our syntheses are both centered around Wipf’s palladium catalyzed method41 for furan synthesis and 
the use of bicycle 119 (figure 7).  
Bicycle 119 was a crucial building block, as it is commercially available in large quantities, albeit only 
in racemic form. Therefore we were forced to develop a chiral resolution giving large quantities of 
enantiopure 119 in a short time. The macrocyclic building blocks which we elaborated further gave us 
very precious insights in the reactivity of such strained compounds, which are currently used in the 
ongoing synthetic studies and will hopefully lead to the total synthesis of providencin.
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2. The Biomimetic Total Syntheses of (-)-Penifulvin A, B and C. 
2.1 Introduction 
The media resound with alarming reports of how the prices for corn and other field crops have 
increased dramatically over the past few months. In this respect pest control to avoid crop damage is 
of ever increasing importance. The fall armyworm (Spodoptera frugiperda) is native to the tropical 
regions of the western hemisphere from the United States to Argentina and its larvae cause enormous 
damage by consuming foliage of a variety of field crops, including barley, buckwheat, cotton, corn, 
oat, rice, sugarcane, soybean, tobacco, wheat and others42 (figure 9)43. In Florida, for example, fall 
armyworm is the most important pest of corn. Resistance to pesticides has been noted and is expected 
to become increasingly problematic from year to year. The only way out of this dilemma is the 
introduction of new environmentally benign pesticides.  
 
Figure 9 
In this respect we were intrigued by two recent papers of Gloer et al., which describe the isolation of 
novel sesquiterpenoids named penifulvin A, B, C, D, E and hydroxyl-silphinenic acid from the fungus 
Penicillium griseofulvum (syn. P. patulum Bain.; P. urticae bain.).4445 From these metabolites 
penifulvin A shows significant antiinsectan activity in assays against the fall armyworm. Penicillium 
griseofulvum is distributed worldwide and has been recorded from grassland, desert soil, decaying 
plants, cereal grains and animal feed. Among its bioactive metabolites are, inter alia, roquefortine C, 
griseofulvin, patulin and cyclopiazonic acid.2 Guided by preliminary antifungal and antiinsectan 
assays, Gloer et al obtained Penifulvins in mg quantities from an organic extract from cultures of an 
isolate of Penicillium griseofulvum Dierckx (MYC-1728= NRRL 35584). This sample was obtained 
from a white mycelia growth on a dead hardwood branch collected in a Hawaiian forest. The overall 
structures of penifulvin A, B, C, D, E and hydroxyl-silphinenic acid, including the relative 
stereochemistry, were secured by X-ray crystallographic analysis and revealed a highly complex 
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dioxa[5.5.5.6]fenestrane structure in which four rings share a central quaternary carbon atom (figure 
10).  
 
Figure 10 
Additionally there are two more quaternary carbon atoms, a γ-and a δ-lactone sharing an acylal center 
and a total of five stereogenic centers in penifulvin A. All other penifulvins bear six stereogenic 
centers as they represent oxidized analogues of penifulvin A and contain an additional hydroxyl group 
at different positions in the carbo-skeleton. All stereogenic centers are adjacent to each other, and two 
quaternary carbon atoms are vicinal to each other. This dioxafenestrane ring system whose absolute 
configuration is unknown, previously has not been described in literature. Due to their unusual and 
complex molecular architecture, penifulvins represent attractive targets for total synthesis. 
Furthermore, for acquiring SAR data and elucidating the full bioprofile of penifulvin A, a rational 
access is of the essence to procure unnatural analogs.  
2.2 The Penifulvin Family: Isolation and Biogenetic Origin. 
The biosynthesis of penifulvins starts, like all other sesquiterpenoid biosynthesis, from farnesyl-
pyrophosphate (scheme 19). A cationic cyclization cascade provides the the silphinene 145 carbon-
skeleton. This is achieved via cyclization of farnesyl-pyrophosphate to the β-caryophyllene cyclobutyl 
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carbo-cation 142. This rearranges with ring enlargement to a secondary carbenium ion, which is 
immediately trapped by the trisubstituted double bond, resulting in the formation of the second 
cyclopentane ring of tertiary carbenium ion 143. A 1,3-H-shift moves the positive charge to the central 
atom in structure 144. From there a Wagner-Meerwein rearrangement with ring contraction occurs, 
and upon deprotonation silphinene 145 is generated. For better visualization the three isoprenoid units 
of farnesylpyrophosphate are differently colored and it is thus easily observable how splinted the three 
isoprenoid starter units get incorporated into the silphinene backbone.  
 
Scheme 19 
Our proposal of the penifulvin biosynthesis implies an oxidation of methyl group 1 to the carboxylic 
acid functional group 146 (scheme 20). In the next step the cyclopentene ring is oxidatively cleaved 
yielding an intermediate dialdehyde 147, which collapses to lactol 148 exhibiting the desired 
dioxafenestrane ring system. A last step is an oxidation to the δ-lactone giving penifulvin A.  
 
Scheme 20 
The other members of the family are derived in analogous fashion. We propose that the additional 
hydroxyl-groups are incorporated at the stage of the silphinene skeleton, and thus before the oxidative 
cleavage of the cyclopentene ring. This hypothesis is supported by the existence of 12-
hydroxysilphinene-15-oic acid, which as we think is the direct precursor of penifulvin B. Therefore we 
propose that the corresponding hydroxysilphinene acids for penifulvins C, D and E exist. 
2.3 Previous Synthetic Works on Silphinene and related Terpenoids using the meta-Photo-
Cycloaddition as the Key Step. 
In 1981, 28 years ago, Wender et al. introduced the alkene-arene meta-photocycloaddition to the 
synthetic community by completing the total synthesis of α-cedrene in only four steps46. Since then 
much work was performed in this area and many applications of this most versatile reaction have 
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commenced in the total synthesis of complex polycyclic natural products. The meta-
photocycloaddition was first reported simultaneously by Bryce-Smith et al47. and Wilzbach Kaplan in 
196648. The first intramolecular examples were published in 1969 by Morrison and Ferree49. 
2.4 Some general Aspects of the Alkene-Arene meta-Photo-Cycloaddition50. 
The meta-photocycloadditon is a photochemical reaction between an aromatic moiety and an olefin. 
Typically the benzene reacts from its first excited state. This requires a light source capable of emitting 
light with a wavelength of 253.7 nm. The mode of the reaction with the olefin can be in ortho-, meta- 
or para-fashion, and in the course of the reaction the benzene ring is doomed (scheme 21). The ortho- 
and meta-adducts are more common. The focus here will lie on the meta-adducts (reviews dealing 
with other aspects see51). 
 
Scheme 21 
2.4.1 Intermolecular reactions 
As soon as substituents are attached, either to the aromatic ring or the alkene, regioselectivity becomes 
an issue (for example see scheme 22)52. In both products the cyclopropane ring is in allyl position to 
the double bond, but the distance between the olefin substituents and the cyclopropane ring is 
different. This is either vicinal (1,2-adduct) or in meta-position (1,3-adduct) (scheme 22).  
 
Scheme 22 
The picture gets even more complicated when the benzene ring bears a substituent. It is generally 
observed that the alkene addition takes place preferentially 2,6-across the benzene ring if the 
substituent is electron donating, and preferentially 2,4 across the benzene with an electron 
withdrawing substituent (scheme 23)53. 
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Scheme 23 
The stereoselectivity of the meta-photocycloaddition can be explained in the same way as in the Diels-
Alder reaction via the endo rule. Secondary molecular orbital interactions as well, play an important 
role in this reaction. The preference in the addition of cyclopentene to anisol is depicted in scheme 24 
and shows high endo-selectivity54. 
 
Scheme 24 
2.4.2 Intramolecular reactions: 
In intramolecular reactions regio and stereoselectivity problems do not occur independently from each 
other as the tether length influences the position of attack (regiochemistry), and the spatial approach of 
the double bond (stereochemistry). Interestingly the regiochemistry of the meta-photocycloaddition is 
also influenced by the double bond geometry. An (E)-double bond on a three carbon atom tether adds 
to the benzene ring across the 2,6- positions on the aromatic ring. Whereas a (Z)-double bond adds in a 
1,3-fashion. Additionally the attack of the (E)-double bond follows the endo-rule but the (Z)-double 
bond attacks in an exo-fashion (scheme 25)55. The reason for the different regio and stereochemical 
outcome is the ring strain, and the steric hindrance which conformation A exerts on the tether. 
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Scheme 25 
The picture changes again when an electron donating substituent ortho to the tether is attached to the 
benzene ring. The regiochemistry then changes regardless of the double bond geometry to the 
preferred 1,3-attack, albeit still with endo-selectivity for the E- and exo-selectivity for the Z-double 
bond. These ortho-substituted tether systems are the most reliable photocycloaddition precursors in 
terms of regio and stereocontrol and have been extensively used in total synthesis. The examples given 
below therefore contain exclusively these ortho-substituted precursors. Concerning the tether length 
the most frequently used is the three-carbon-atom tether. It forms a cyclopentane ring which is 
kinetically the most favourable ring size. Tether lengths of four to five carbon atoms are also known. 
2.4.3 The Application of the meta-Photocycloaddition in Total Synthesis 
To expediently use the meta-photocycloaddition in natural product synthesis, certain criteria have to 
be fulfilled. The photocycloaddition precursor has to be easily accessible, the cycloaddition itself 
should be selective or the isomers at least separable. And last but not least the conversion of the 
cycloaddition product to the target structure should not be cumbersome. Paul Wender’s group 
pioneered this field but of course other groups have done significant contributions56. 
2.4.4 The Total Synthesis of α-Cedrene46 
The first example comprises the total synthesis α-cedrene by Wender et al.(scheme 26). Synthesis of 
cycloaddition precursor 151 was achieved by addition of an aryllithium species generated from 149 to 
ketone 150. The benzylic alcohol was reduced to give 151. The stereogenic center in 151 allows to 
control the stereoselectivity of the photo cycloaddition in such a way that according to the A1,3-strain 
model the proton stays in-plane with the aromatic ring. The regioisomers 152/153 are converted to 
ketone 154 via a bromonium ion catalyzed fragmentation reaction of the cyclopropane ring. The allylic 
bromides are defunctionalized in a Barton McCombie reaction yielding only one double bond isomer 
154. This compound is further defunctionalized in a Wolff Kishner reduction giving α-cedrene 155. 
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Scheme 26 
Scheme 26Wender’s synthesis of α-cedrene: Reagents and conditions: (a) Li, Et2O, then 150; (b) Li, NH3, then NH4Cl, 74% over two steps; 
(c) hυ (vycor filter) pentane, 65%; (d) Br2, CH2Cl2; (e) Bu3SnH (neat), 59% over two steps; (f) NH2NH2, KOH, (OHCH2CH2)O, 200°C, 58%. 
2.4.5 The Total Synthesis of Rudmollin57 
Rudmollin was also completed by the Wender group. It is far more oxidized and the sequence is 
longer. Again the photo-addition precursor is rapidly accessible (156/157 → 158 scheme 27). In this 
synthesis the tether contains a Z-double bond, and thus the exo-transition state is formed. Regiomers 
159 and 160 are formed in a 1:1 ratio, but are both submitted to the next step – an oxy-mercuration 
with concomitant fragmentation – to give a 12:1 mixture in favour of the desired regioisomer 162. 
This is reduced to the diol, and treatment with manganese dioxide selectively reoxidizes the allylic 
alcohol, giving an enone-sytem. The double bond is hydrogenated, the remaining alcohol benzoylated 
and the ketone is alkylated  with allyl iodide yielding 164. Ketone 164 is reduced to give 3:1 in favour 
of the α- isomer. The double bond is cleaved by ozonolysis, and the resulting aldeyde is reduced and 
selectively protected with TBSCl at the primary position giving 165. Mesylation of the secondary 
alcohol in 165 with subsequent treatment with lithium aluminum hydride resulted in fragmentation to 
give compound 166. Benzylation of the primary alcohol, iodolactonization and Barton-McCombie 
dehalogenation introduced the γ-lactone. The exo-methylene-double bond was introduced by a 
procedure from Wassermann58 yielding rudmollin. 
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Scheme 27 
Scheme 27 Wender’s synthesis of rudmollin: Reagents and conditions: (a) THF, 0°C, then 156, 98%; (b) TBSCl, DMF, NEt3, DMAP, 97%; 
(c) hυ (vycor filter) pentane, 63%; (d) Hg(OAc)2, THF, H2O (71% 159 + 6% 160); (e) NaBH4, MeOH, 94%; (f) MnO2, CH2Cl2, 93%; (g) H2, 
5%Pd/C, Et2O, 99%; (h) (PhO)2O, DMAP, NEt3, DMF, 50°C, 95%; (i) KHMDS, DME, 0°C, then BEt3, THF, allyl iodide, 50% (j) NaBH4, 
CeCl3, MeOH, 72% (α:β=3:1); (k) O3, MeOH, CH2Cl2, -78°C then NaBH4 98%; (l) TBSCl, imidazole, DMF, 97%; (m) MsCl, pyridine, then 
LiAlH4, DME, 0-25°C, 84%; (n) KH, THF, BnBr, 96%; (o) HF-H2O, CH3CN, THF, Jones acetone, 82%; (p) I2, sym-collidine, CH3CN, 
Bu3SnH, AIBN, PhH, 80°C, 53%; (q) NaBH4, MeOH, -78-25°C, 92%; (r) H2 (40 psi), 10% Pd/C, 70% HClO4 (cat.), MeOH, 82%; (s) 
(Me2N)3CH, 90°C, then DIBAL, THF, 0°C, 54%. 
2.4.6 The Total Synthesis of Isocumene59 
Isocumene a member of the pentalene family was synthsized by Wender et al. via photoaddition 
precursor 172 yielding isomers 173 and 174. In this case only one isomer was of further use in the 
synthesis, but fortunately the undesired 173 could be equilibrated to the desired isomer 174 upon 
further irradiation. Dehydroisocumene was obtained via a 1,5-H-shift. The last step is a selective 
hydrogenation of the less substituted double bond yielding isocumene (scheme 28).  
 
Scheme 28 
Scheme 28 Wender’s synthesis of isocumene: Reagents and conditions: (a) Li, Et2O then CuI, -65°C, MVK, 56%; (b) ortho-bromotoluene, 
Li, Et2O, rt, then 170  then NH3, -78°C, 78%; (c) hυ (vycor filter) cyclohexane, 72%; (d) 235-240°C, 69%; (e) H2, 5% Pd/C, hexane, 98%. 
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2.4.7 The Total Synthesis of Silphinene60 
Silphinene 145 is the structure biogenetically related to penifulvins. Wender et al. performed a most 
elegant and rapid access to this structure without the introduction of any unnecessary functional group 
(scheme 29). As in the foregoing syntheses the stereochemical course of the cycloaddition is governed 
by the A1,3-allyl-strain model leading to regioisomers 179 and 180. The tricyclic carbon-skeleton is set 
up in this way except that the cyclopropane ring needs to be cleaved. This was achieved by a Birch 
reduction giving silphinene and its 2,3-Δ-double bond isomer in a 9:1 ratio for the desired natural 
product. 
O
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Scheme 29 
Scheme 29 Wender’s synthesis of silphinene: Reagents and conditions: (a) Li, Et2O, then ortho-bromotoluene, then NH4Cl, 87%; (b) hυ 
(vycor filter) pentane, 72%; (c) Li, MeNH2, -78°C, 74%. 
2.4.8 The Total Synthesis of Laurene61 
Laurene 189 is one of the most complex natural products synthesized by using the meta 
photocycloaddition (scheme 30). In contrast to the foregoing examples it belongs to the diterpenes and 
has a fenestrane-type structure. The synthesis of the photoaddition precursor is a little bit more 
laborious but proceeds in standard steps. Like in the silphinene synthesis, the cyclopropane ring is 
removed in a Birch reduction, but additional deoxygenations have to be performed to reach laurellene. 
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Scheme 30 
Scheme 30 Wender’s synthesis of laurenene: Reagents and conditions: (a) isopentyl nitrite, Cl3CCO2H, cycloheptadiene, CH2Cl2, 84% 
brsm.; (b) O3, DMS, NEt3, 68%; (c) Zn(BH4)2, Et2O, 98%; (d) TsCl, 72%; (e) PCC, 98%; (f) NBS, AIBN, then KOH, 72%; (g) H2, Pt, 96%; 
(h) LDA, DMPU, hompoprenyl iodide, 48%; (i) LiALH4, THF, 95%; (j) hυ, (BiCl3-filter), 51%; (k) Li, MeNH2, -60°C, 96%; (l) KHMDS, 
HMPA, ClPO(NMe2)2, 55%; (m) Li, EtNH2, 65%. 
2.4.9 The Total Synthesis of Retigeranic acid62 
Retigeranic is a most complex pentacyclic structure which contains the pentalene core in the shape of 
three adjacent cyclopentane rings. The cyclohexane and the terminal cyclopentane ring are formed in 
an intramolecular Diels-Alder reaction (scheme 31). Further functional group manipulations finally 
lead to the natural product. Remarkable in this synthesis is the possibility to interconvert the two 
regioisomers evolving from the photocycloaddition, and the radical ring cleavage of the cyclopropane 
ring which introduces the carbon atom that finally represents the carboxylic acid in the natural 
product. 
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Scheme 31 
Scheme 31 Wender’s synthesis of retigeranic acid: Reagents and conditions: (a) PLE; (b) dipyridyl disulfide, PPh3, CH2Cl2, 96%; (c) p-xylyl 
bromide, Li, Et2O, CuI, -78°C to 0°C then 191, -78°C, 90%; (d) LiAlH4, Et2O; (e) H2, 10% Pd/C, EtOH-HClO4 (100:1), 93% 2 steps; (f) n-
Bu3P, o-nitrophenylSeCN, H2O2 30%, 84%; (g) hυ (vycor filter) pentane, 72%; (h) hυ (pyrex filter) acetone, HCONH2, t-BuOH; (i) KOH, 
DMSO, MeI, 80%; (j) SeO2, t-BuOOH, (CH2Cl2)2, Δ, 53%; (k) 197, LDA, 50°C to 0°C then 196 (at -78°C), to 25°C, AcOH, N,N-
dimethylformamide dimethyl acetal, Δ, 65%; (l) 230°C, PhCH3, 65%; (m) m-CPBA, NaOAc, CH2Cl2; (n) t-BuOK, DMSO, 100°C; (o) 10%-
Pd/C, H2, PhH, 400psi; (p) LiAlH4, THF,(q) PDC, CH2Cl2; (r) oxidation to acid. 
2.4.10 The Total Synthesis of Modhephene63 
Modhephene (scheme 32) represents the intermolecular application of the meta-photocycloaddition in 
total synthesis and varies in this respect from the previous applications. Dihydroindane and 
vinylacetate undergo the photo-reaction to give regioisomers 203 and 204 (10:1 for the desired 
compound). The acetate group is cleaved under basic conditions and oxidized to the ketone. Then 
extensive α-methylation of the ketone followed by a homo-1,4-addition of dimethyl-cuprate introduces 
the missing methyl groups, and opens the cyclopropane ring. The ketone is reduced and thus 
modhephene obtained. 
Penifulvin A, B and C 
 
 
36 
OAc
OAc OAc
1 : 10
a b-d
O
e
OPO(NMe2)2
f,g
modhephene
202 203 204 205
206 207  
Scheme 32 
Scheme 32 Wender’s synthesis of modhephene: Reagents and conditions: (a) hυ (vycor filter) cyclohexane, 21%; (b) KOH, MeOH, 86%; (c) 
Ba(MnO4)2, 95%; (d) t-BuOK (15 eq), MeI, THF, 68%; (e) Me2CuLi, THF, -78°C, ClPO(NMe2)2, then Me2NH, 76%; (f) Li, EtNH2, THF, t-
BuOH, 0°C, 93%; (g) H2, PtO2, 100%. 
2.5 Own Synthetic Work – The Biomimetic Total Synthesis of (-)-Penifulvin A 
Appendix 4  
Gaich, Tanja; Mulzer, Johann.   Total Synthesis of (-)-Penifulvin A, an Insecticide with a 
Dioxafenestrane Skeleton. Journal of the American Chemical Society (2009), 131(2), 452-453. 
2.6 Experimental (-)-Penifulvin A 
Appendix 5 
2.7 Unpublished Work – Biomimetic Total Synthesis of Penifulvin B and C ) 
After we had completed the total synthesis of penifulvin A we wanted to apply the meta-
photocycloaddition to the other members of the family, to show that we were able to provide access to 
all penifulvins with this method.  
We chose penifulvins B and C because both structures contain an additional stereogenic quaternary 
carbon atom (figure 11). This additional quaternary carbon atom makes these two members the most 
challenging ones of this family, and can be directly formed from the olefin in the meta-
photocycloaddition. This provides us with the opportunity to test whether this additional quaternary 
carbon stereogenic center is as well formed stereoselectively in the course of the reaction.  
 
Figure 11 
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To the best of our knowledge no examples in total synthesis are known, where a quaternary 
stereogenic center in this position was generated via the photo-cycloaddition. If the 1,3-exo-addition 
during this reaction remains unbiased, penifulvin B 137 is exclusively formed from the E-double bond 
209, whereas penifulvin C 139 is generated from the corresponding Z-double bond 214. In this way we 
could additionally contribute to the mechanistic considerations of this reaction.  
We therefore prepared both trisubstituted E- and Z-double bond precursors 209 and 214 and attached 
them to compound 210 via Myers alkylation (scheme 33). Reductive cleavage of the auxiliary gave the 
corresponding alcohols 211 and 215, which were submitted to the photocycloaddition respectively 
(scheme 34).  
 
Scheme 33 
Scheme 33 Synthesis of the meta-photocycloaddition precursors of penifulvins B and C: Reagents and conditions: (a) SeO2, t-BuOOH, 
CH2Cl2, 61%; (b) TBSCl, imidazole, DMF; (c) LiCl (6eq), LDA (2.2 eq), THF, 0°C to rt; (d) BH3*NH3, LDA, THF, 0°C; (e) THF, KHMDS, 
(CF3CH2O)2P(O)CH(Me)CO2Et, -78°C; (f) DIBAL, hexane, -78°C, 43% two steps; (g) TIPSCl, imidazole, DMF, 98%; (h) montmorillionite 
K10 MeOH, 68%; (i) MsCl, pyridine then acetone, NaI, 98%. 
To our delight we found that the 211 (containing the E-double bond), indeed only gave the quaternary 
stereogenic center found in Penifulvin B, and 215 (containing the Z-double bond) exclusively gave the 
stereogenic center with the configuration found in penifulvin C.  
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Scheme 34 
Scheme 34 meta-photocloaddition of 211 and 215. 
Completion of the syntheses was achieved in analogue fashion to the total synthesis of penifulvin A, 
plus an additional deprotection of the silyl-protecting group in the last step (scheme 35). 
 
Scheme 35 
Scheme 35 Completion of the synthesis of penifulvins B and C: Reagents and conditions: (k) Li (6 eq.), EtNH2; (l) IBX, DMSO, rt then 
NaClO2, t-BuOH, NaH2PO4;96% (m) O3, thiourea, CH2Cl2, -78°C to rt, 36%; (n) AcOH cat., CH2Cl2, PDC, 83%; (o) 50% HF-pyridine in 
CH3CN, 82%. 
2.8 Summary 
In conclusion we have developed the first total syntheses to Penifulvins A, B and C, which have been 
isolated from the fungus Penicillium griseofulvum.. The dioxa[5.5.5.6]fenestrane ring system of these 
natural products is unprecedented in nature.  
The total synthesis of penifulvin A 136 is the shortest one with 5 steps from commercially available 
starting materials for the racemic route, and 8 steps for the enantioselective route.  
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The enantioselective synthesis of penifulvin B 137 takes 10 steps and requires only one protecting 
group. For the synthesis of penifulvin C 139 13 steps are required, as the synthesis of the Z-double 
dond in 214 takes more steps. Like in penifulvin B 137 only one protecting group is required.  
The three syntheses represent a biomimetic approach to this family, as they use the well known 
silphinene carbon framework to build up the final acylal structure. Silphinene 145 is considered to be 
biogenetically related to penifulvins. This hypothesis is substantiated by the fact that 12-
hydroxysilphinen-15-oic-acid 138 was also isolated from the same natural source. 
2.9 Experimental – Total Syntheses of Penifulvins B and C 
Appendix 6 
3.0 Appendix 1(Experimental of unpublished work of 
Providencin) page 43-48 
4.0 Appendix 2 (Publications Providencin) page 49-76 
5.0 Appendix 3 (Experimental of Providencin) page 77-135 
6.0 Appendix 4 (Publication of Penifulvin A) page 136-138 
7.0 Appendix 5 (Experimental of Penifulvin A) page 139-156 
8.0 Appendix 6 (Experimental of Penifulvins B and C)  page157-
181 
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Appendix 1 
tert-butyl((-2-(2-(tert-butyldimethylsilyloxy)ethyl)-3-methylenecyclobutyl)methoxy)dimethylsilane 
128 
OTBS
TBSO
OAc
H
H
OTBS
TBSO
OH
 
Literature known acetate (1g, 6.6 mmol, 1eq) was dissolved in 40 mL DCM/methanol 4:1 and cooled 
to -78°C. . Ozone was bubbled through until the solution turned dark blue. Air was then bubbled 
through until the color deceased again and the cooling bath was removed. 20 mL MeOH and NaBH4 
(19.7 mmol, 745 mg, 3eq) were added. The reaction mixture was stirred at room temperature for two 
hours and quenched by slow addition of water (5 mL then 50 mL 1M HCl). The phases were separated 
and the water phase was further extracted three times with DCM. The combined organic layers were 
dried over magnesium sulfate, the solvents were removed under reduced pressure and crude product 
was submitted to the next reaction without further purification. 
This diol was dissolved in 7 mL DMF and imidazole (31.6 mmol, 2.2 g, 4.8 eq) and TBS-Cl (13.8 
mmol, 2.1 g, 2.1eq) were added sequentially. After stirring the reaction over night at room temperature 
it was diluted with water. The phases were separated and the aqueous phase was extracted three times 
with diethyl ether, the combined organic layers were dried over magnesium sulfate, the solvents were 
removed in vacuo and the crude product was hydrolyzed with ethanolic KOH (30%) to give the 
corresponding alcohol, which was again submitted crude to the next reaction. 
IBX (7.8 mmol, 2.2 g, 1.2 eq) was added to a solution of the crude alcohol in DMSO. The reaction 
was stirred for 1 hour and was diluted with water and diethyl ether. The phases were separated and the 
aqueous phase was extracted three times with diethyl ether, the combined organic layers were dried 
over magnesium sulfate, the solvents were removed in vacuo and the crude product was added to a 
solution of methyl triphenyl phosphonium ylid (20 mmol, 3eq, 0.5M in THF) at -78°C. After stirring 
the reaction mixture for 30 minutes at that temperature it was quenched with ammonium chloride. The 
phases were separated and the aqueous phase was extracted three times with diethyl ether, the 
combined organic layers were dried over magnesium sulfate, the solvents were removed in vacuo and 
the crude product was purified by flash column chromatography (hexane:ethylacetate 40:1) to give 1.4 
g 57% of olefin 128. 
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1H-NMR (400MHz, CDCl3): δ= 5.00-4.98 p.p.m. (m, 1H), 4.85 (m, 1H), 3.94 (ddd, J=10.2, 10.2, 3.3 
Hz, 1H), 3.85-3.80 (m, 1H), 3.71-3.70 (m, 2H), 2.45-2.34 (m, 2H), 2.17-2.07 (m, 1H), 1.97 (ddd, 
J=14.6, 10.2, 4.5 Hz, 1H), 1.77 (dt, J=14.4, 3.5 Hz, 1H), 0.86 (s, 9H), 0.84 (s, 9H), 0.05 (d, J=3.3 Hz, 
3H), 0.00 (d, J=2.0 Hz, 3H). 
13C-NMR (100MHz, CDCl3): δ= 154.46 p.p.m., 105.91, 62.24, 61.53, 47.56, 34.32, 28.44, 26.59, 
26.46, 19.36, -4.91. 
HRMS (ESI) (m/z ): [M]+  calcd for C20H42O2Si2 370.2723; found, 370.2711. 
Methyl-2-((1S,2R)-2-(2-(tert-butyldimethylsilyloxy)ethyl)-3-oxocyclobutyl)-5-vinylfuran-3-
carboxylate 132b 
 
Furan 132a (230 mg, 0.54 mmol, 1eq), was dissolved in 5mL THF and tetrabutyl ammonium fluoride 
(1M in THF, 1.6 mL, 1.6 mmol, 3 eq) was added at room temperature. The mixture was stirred for 4.5 
hours, quenched with brine and the phases were separated. The aqueous phase was extracted three 
times with diethyl ether, the combined organic layers were dried over magnesium sulfate, the solvents 
were removed in vacuo and the crude product was purified by flash column chromatography 
(hexane:ethylacetate 1:1) to give the corresponding diol which was immediately used in the next step. 
The diol was dissolved in 2mL DMF and imidazole (1.3 mmol, 90 mg, 2.4 eq), and TBS-Cl (0.54 
mmol, 82 mg, 1eq) were added sequentially at room temperature. The reaction was stirred over night 
then it was diluted with water and diethyl ether. The phases were separated and the aqueous phase was 
extracted three times with diethyl ether, the combined organic layers were dried over magnesium 
sulfate, the solvents were removed in vacuo and the crude product was dissolved in 2mL DMSO. IBX 
(0.81 mmol, 228 mg, 1.5eq) was added and after stirring at ambient temperature for one hour the 
reaction was quenched with water, diluted with diethyl ether and extracted three times with diethyl 
ether, the combined organic layers were dried over magnesium sulfate, the solvents were removed in 
vacuo and the crude product was purified by flash column chromatography (hexane:ethylacetate 7:1) 
to give 125 mg 61% of ketone 132b. 
1H-NMR (400MHz, CDCl3): δ= 6.55 p.p.m. (s, 1H), 6.45 (dd, J=17.6, 11.2 Hz, 1H), 5.68 (d, J=17.7 
Hz, 1H), 5.24 (d, J=11.1 Hz, 1H), 4.29 (dd, J=14.3, 7.2 Hz, 1H), 4.17-4.09 (m, 1H), 3.83 (s, 3H), 
3.81-3.68 (m, 2H), 3.55 (ddd, J=17.4, 8.3, 2.8 Hz, 1H), 3.31 (ddd, J=17.4, 8.9, 2.1 Hz, 1H), 2.02-1.90 
(m, 2H). 
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13C-NMR (100MHz, CDCl3): δ= 208.89 p.p.m., 160.34, 151.51, 128.22, 124.55, 116.21, 113.76, 
108.61, 64.23, 60.80, 52.46, 49.77, 32.11, 28.44, 14.46. 
HRMS (ESI) (m/z ): [M]+  calcd for C14H16O5 378.1862; found, 378.1854. 
Methyl-2-((1S,2R)-2-(2-(tert-butyldimethylsilyloxy)ethyl)-3-methylenecyclobutyl)-5-vinylfuran-3-
carboxylate 133 
 
Ketone 132b (125 mg, 0.33 mmol, 1eq) was added at -78°C to a 0.5M solution of methyl 
triphenylphosphonium ylide in THF (1 mmol, 2mL, 3eq). The reaction was stirred for one hour at that 
temperature before it was quenched with a saturated ammonium chloride solution. The phases were 
separated and the aqueous phase was extracted three times with diethyl ether, the combined organic 
layers were dried over magnesium sulfate, the solvents were removed in vacuo and the crude product 
was purified by flash column chromatography (hexane:ethylacetate 15:1) to give 110 mg 88% of 
olefin 133 
1H-NMR (400MHz, CDCl3): δ= 6.56 p.p.m. (s, 1H), 6.51 (dd, J=17.8, 11.3 Hz, 1H), 5.76 (d, 17.8 Hz, 
1H), 5.28 (dd, J=11.2, 0.9 Hz, 1H), 4.97 (dd, J=5.1, 2.5 Hz, 1H), 4.94 (dd, J=4.1, 2.6 Hz, 1H), 4.00 
(dd, J=17.0, 8.7 Hz, 1H), 3.90 (s, 3H), 3.73-3.68 (m, 1H), 3.67-3.62 (m, 1H), 3.59-3.54 (m, 1H), 3.14-
3.08 (m, 1H), 3.03-2.98 (m, 1H), 2.09-2.03 (m, 1H), 1.84-1.78 (m, 1H), 0.89 (s, 9H), 0.04 (s, 3H), 0.00 
(s, 3H). 
13C-NMR (100MHz, CDCl3): δ= 164.61 p.p.m, 163.20, 150.35, 136.23, 124.71, 114.81, 113.57, 
108.98, 104.52, 60.82, 51.83, 47.97, 37.08, 35.98, 35.24, 30.16, 26.19, -5.07.  
HRMS (ESI) (m/z ): [M]+  calcd for C21H32O4Si 376.2069; found, 376.2057. 
[α]D= +21 (c 0.37g/100mL, CHCl3). 
Methyl-2-((1S,2S)-2-(2-(tert-butyldimethylsilyloxy)ethyl)-2-hydroxy-3-methylenecyclobutyl)-5-
vinylfuran-3-carboxylate 135 
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Selenium dioxide (146 µmol, 16 mg, 0.5 eq) was suspended in 500µL DCM and cooled to 0°C. tert-
butyl-hydroperoxide (5.5 M in decane, 0.58mmol, 106µL, 2eq) was slowly added. After the addition 
was completed the ice bath was removed and the suspension was stirred at ambient temperature for 30 
minutes. The reaction mixture was cooled to 0°C and the olefin 133 (110 mg, 0.29mmol, 1eq) was 
added in 0.5mL DCM. The ice bath was removed and the mixture was stirred for 10 hours. The 
reaction was quenched with 30% KOH (5mL), diluted with diethyl ether and the phases were 
separated. The aqueous phase was extracted three times with diethyl ether, the combined organic 
layers were washed with brine, dried over magnesium sulfate, the solvents were removed in vacuo and 
the crude product was purified by flash column chromatography (hexane:ethylacetate 10:1) to give 48 
mg 42% of alcohol 135. 
1H-NMR (400MHz, CDCl3): δ= 6.55 p.p.m. (s, 1H), 6.44 (dd, J=17.4, 11.4 Hz, 1H), 5.62 (d, J=17.4 
Hz, 1H), 5.20 (d, J=11.4 Hz, 1H), 5.17 (dd, J=2.4, 2.4 Hz, 1H), 5.02 (dd, J=1.9, 1.9 Hz, 1H), 4.26 
(dd, J=9.8, 9.8 Hz, 1H), 3.87-3.80 (m, 1H), 3.82 (s, 3H), 3.57 (dt, J=10.6, 5.3 Hz, 1H), 2.98-2.90 (m, 
1H), 2.76 (ddt, J=15.1, 9.5, 1.7 Hz, 1H), 1.88-1.82 (m, 1H), 1.79-1.72 (m, 1H), 0.91 (s, 9H), 0.03 (s, 
3H), 0.01 (s, 3H). 
13C-NMR (100MHz, CDCl3): δ= 164.26, p.p.m., 151.83, 127.98, 124.39, 116.21, 113.20, 108.90, 
106.12, 84.49, 77.32, 77.00, 76.68, 60.28, 51.52, 43.46, 35.70, 29.69, 28.21, 25.80, -5.63. 
HRMS (ESI) (m/z ): [M]+  calcd for C21H32O5Si 392.2019; found, 392.2009. 
[α]D= +24 (c 0.14g/100mL, CHCl3). 
 
 
47 
7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 ppm
3.
09
2.
92
9.
46
9.
10
1.
23
1.
16
1.
51
1.
09
1.
03
1.
07
1.
09
1.
08
2.
56
1.
06
0.
48
2.
13
0.
50
1.
07
0.
34
1.
05
2.
00
1.
04
O
CO2Me
OTBS
160 155 150 145 140 135 130 125 120 115 110 105 100 95 90 85 80 75 70 65 60 55 50 45 40 35 30 25 20 15 10 5 0 ppm
O
CO2Me
OTBS
 
48 
 
7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 ppm
6.
27
10
.9
4
1.
08
0.
94
1.
01
0.
99
1.
02
4.
03
1.
06
0.
85
1.
00
1.
99
1.
00
1.
03
0.
94
O
CO2Me
OTBS
OH
 49 
Abstract: Providencin is a novel highly oxygenated marine 
furanocembranolide featuring a cyclobutane ring and a highly 
strained 7,8-trans-epoxide. Various approaches to the total 
synthesis of this compound are reported. The cyclobutane moiety 
is generated via [2+2]-cycloaddition and the furan ring is 
constructed via a Wipf palladium catalyzed alkynone cyclization. 
The macrocyclic ring was closed via HWE olefination and RCM. 
The latter reaction, however, produced the undesired 7,8-Z-olefin 
exclusively, and thus far, the conversion into the cis-isomer has 
been unsuccessful. 
 
1. Introduction. 
2. Retrosynthetic Analysis 
3. First Generation Approach 
3.1.  Cyclobutane Synthesis 
3.2.  Western Fragment 
3.3.  Combination of Both Fragments and Ring Closure via 
HWE 
4. Second Generation Approach via RCM 
5. Cyclobutane Model Studies 
6. Conclusion.  
 
Key words: furanocembranolides, total synthesis, Horner-
Wadsworth-Emmons-olefination, macrocyclization, ring closing 
metathesis 
1. Introduction 
 
Figure 1 Some Representative Furanocembranolides 
The class of the furanocembranolides offers a diverse 
sprectrum of structurally interesting natural compounds 
which are effective against various cancer types, reveal 
analgesic or anti-inflammatory activity, or display potent 
neuro- and cytotoxic properties.1 Common structural 
features are the 2,5-bridged furan ring, a more or less 
modified butenolide moiety, and two isopropenyl side 
chains, placed on a macrocyclic ansa carbon chain for 
example in gorgiacerone, pseudopterolide, didehydro-
pseudopterolide and tobagolide (Figure 1). From this 
general pattern acerosolide is different by the fact that 
one of the two isopropenyls is incorporated into the 
macrocyclic ring, where it forms an E-olefin.2 A similar 
motif is found in providencin (1), however, now also the 
second isopropenyl moiety is modified by forming a 
cyclobutanol ring which is trans annulated to the 
macrocycle. Additionally two epoxides are incorporated, 
which makes 1 the most highly oxygenated member of 
the family. 
Providencin was isolated by the Rodriguez group3 from 
the sea plume Pseudopterogorgia kallos (Bielschowsky, 
1918), which was collected near Providencia (Old 
Providence) Island located in the Southwestern 
Caribbean Sea. 1.07 kg dry animal specimens gave 20 
mg 1 (0.012% dry weight). The relative configuration 
was secured via single-crystal X-ray analysis (Figure 2). 
The absolute configuration is unknown. Biologically, 1 
exhibits moderate antibacterial activity. 
 
Figure 2  Crystal structure of providencin (1) 
The crystal structure shows the perpendicular 
arrangement of the butenolide and the macrocyclic ring. 
The high ring strain became noticeable when we 
attempted to build a Dreiding model. This turned out 
impossible without breaking the bonds. Quite obviously 
the ring strain is mainly due to the trans-arrangement of 
the C7/C8-epoxide and the rigid 120°-angle between the 
C7 and C2 appendages around the furan ring. 
Biogenetically 1 can be considered to be the result of a 
head-to-tail- oligomerization of four isoprenoid moieties 
(Figure 3) with subsequent ring contraction under 
Synthetic efforts towards the synthesis of the complex diterpene Providencin 
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cyclobutane formation and finally poly-oxygenation. A 
more detailed biosynthesis was suggested by 
Pattenden,4a  by starting from 13-acetoxy-11β,12β-
epoxy-pukalide, which is also found in Nature.4b 
Oxidation to bipinnatin E should be followed by 
photochemical formation of a biradical which could 
cyclize to 1. 
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Figure 3 Postulated biosynthetic origin of providencin 
In any event, the unusual molecular architecture and in 
particular the ring strain and the high densitiy of 
oxygenated stereocenters makes 1 a desirable synthetic 
target. 
 
2. Retrosynthetic analysis 
So far, there is only one model study towards the 
synthesis of providencin.4a From the very beginning it 
was clear to us that the synthesis required careful 
consideration how to prepare the three key fragments 
(furan, butenolide and cyclobutane), how to connect 
them, and finally how to close the highly strained 
macrocyclic ring.5 We decided to center our strategy 
around the formation of the furan via a protocol by Wipf 
(Scheme 1),6 which furnishes the desired vinyl furan 
moiety in one step.  
 
Scheme 1 The Wipf cyclization approach to furan carboxylates6 
More specifically, compounds 2 or 4 were treated with a 
palladium catalyst to form furan esters 3 and 5 under 
elimination of carbon dioxide and ethanol. 
Mechanistically (Scheme 2) it may be assumed that 
palladium(0) attacks 2 under formation of the C-Pd-
tautomers 6 and 7. Enolate formation and cyclization 
leads to allene 8 which tautomerizes to 3 eventually. If 
the reaction is applied to the tertiary benzoate 4, an E/Z- 
mixture of olefin 5 has to be expected. 
 
Scheme 2 Suggested mechanism of the Wipf cyclization 
Attempting to incorporate this methodology into our 
synthetic concept (Scheme 3) we came up with 
fragments 10 and 11, which should be connected via 
alkylation and then converted to furan 9 via Wipf 
cyclization. Seco-intermediate 9, in turn, would have to 
be transformed into the Horner-Wadsworth-Emmons 
(HWE)-precursor 12, and after macrocyclization be 
converted to vinyl iodide 13. Pd-catalyzed carbonylation 
would then serve to generate butenolide 14 which has 
finally to be elaborated into 1. 
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Scheme 3 Retrosynthetic analysis of 1 
3. First Generation Approach 
3.1 Synthesis of the Cyclobutane Moiety.  
We started with the synthesis of cyclobutane fragment 
11 in optically pure form.5a Known racemic bicyclic 
ketone 15 was chirally resolved via the diastereomeric 
ketals 16 and 17. The crystalline diastereomer 17 was 
isolated and cleaved to give enantiomerically pure (+)-15 
(Scheme 4). 
 
Scheme 4 Synthesis of nonracemic ketone 15 
In a second approach we used enzymatic resolution 
(Scheme 5). Chloroacetate 19 was hydrolyzed with 
lipase to give (+)-18 in 24h with >95% ee, whereas 
acetate 20 required 14 days! With multigram quantities 
of (+)-18 in hand we went for the preparation of 
fragment 11 (Scheme 6). TIPS-protection of the 
secondary alcohol followed by ozonolysis/reduction 
gave diol 21. The differentiation of the primary OH-
functions turned out to be cumbersome, until we found 
that treatment of diol 21 with one equivalent of MMTrCl 
furnished an easily separable 4:1-mixture of the mono-
tritylated derivatives 22 and 23, respectively. 22 was 
oxidized to the aldehyde which was in situ converted to 
the trans-diastereomer 24 by base catalyzed 
epimerization. Reformatsky reaction with bromoacatete 
followed by oxidation furnished ketoester 11 in excellent 
overall yield. Regioisomer 23 was recycled to 21 by 
MMTr-removal. 
 
Scheme 5 Lipase catalyzed chiral resolution of alcohol 18 
 
Scheme 6 Synthesis of the cyclobutane fragment 11 
      3.2 Western Fragment. 
For the synthesis of the western fragment 10 (Scheme 7) 
we started from (S)-malic ester 25 which was 
transformed into the protected diol 26. Conversion of the 
ester into the Weinreb amide was followed by addition 
of methylmagnesium bromide to furnish the methyl 
ketone. Addition of alkyne 27 generated the tertiary 
alcohol 28 as an inconsequential diastereomeric mixture. 
O-Benzoylation proved difficult and could only be 
achieved by means of Vedejs’ protocol.7 Removal of the 
PMB-group led to alcohol 29, which was iodinated to 
10. 
 
Scheme 7 Synthesis of the propargylic iodide 10 
3.3 Combination of Both Fragments and Ring 
Closure via HWE. 
Now the stage was set for the connection of both 
fragments by alkylation of the keto ester 11 with 
propargyl iodide 10 (Scheme 8). In fact, compound 30 
was obtained in 85% yield. Wipf-cyclization gave a 
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quantitative yield of a 1:1-mixture of E- and Z-propenyl 
furan which was equilibrated to the E-isomer 31 by 
reversible addition/elimination of phenylselenyl radical. 
Detritylation with hexafluoro-isopropanol (HFIP) and 
oxidation of the primary alcohol gave the aldehyde 
which was converted to keto-phosphonate 32 in two 
steps. The primary TBS-ether was desilylated selectively 
and the resulting alcohol was oxidized to aldehyde 33. 
HWE-macrocyclization with n-butyllithium in HFIP 
under high dilution conditions proceeded in moderate 
yield to furnish the providencin skeleton 34. 
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Scheme 8 Successful Ring closure via HWE cyclization of keto 
phosphonate 33 
From 34, several steps were envisaged to complete the 
synthesis (Scheme 9). Thus, a sequence of α-iodination, 
Luche reduction of the ketone and deprotection should 
provide 35 as a suitable substrate for palladium mediated 
carbonylation to give butenolide 36. From there six more 
steps should lead to 1. 
 
Scheme 9 Planned endgame 
4. Second Generation Approach via RCM 
As a backup we initiated a second approach which was 
centered around a RCM reaction8 of intermediate 38 
which should produce 36 directly (Scheme 10). 38 in 
turn should be formed via an aldol type addition2d of 
lactone 39 to aldehyde 40, which was to be elaborated 
from intermediate 11. 
 
Scheme 10 Retrosynthetic analysis via RCM 
Selenolactone 39 was prepared (Scheme 11) from (R)-
glycidyl tosylate (41) via cuprate addition to furnish 
alcohol 42, which was converted into epoxide 43 under 
retention of configuration. In situ treatment with the 
dianion of phenylselenyl acetic acid2d furnished hydroxyl 
acid 44 which was cyclized to 39 under acidic 
conditions. 
 
Scheme 11 Synthesis of seleno lactone 39 
The synthesis of compound 40 started with the alkylation 
of 11 to give 45, which was cyclized to vinyl furan 46. 
Detritylation and Swern oxidation gave aldehyde 40 
which was treated with deprotonated lactone 39 to give 
the aldol adduct 47 as a mixture of four diastereomers. 
Oxidative elimination of the selenide led to seco 
intermediate 38 as a mixture of two epimers. Grubbs II 
catalyst mediated RCM furnished macrocycles 48a,b as 
a readily separable diastereomeric 1:1-mixture. All 
attempts to invert Z-olefins 48 to the E-isomers failed. 
Therefore it was decided to proceed with the formation 
of the epoxides. Hence, alcohol 48a was converted to 
acetate 49, whose reaction with hydrogen peroxide under 
basic conditions gave a diastereomerically pure 
compound which we thought to be epoxy alcohol 50. 
Treatment with acetic anhydride, however, failed to 
produce the expected acetate, and furnished ketone 51 
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instead (Schemes 12-14), which was unambiguously 
characterized by its 1H and 13C NMR spectra. 
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Scheme 12 Synthesis of RCM-seco precursor 38 
 
Scheme 13 Successful RCM of precursor 38 
 
Scheme 14 Unexpected result of the Scheffer-Weitz-epoxidation of 
butenolide 49 
After some consideration the following mechanism was 
devised (Scheme 15). 1,4-Addition of hydroperoxide 
anion to 49 led to 52 under elimination of acetate. A 
second 1,4-attack of the hydroperoxide anion generated 
epoxy hydroperoxide 53, which we had mistaken for 
alcohol 49. Treatment with acetic anhydride led to 
intermediate 54 which eliminated acetic acid under the 
basic conditions to give ketone 51 eventually. 
 
Scheme 15 Suggested mechanism of the epoxidation of 49 
In contrast, when acetate 49 was treated with NaOCl, 
epoxy acetate 55 was formed smoothly (Scheme 16). 
 
Scheme 16 Uneventful epoxidation of 49 with NaOCl 
Next, the second epoxide was introduced 
stereoselectively with mCPBA to give bis-epoxide 56. 
Various methods were tried to achieve inversion of the 
trans-epoxide to the cis-isomer (Scheme 17). For 
instance, addition of PBu3 and subsequent Wittig 
elimination9 to form 57 failed. On the other hand, acid 
induced conversion of 56 into diol 58 under inversion of 
configuration was achieved without problems, however, 
the Corey-Winter-deoxygenation protocol10 to obtain the 
trans-olefin was totally unsuccessful, as not even 
thiocarbonate 59 could be formed. 
 
 
Scheme 17 Unsuccessful attempts to invert the configuration of the 
7,8-epoxide in 55 
In another attempt to switch to the trans-series, Z-olefin 
49 was converted into bromohydrin 60 stereoselectively 
(Scheme 18). Swern-oxidation smoothly gave ketone 61, 
which was reduced with sodium borohydride to form 
diastereomerically pure bromohydrin 62. However, the 
attempt to eliminate HBr under formation of the trans-
epoxide, failed. Instead, HBr-elimination furnished 
ketone 64 as an epimeric mixture, presumably via an E2-
type mechanism generating enol 63 first.  
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Scheme 18 Further attempts to invert the 7,8-cis-configuration 
. 
5. Cyclobutane Model studies 
It was our permanent concern how to introduce the 
allylic OH-function onto the cyclobutane ring (Figure 4). 
 
Figure 4 Problem of allylic oxidation 
Therefore, model studies were undertaken from the very 
beginning (Scheme 19). For instance, racemic ketone 15 
was converted into the TBS-enol ether 65 and then 
treated with AD-mix. To our surprise, diol 68 was the 
only product. We speculate that the primary adduct 66 
undergoes a retro-[2+2] cycloaddition to form 
cyclopentadiene, which undergoes in situ dimerization. 
The dimer is then dihydroxylated to give 68. Another 
attempt was made with Davis’ oxaziridine.11 However, 
on deprotonating 15 with LDA, a rapid aldol 
dimerization to 69 was observed. 
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Scheme 19 Unsuccessful attempt to introduce a second oxygen onto 
the cyclobutane ring 
 
Scheme 20 Unexpected formation of the caged lactone 84 
Another option for introducing the desired OH-function 
was hydroboration/reduction of enolsilane 65 (Scheme 
20). Hence, treatment of 65 with 9-BBN furnished diol 
70 which was OPMB-protected to 71 and then subjected 
to ozonolysis/reduction. Presumably, di-aldehyde 72 was 
formed first which under loss of the OTBS-group 
cyclized to the stable hemiacetal 73. PCC-oxidation 
furnished lactone 74. 
 
Scheme 21 Synthesis of oxygenated cyclobutane derivatives 
To continue in the synthesis (Scheme 21), lactone 74 was 
converted into methyl acetal 75 and then reduced to the 
labile aldehyde 76. On treatment with the Bestmann-
Ohira reagent,12 76 was partially epimerized under the 
basic conditions and gave a mixture of alkynes 77/78. 
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However, the bicyclic system of 77 was so stable, that all 
attempts to open the acetal cage resulted in destruction 
of the material. To avoid this problem (Scheme 22), 65 
was converted into diol 79, which was monotritylated to 
a separable mixture of regioisomers 80 and 81. 
Compound 81 was oxidized to the aldehyde, epimerized 
and converted into isomerically pure alkyne 82. Chain 
elongation with epoxide 83 gave diol 84, which was 
transformed into allylic alcohol 85 via the epoxide. 
Benzoylation furnished 86, which was detritylated, 
oxidized to the aldehyde and then subjected to an aldol 
addition with lactone 39 to give diene 87 in 47% overall 
yield. However, all attempts to use 87 in a RCM reaction 
failed. Even delinearizing the alkyne moiety by 
converting 87 into cobalt complex 88 did not help 
(Scheme 23). 
6. Conclusion.  
In conclusion, the characteristic fragments of 
providencin, namely the furan, cyclobutane and the 
butenolide rings, have been prepared and assembled in a 
linear arrangement. The ring closure has turned out to be 
the bottleneck of the synthesis, undoubtedly due to the 
ring strain exerted by the trans-configuration of the 7,8-
olefin. The corresponding Z-olefin can be generated 
smoothly by RCM, however, inversion to the E-
geometry has been unsuccessful thus far. This called for 
alternative strategies which are focused on the 
installation of an (E)-double bond prior to closing the 
macrocycle. Alternative efforts to close the macrocyclic 
ring by RCM have been unsuccessful and show the 
limitations of this method, however a macrocyclic 
derivative devoid of the butenolide ring has been 
prepared by HWE ring closure. Although the missing 
butenolide has yet to be annulated, we are confident to 
complete the synthesis along this route. 
 
Scheme 22 Synthesis of 87 as another RCM precursor 
 
Scheme 23 Unsuccessful RCM attempts with 87 
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TITLE : SYNTHESIS OF THE CYCLOBUTANE MOIETY OF 
PROVIDENCIN (MS WORD STYLE “01 HET-TITLE”) 
Tanja Gaich,1 Vladimir Arion, 2 and Johann Mulzer1* (MS Word Style “02 
Het-Author’s name”) 
1 Institute for Organic Chemistry, University of Vienna, Waehringerstrasse 38, 
A-1090 Wien, Austria, 2 Institute of Bioinorganic Chemistry,  University of 
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Abstract –A short and stereoselective synthesis of the protected cyclobutane diol 
moiety of the natural compound providencin is reported. Key step is the chemo- 
and stereoselective hydroboration of the silyl-enol ether obtained from 
commercially available bicyclo[3.2.0]hept-6-en-2-one. (MS Word Style “04 
Het-Abstract”)
INTRODUCTION (MS Word Style “06 Het-Sub-heading”) 
Quite recently, the diterpene providencin ((+)-1)1 was isolated from the gorgonian octocoral 
Pseudopterogorgia kallos, featuring an uncommon furyl cyclobutane ring system. The synthesis of highly 
functionalized cyclobutanes still represents a challenge for synthetic chemists, as substituents and 
functional groups attached to the cyclobutane ring are highly congested and the ring-geometry forces them 
into a fully eclipsed conformation2. The cyclobutane ring in 1 is trans-fused to the 13-membered 
macrocycle. Furthermore it exhibits an exo-methylene group with an allylic alcohol. In our retrosynthetic 
analysis we planned to introduce this allylic alcohol via an α-hydroxylation of commercially available 
non-racemic bicyclo[3.2.0]cyclo-hept-6-en-2-one (3) (Figure 1).  
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The use of 3 has the big advantage to provide us, not only the cyclobutanone ring, but to give after 
ozonolysis, two differentiable carbon appendages of suitable length for further elaboration. The 
cis-stereochemistry of the two carbon chains originates from bicycle 3 and was to be inverted to the desired 
trans-relation as shown in figure 1. In our current studies, racemic 3 was used to keep costs low. 
 
RESULTS AND DISCUSSION 
We tried various methods for the α-hydroxylation of bicyclic structure 3.3,4 Unfortunately we either got 
decomposition of starting material, or unwanted side products. For instance, after converting 3 into the silyl 
enol ether 4, reaction with osmium tetroxide did not lead to α-hydroxylation. Instead compound 5 was 
isolated, obviously resulting from a sequential dihydroxylation retro-[2+2]–cycloaddition to give glycolic 
ester 7 and cyclopentadiene, which immediately undergoes Diels-Alder dimerization (8) /dihydroxylation 
to 5 (Scheme 1).  
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As we could not introduce the hydroxyl group by α-hydroxylation, we tried a hydroboration of 4 with 
9-BBN. To our delight, the desired diol 9 was formed in 52% yield (Scheme 2). The reaction not only 
established a trans-configuration of the diol, but also allowed complete differentiation of the two 
hydroxy-groups, as the former enol ether was converted to a TBS-protected alcohol and the free hydroxy 
group was protected as PMB ether 10. 
Next we aimed for cleaving the cyclopentene ring and inverting the configuration at C-3. To differentiate 
the two aldehyde functions resulting from ozonolysis we removed the TBS group to obtain 11 and hoped 
for an intramolecular lactol formation to give 13 from di-aldehyde 12. However, the lactol OH function in 
13 immediately added to the second aldehyde group to give 14 instead (Scheme 2).  
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This result is a nice illustration for the ease of transannular reactions in this bicyclic system. For further 
differentiation of the two acetals, we converted lactol 14 with PCC to lactone 15 in 35% yield. To 
corroborate the structure of 14 we performed an analogous sequence with dichloro-compound 16 (Scheme 
3). In this case, lactol 17 crystallized nicely and we were able to confirm the cage structure via single crystal 
diffraction (Figure 2). 
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Figure 2. Crystal structure of compound 17 
 
 
To avoid the low yielding oxidation of 14 we decided to prevent the double acetalization of 13 and used the 
doubly silylated diol 18 in the ozonolysis step. 
 
This time we used a reductive work up to get diol 19a. To our delight we found that mono-tritylation 
furnished 19b and 19c with 5:1 regioselectivity, The regioisomers were easily separated by column 
chromatography. Oxidation of 19b to the aldehyde and base catalyzed isomerization to the trans isomer 20 
proceeded smoothly in 92% yield with 9:1 diastereomeric excess (Scheme 4). Evidence for this 
isomerization has been found in the 1H NMR spectrum. The signal of the aldehyde-H changes its position 
from 9.67 to 9.74 ppm. By detritylation with formic acid, 19c could be recycled to 19a so that no material 
was lost. 
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In conclusion we have developed a stereoselective and short approach to the tetrasubstituted cyclobutane 
moiety of providencin 1.(MS Word Style “05 Het-Text”) 
EXPERIMENTAL 
Analytical data of key intermediates: 
Compound 4 (Bicyclo[3.2.0]hepta-2,6-dien-6-yloxy) (tert-butyl)dimethylsilane): 
To a solution of 3 (1.00 g, 9.24 mmol, 1eq.) in 40 mL dry THF at -78°C was slowly added TBSOTf (6.4 mL, 
27.7 mmol, 3eq.). To this mixture at -78°C was rapidly added LiHMDS (1M in hexane, 46 mL, 46 mmol, 
5eq.). The reaction mixture was stirred for one hour at -78°C, and then quenched with saturated NH4Cl 
solution and extracted two times with diethylether (100 mL). The combined organic layers were dried over 
MgSO4 and the solvents were removed under reduced pressure. The crude product was filtered over silica 
gel with (hexane/ethylacetate 20:1 and 5% triethylamine) and was then further purified via a bulb to bulb 
distillation to yield 95% 1.95 g of pure 4.   
1H-NMR:  5.90-5.85 (m, 1H), 5.62-5.57 (m, 1H), 4.99 (s, 1H), 3.51-3.44 (m, 1H), 3.25-3.20 (m, 1H), 
2.46-2.17 (m, 2H), 0.95 (s, 9H), 0.19 (s, 6H). 13C-NMR:  134.97, 130.52, 111.52, 49.09, 45.52, 30.77, 
26.04, -4.17, -4.33. HRMS (EI) m/z calcd for C13H22OSi 222.3987, found 222.3982. 
 
Compound 5 (4,7-Methano-1H-indene-5,6-diol, 3a,4,5,6,7,7a-hexahydro-, (3a,4,5,6,7,7a): 
To a solution of 4 (743 mg, 3.3 mmol, 1eq.) in tBuOH:H2O (1:1, 30 mL) at 0°C was added OsO4 ( 4 mg, 
0.016 mmol, 0.5mol%) and N-morpholine-N-oxid (390 mg, 3.3 mmol, 1eq.). The reaction mixture was 
stirred for 20 hours, quenched with an aqueous sodium thiosulfate solution, and extracted two times with  
diethylether (50 mL). The combined organic layers were washed with brine and dried over MgSO4. The 
solvents were removed under reduced pressure. Crude 5 was purified by chromatography (silica gel, 
hexane/ethyl acetate 1:1) to yield 488 mg 89% of pure 5.   
1H-NMR:  5.45-5.37 (m, 2H), 3.61 (d, J = 5.38 Hz, 1H), 3.52 (d, J = 5.56 Hz, 1H), 2.94-2.88 (m, 1H), 
2.69-2.59 (m, 2H OH broad), 2.42-2.35 (m, 1H), 2.15-2.06 (m, 3H), 1.92 (d, J = 4.29 Hz, 1H), 1.70-1.67 (m, 
1H), 116-1.12 (m, 1H). 13C-NMR:  131.33, 131.13, 71.81, 70.19, 51.29, 48.47, 46.87, 40.92, 35.35, 32.35. 
HRMS (EI) m/z calcd for C10H14O2 166.2170, found 166.2178. 
 
Compound 9 (7-(tert-butyldimethylsilyloxy)bicyclo[3.2.0]hept-3-en-6-ol): 
To a solution of 4 ( 743 mg, 3.3 mmol, 1eq.) in dry THF (7 mL) at 0°C was added 9-BBN (0.5M in THF 6.6 
mL, 1eq.). The reaction mixture was warmed to room temperature and stirred for 14 hours. The reaction 
was quenched with 3mL 0.5M NaOH and 1mL H202 (30%), diluted with brine and extracted two times with 
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diethylether (50 mL). The combined organic layers were dried over MgSO4 and the solvents were removed 
under vacuum. Crude 9 was purified by flash column chromatography (hexane/ethylacetate 3:1) to yield 
412 mg 52% of pure 9. 
1H-NMR:  5.79-5.72 (m, 2H), 4.11 (dd, J = 8.96, 4.92 Hz, 1H), 3.59-3.56 (m, 1H), 2.96-2.88 (m, 1H), 
2.67-2.60 (m, 2H), 2.25-2.17 (m, 1H), 0.83 (s, 9H), 0.01 (s, 3H), 0.00 (s, 3H). 13C-NMR:  134.46, 131.79, 
84.38, 74.59, 49.47, 37.69, 26.24, -4.47. (HRMS (EI) m/z calcd for C13H24O2Si 240.4140, found 240.4133. 
 
Compound 10 (tert-butyl(-7-(4-methoxybenzyloxy)bicyclo[3.2.0]hept-2-en-6-yloxy)dimethylsilane): 
To a solution of alcohol 9 ( 2.1 g, 8.7 mmol, 1eq.) in dry DCM (10 mL) was added a solution of Bundles 
reagent ( 5 g, 17.5 mmol, 2eq.) in hexane (30 mL) and cooled to 0°C. Then 20 mg of camphor sulfonic acid 
were added and the reaction mixture was stirred over night. The reaction was quenched with saturated 
NaHCO3 solution, and extracted two times with diethylether (100 mL). The combined organic layers were 
washed with brine and dried over MgSO4. Solvents were removed under reduced pressure and crude 10 was 
purified by column chromatography (silicagel, hexane/ethylacetate 7:1) to yield 1.63 g 52% of pure 10.   
1H-NMR:  7.30-7.26 (m, 2H), 6.92-6.88 (m, 2H), 5.83-5.79 (m, 1H), 5.76-5.71 (m, 1H), 4.44 (s, 2H), 3.83 
(s, 3H), 3.49-3.45 (m, 1H), 3.09-2.96 (m, 1H), 2.81-2.69 (m, 2H), 2.38-2.24 (m, 1H), 0.94 (s, 9H), 0.10 (s, 
3H), 0.09 (s, 3H). 13C-NMR:  159.71, 134.31, 131.75, 129.82, 129.61, 114.27, 91.22, 74.59, 73.18, 55.86, 
49.47, 37.69, 26.24, 18.43, -4.51. HRMS (EI) m/z calcd for C21H32O3Si 360.5625, found 360.5620. 
 
Compound 14 2-(4-methoxybenzyl)oxy-4,9-dioxatricyclo[3.2.2.03,7]nonan-8-ol: 
Ozone was bubbled through a solution of 11 (219 mg, 0.89 mmol, 1eq.) in DCM/MeOH 4:1 (5 mL) at 
-78°C for 10 minutes. To remove unreacted ozone, air was subsequently bubbled through the reaction 
mixture at the same temperature for 5 minutes. Then thiourea (71 mg, 0.93 mmol, 1.05 eq.) was added and 
the reaction was warmed to room temperature. The solid was filtered off, the solvents were removed under 
reduced pressure and crude 14 was submitted to flash column chromatography (silicagel, hexane/ethyl 
acetate 2:1) to yield 200 mg 81% of pure 14. 
1H-NMR:  7.30-7.21 (m, 2H), 6.90-6.82 (m, 2H), 5.67-5.54 (m, 1H), 5.17 (s, 1H), 4.63-4.35 (m, 3H), 3.78 
(s, 3H), 3.51-3.22 (m, 1H), 3.06-2.91 (m, 1H), 2.75-2.69 (m, 1H), 2.64-2.55 (m, 1H), 1.55-1.45 (m, 1H). 
HRMS (EI) m/z calcd for C15H18O5 278.3004, found 278.2999. 
 
Compound 15 2-(4-methoxybenzyl)oxy-4,9-dioxatricyclo[3.2.2.03,7]nonan-3-one 
Lactol 14 ( 200 mg, 0.72 mmol, 1eq.) was dissolved in dry DCM (12 mL) at 0°C. The PCC (170 mg, 0.8 
mmol, 1.2 eq.) was added. After 30 minutes another portion of PCC (240 mg, 1.21 mmol, 1.7 eq.) was 
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added and a last portion of PCC ( 240 mg, 1.21 mmol, 1.7 eq.) was added after 2 hours. The reaction was 
then stirred for 24 hours, quenched with saturated NaHCO3 solution, and extracted two times with 
diethylether (50 mL). The combined organic layers were washed with brine and dried over MgSO4. 
Solvents were removed under reduced pressure and crude 15 was purified by column chromatography 
(silicagel, hexane/ethyl acetate 2:1) to yield 70 mg 35% of pure 15.   
1H-NMR:  7.32-7.26 (m, 2H), 6.94-6.89 (m, 2H), 5.99 (dd, J = 3.08, 1.03 Hz, 1H), 4.62-4.46 (m, 3H), 3.93 
(s, 1H), 3.83 (s, 3H), 3.66-3.59 (m, 1H), 3.28-3.24 (m, 1H), 2.11-2.04 (m, 1H), 2.00-1.91 (s, 1H). HRMS 
(EI) m/z calcd for C15H16O5 276.2845, found 276.2855. 
 
Compound 17 (5,5-Dichloro-2,9-dioxatricyclo[3.2.2.03,7]nonan-3-ol): 
See procedure for compound 14. 
1H-NMR:  5.70 (dd, J = 3.48, 0.50 Hz, 1H), 5.41 (s, 1H), 4.76-4.73 (m, 1H), 3.62-3.58 (m, 1H), 3.26-3.22 
(s, 1H OH, broad), 3.19 (ddd, J = 7.39, 4.47, 1.57 Hz, 1H), 2.78 (d, J = 12.28 Hz, 1H), 1.70 (ddd, J = 12.14, 
4.16, 4.16 Hz, 1H)  13C-NMR:  101.60, 90.31, 88.38, 82.36, 56.06, 35.22, 31.26. HRMS (EI) m/z calcd for 
C7H8Cl2O3 211.0426, found 211.0420. 
 
Compound 19a ((3-(tert-butyldimethylsilyloxy)-2-(triisopropylsilyloxy)-4-(2-(trityloxy)ethyl)- 
cyclobutyl)methanol): 
Ozone was bubbled through a solution of 18 (385 mg, 1.0 mmol, 1eq.) in DCM/MeOH 4:1 (7 mL) at -78°C 
for 10 minutes. To remove unreacted ozone air was bubbled through the reaction mixture at the same 
temperature for 5 minutes. Then NaBH4 (71 mg, 2.0 mmol, 2 eq.) were added and the reaction was warmed 
to room temperature. The reaction was then stirred for 2 hours, quenched with saturated NH4Cl solution, 
and extracted two times with diethylether (50 mL). The combined organic layers were washed with brine 
and dried over MgSO4. Solvents were removed under reduced pressure and crude 19a (330 mg, 0.76 mmol, 
1eq.) was directly used in the next step. 19a was dissolved in dry DCM (15 mL) cooled to 0°C and pyridine 
(250µl, 2.28 mmol, 3eq.) were added at that temperature. To this solution was added dropwise tritylchloride 
in dry DCM (2 mL) and the reaction was stirred over night. The mixture was quenched with brine and 
extracted two times with diethylether (50 mL). The combined organic layers were washed with brine and 
dried over MgSO4. Solvents were removed under reduced pressure and crude product was purified by flash 
column chromatography (silicagel, hexane/ethyl acetate 7:1) to yield 267 mg 52% of 19b and 41 mg 8% of 
19c 35% of pure 15.   
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1H-NMR:  7.54-7.25 (m, 15H), 4.00-3.62 (m, 4H), 3.37-3.14 (m, 2H), 2.34 (ddd, J = 16.9, 8.79, 4.23 Hz, 
1H), 2.08-1.94 (m, 2H), 1.76-1.61 (m, 1H), 1.69 (s, broad 1H), 1.12 (s, 21H), 0.95 (s, 9H), 0.11 (s, 3H), 0.05 
(s, 3H). HRMS (EI) m/z calcd for C41H62O4Si2 675.0996, found 675.0989. 
 
Compound 20 (3-(tert-butyldimethylsilyloxy)-2-(triisopropylsilyloxy)-4-(2-(trityloxy)ethyl)- 
cyclobutanecarbaldehyde): 
Alcohol 19b (175 mg, 0.26 mmol, 1eq.) was dissolved in ethyl acetate (3 mL) and IBX (218 mg, 0.78 mmol, 
3eq.) was added. The suspension was refluxed for 2 hours, and then cooled to room temperature and the 
solid was filtered off. The organic layer was concentrated, re-dissolved in MeOH (10 mL) and K2CO3 (361 
mg, 2.6 mmol, 10eq.) was added to the solution. The reaction was stirred for 1.5 hours, diluted with 
diethylether, the solids filtered off, and extracted with saturated NH4Cl solution. The combined organic 
layers were washed with brine and dried over MgSO4. Solvents were removed under reduced pressure and 
crude 20 was purified by flash column chromatography (silicagel, hexane/ethyl acetate 7:1) to yield 152 mg 
87% of pure 20. 
1H-NMR:  9.74 (t, J = 1.37 Hz, 1H), 4.13-4.05 (m, 1H), 3.77-3.71 (m, 1H), 3.53 (dd, J = 9.50, 4.23 Hz, 1H), 
3.17-3.05 (m, 1H), 2.86 (t, J = 10.16 Hz, 1H), 2.46-2.18 (m, 2H), 1.02 (s, 21H), 0.89 (s, 9H), 0.10 (s, 3H), 
0.07 (s, 3H). HRMS (EI) m/z calcd for C22H45O3Si2 413.7619, found 413.7611. 
 
Crystal Data of Compound 17. 
Symmetry cell setting monoclinic, symmetry space group P21, a =5.9039(2), b= 10.8209(4), c= 6.4507(2), 
alpha =90.00, beta =90.510(2), gamma = 90.00, V = 412.09(2), Z = 2, density calc  = 1.710,  
T = 373 K, diffrn radiation wavelength  0.71073 ,diffrn radiation type MoKα, graphite,  diffrn reflns 
number 15712, diffrn reflns av R equivalents 0.0202, diffrn reflns av_sigmaI/netI 0.0128, diffrn reflns limit 
h min 8, diffrn reflns limit h max 8, diffrn reflns limit k min -15, diffrn reflns limit k max 15, diffrn reflns 
limit l min 9, diffrn reflns limit l max 9, diffrn reflns heta min 3.16, diffrn reflns theta max 30.02, reflns 
number total 2409, reflns number gt 2379, reflns threshold expression >2sigma(I), computing structure 
solution  SHELXS-97 (Sheldrick, 1990),' computing structure refinement SHELXL-97 (Sheldrick, 1997).'  
Refinement of F^2^ against ALL reflections. The weighted R-factor wR and goodness of fit S are based on 
F^2^, conventional R-factors R are based on F, with F set to zero for negative F^2^. The threshold 
expression of F^2^ > 2sigma(F^2^) is used only for calculating R-factors(gt) etc. and is not relevant to the 
choice of reflections for refinement. R-factors based on F^2^ are statistically about twice as large as those 
based on F, and R-factors based on ALL data will be even larger. Refine ls number reflns 2409, refine, ls 
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number parameters 111, refine ls number restraints 1, refine ls R factor all 0.0161, refine ls R factor gt 
0.0158, refine ls wR factor ref 0.0427, refine ls wR _factor gt 0.0424, refine ls goodness of fit ref 1.069. 
Abbreviations: TBSOf tertButyldimethylsilyltriflate, LiHMDS lithium hexamethyldisilazide, DCM 
dichloromethane, PCC pyridinium chlorochromate, IBX o-iodoxy-benzoxy acid. 
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Abstract: A synthetical approach to assemble the uncommon 
furylcyclobutane substructure in providencin ((+)-1) has been 
developed starting from a commercially available cyclobutane 
precursor. 
Key words: Furan - Cyclization - Natural product - Stereose-
lective synthesis - Total synthesis. 
The abundance of variably functionalized furans in 
biologically active compounds has stimulated consi-
derable synthetic interest.1 Hence, a variety of me-
thods have been devised to assemble furan interme-
diates.2 to Furanocembranes have received particular 
attention (Figure 1), because they are effective against 
various cancer types, reveal analgesic or anti-
inflammatory activity, or display potent neuro- and 
cytotoxic properties.3 Most notable contributions 
came from the groups of Paquette, Marshall, Wipf, 
and Pattenden,4 who developed "furan first"5 or "furan 
last" strategies, depending on the stage at which the 
furan moiety was introduced into the carbon skeleton. 
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Figure 1 Examples of furanocembranolides isolated from marine 
invertebrates. 
Quite recently, the diterpene providencin ((+)-1)6 was 
isolated from the gorgonian octocoral Pseudoptero-
gorgia kallos, featuring an uncommon furyl cyclobu-
tane ring system. Bray and Pattenden lately reported a 
photochemical access to the furyl cyclobutane seg-
ment of 1.7 We also envisaged a "furan first" strategy 
for the synthesis of 1 starting from a readily available 
cyclobutane. Thus, the deoxy compound 2 would 
serve as a late stage key intermediate, which might be 
accessible via metathesis and Horner-Wadsworth-
Emmons (HWE) olefination from the cyclobutyl furan 
4 (Scheme 1). 
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Scheme 1 Retrosynthetic considerations for the total synthesis of 
providencin ((+)-1). 
Fragment 4 can be further disconnected to aldehyde 5, 
in turn obtainable from the commercially available 
bicycloheptenone 6.  
First we had to develop methodology for attaching a 
highly substituted furan ring to the cyclobutane moie-
ty present in 5. After extensive experimentation, a 
Paal-Knorr type reaction turned out to be the method 
of choice. Therefore, in a preliminary model study, 
ethyl ester 7, obtained via Roskamp reaction8 from 2-
methylbutyraldehyde and commercially available 
ethyl diazoacetate, was alkylated with chloroacetone, 
leading to the 1,4-diketone 8. Microwave assisted 
cyclization led to furan 9 in excellent yield (Scheme 
2). Further functionalization by selective bromination 
at the less substituted α-position afforded furans 10–
12 as versatile intermediates for a variety of potential 
coupling reactions. 
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Scheme 2 Synthesis of the furans 9-12. Reagents and conditions: 
(a) ethyl diazoacetate, SnCl2, CH2Cl2, 25 °C, 4 h (97%); (b) chlo-
roacetone, NaH (60% in mineral oil), THF, 25 °C, 36 h (63%); (c) 
concd HCl, EtOH, microwaves, 100 °C, 8 min (98%); (d) NBS, 
AIBN, CCl4, 76 °C, 1 h (79%); (e) Me2SO, 190 °C, 10 min (45%); 
(f) Ph3PCH3Br, n-BuLi, THF, 0 °C to 25 °C, 12 h (55%). 
For the synthesis of furylcyclobutane 19 racemic bi-
cycloheptenone 6 was stereoselectively reduced to the 
alcohol and converted to the corresponding benzoate 
13. Ozonolysis of the double bond followed by reduc-
tive workup with NaBH4 afforded the diol 14 which 
was tritylated with TrCl to both monoprotected regioi-
somers 15 and 16 in a 4:1 ratio, separable by column 
chromatography. Bis-tritylated diol and unreacted 
starting material was recovered and recycled. Alcohol 
15 was oxidized to aldehyde 17 which was isomerized 
at C(1) with aqueous K2CO3 and then converted to the 
1,4-diketone 18 by using the protocol described in 
Scheme 3. Microwave irradiation led finally to the 
desired furan 19, under cleavage of the trityl protect-
ing group (Scheme 3). 
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Scheme 3 Synthesis of the C(1),C(2) trans-substituted furylcyclo-
butane 19. Reagents and conditions: (a) NaBH4, MeOH, –78 °C, 1 
h; (b) benzoyl chloride, pyridine, 0 °C to 25 °C, 4 h (97% over two 
steps); (c) i) O3, CH2Cl2, –78 °C, 20 min; ii) PPh3, 25 °C, 4 h 
(85%); (d) TrCl, NEt3, 4- dimethylamino-pyridine, CH2Cl2, 25 °C, 
18 h (15: 35%; 16: 9%); (e) Dess-Martin periodinane, NaHCO3, 
CH2Cl2, 25 °C, 3 h (87%); (f) 0.1 M K2CO3, MeOH, CH2Cl2, 25 
°C, 15 min (87%); (g) ethyl diazoacetate, SnCl2, CH2Cl2, 25 °C, 2 
h (73%); (h) chloroacetone, NaH (60% in mineral oil), THF, 25 °C, 
50 h (46%); (i) concd HCl, MeOH, CH2Cl2, microwaves, 100 °C, 
10 min (90%). 
For the synthesis of enantiomerically pure compounds 
bicycloheptenone 6 was reduced with NaBH4 and 
converted to the corresponding acetate. Digestion with 
lipase SAM-II afforded the undesired alcohol and the 
desired enantiomer as unreacted acetate, which was 
hydrolyzed with LiOH. The alcohol thus obtained can 
be benzoylated and further transformed as described 
for the racemate 13. 
To validate our approach towards the total synthesis of 
the providencin ((+)-1) macrolide, (R)-glycidol was 
tritylated to 20, and then treated with i-
propenylmagnesium bromide in the presence of CuI to 
give alcohol 21 which was protected as the PMB ether 
22. After detritylation alcohol 23 was formed and 
oxidized to aldehyde 24. In a parallel sequence, alco-
hol 16 was oxidized to aldehyde 25, which was con-
verted to β-ketophosphonate 27 and coupled with 
aldehyde 24 to give ketone 28, which was reduced to 
alcohol 29 and acetylated. After detritylation alcohol 
31 was obtained which was oxidized to aldehyde 32. 
Base catalyzed epimerization delivered aldehyde 33, 
which corresponds to the C14-C9-fragment of (+)-1. 
Roskamp reaction finally led to ketoester 34 (Scheme 
4). 
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Scheme 4 Synthesis of the fragment 34. Reagents and conditions: 
(a) TrCl, NEt3, 4-dimethylamino-pyridine, CH2Cl2, 0 °C to 25 °C, 
24 h (quant.); (b) i-propenylmagnesium bromide, CuI, THF, –78 
°C to –40 °C, 2 h (quant.); (c) i) PMBCl, NaH (60% in mineral 
oil), tetrabutyl ammonium bromide, THF, 25 °C, 1 h, 60 °C, 24 h; 
(d) p-TsOH, MeOH, 25 °C, 30 min (71%); (e) (COCl)2, Me2SO, 
NEt3, CH2Cl2, –78 °C, 1 h, 0 °C, 2 h (88%). (f) Dess-Martin peri-
odinane, NaHCO3, CH2Cl2, 25 °C, 3 h (95%); (g) MeP(O)(OMe)2, 
n-BuLi, THF, –78 °C, 6 h (84%); (h) Dess-Martin periodinane, 
NaHCO3, CH2Cl2, 25 °C, 2 h (78%); (i) NaH (60% in mineral oil), 
(–)-24, THF, –10 °C, 10 min, 25 °C, 2 h (92%); (j) NaBH4, 
CeCl3•7H2O, MeOH, –78 °C, 3 h (78%); (k) Ac2O, Et3N, 4-
dimethylamino-pyridine, CH2Cl2, 25 °C, 2 h (97%); (l) p-TsOH, 
MeOH, 25 °C, 2 h (81%); (m) Dess-Martin periodinane, NaHCO3, 
CH2Cl2, 25 °C, 2 h (85%); (n) 0.1 M K2CO3, MeOH, 25 °C, 15 min 
(66%); (n) ethyl diazoacetate, SnCl2, CH2Cl2, 25 °C, 2 h (79%). 
In conclusion, we have described the synthesis of the 
trans-fused furylcyclobutane moiety 34 of providen-
cin ((+)-1), starting from the commercially available 
cyclobutane derivative 6. Functionalization of the 
substituents at both the C(1) and C(2) position of the 
cyclobutane ring was possible, thus corroborating our 
strategy. Moreover, the synthesis of highly functiona-
lized furan derivatives provided versatile interme-
diates, which might be employed in a variety of coupl-
ing reactions. 
 
All 1H NMR (250 MHz or 400 MHz) and 13C NMR 
(63 MHz or 100 MHz) spectra were recorded on 
Bruker Avance DPX 250 or DRX 400 spectrometers. 
The chemical shifts are reported in δ values (ppm) 
relative to the solvent peak as internal standard. IR 
spectra were recorded as a film on NaCl plates with a 
Perkin-Elmer Spectrum 1600 Series FTIR spectrome-
ter. MS spectra were recorded on a Finnigan MAT 
8230 apparatus with a resolution of 10000. Products 
were purified by flash column chromatography (silica 
gel from Merck, 40–63 μm, 240–400 mesh). THF was 
distilled from sodium/benzophenone.  
 
General procedure for the microwave assisted fu-
ran cyclization 
The diketone (1.75 mmol) was dissolved in MeOH or 
EtOH (3 mL), then concd HCl (30 μL) was added and 
the mixture was subjected to microwave irradiation 
(Biotage Initiator) for 4–15 min at 100–120° C. Satu-
rated aq NaHCO3 soln (5 mL) was added and the mix-
ture was extracted with AcOEt (3 × 10 mL). The 
combined organic phases were washed with H2O (30 
mL) and brine (30 mL), dried over MgSO4, and con-
centrated in vacuo. 
 
2-sec-Butyl-5-methylfuran-3-carboxylic acid ethyl 
ester (9) 
SnCl2 (38 mg, 0.2 mmol), ethyl diazoacetate (126 μL, 
1.2 mmol) and isobutyraldehyde (107 μL, 1.0 mmol) in 
CH2Cl2 (2 mL) were stirred for 4 h. The mixture was 
quenched with sat. aqueous ammonium fluoride and 
extracted with Et2O. the organic layer was dried over 
MgSO4, evaporated and purified by chromatography 
(silicagel, hexane/AcOEt 3:1) to give ketoester 7 (171 
mg, quant.). as a colorless oil. 
IR: 2961, 2930, 2870, 1740, 1709, 1649, 1626, 1459, 
1406, 1368, 1307, 1224, 1171, 1148, 1125, 1095, 1027 
cm-1. 
1H NMR (250 MHz, CDCl3): δ = 0.93 (t, J = 7.4 Hz, 3 
H, H-C(1)), 1.13 (d, J = 7.0 Hz, 3 H, H-C(4)), 1.30 (t, J = 
7.2 Hz, 3 H, H-C(7)), 1.38–1.55 (m, 1 H, H-C(2)), 1.62–
1.84 (m, 1 H, H-C(2)), 2.53–2.68 (m, 1 H, H-C(3)), 3.49 
(s, 2 H, H-C(5)), 4.22 (q, J = 7.2 Hz, 2 H, H-C(6)).   
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13C NMR (63 MHz, CDCl3): δ = 11.8, 14.5, 15.8, 26.0, 
48.1, 48.4, 61.6, 167.7, 206.8.  
NaH ((60% suspension in mineral oil) (650 mg, 16.3 
mmol) and ketoester 7 (2.80 g, 16.3 mmol) in THF 
(20 mL) were stirred at 25°C for 1h. Chloroacetone 
(1.2 mL, 15.5 mmol) was added dropwise and the 
mixture was stirred at 25°C for 50h. Workup with 
water and ether furnished after chromatography (sili-
cagel, hexane/EtOAc 20:1) diketone 8 (2.24 g, 63%) 
as a colorless oil, which was used in the next step 
without further purification.  
Diketone 8 (400 mg, 1.75 mmol), EtOH (3 mL), and 
concd HCl (30 μL) were reacted according to general 
procedure A. The residue was purified by column 
chromatography on silicagel (hexane/AcOEt 20:1) to 
yield 9 as pale yellow oil (360 mg, 98%). 
IR: 2968, 2930, 1709, 1580, 1383, 1277, 1231, 1201, 
1064 cm-1. 
1H NMR (250 MHz, CDCl3): δ = 0.84 (t, J = 7.5 Hz, 3 
H), 1.23 (d, J = 6.9 Hz, 3 H), 1.33 (t, J = 6.9 Hz, 3 H), 
1.49–1.79 (m, 2 H), 2.24 (d, J = 0.9 Hz, 3 H), 3.45–
3.61 (m, 1 H), 4.24 (q, J = 6.9 Hz, 2 H), 6.20 (d, J = 
0.9 Hz, 1 H). 
13C NMR (63 MHz, CDCl3): δ = 12.3, 13.5, 14.7, 
18.9, 28.9, 34.2, 60.1, 106.4, 113.7, 150.1, 164.6, 
165.2. 
HRMS (EI) m/z calcd for C12H18O3: 210.1256, found: 
210.1258. 
 
5-Bromomethyl-2-sec-butylfuran-3-carboxylic acid 
ethyl ester (10) 
Methylfuran 9 (360 mg, 1.71 mmol), N-
bromosuccinimide (320 mg, 1.80 mmol), and azo-
bisisobutyronitrile (32 mg, 0.19 mmol) were dissolved 
in CCl4 (10 mL) and the reaction mixture was refluxed 
for 1 h. The succinimide was filtered off and the fil-
trate was concentrated in vacuo. The residue was puri-
fied by column chromatography on silica (hex-
ane/AcOEt 10:1) to afford 10 as a pale yellow oil (390 
mg, 79%). 
IR: 2968, 2930, 1709, 1611, 1558, 1216, 1057 cm-1.   
1H NMR (250 MHz, CDCl3): δ = 0.85 (t, J = 7.4 Hz, 3 
H), 1.26 (d, J = 6.9 Hz, 3 H), 1.33 (t, J = 7.1 Hz, 3 H), 
1.56–1.84 (m, 2 H), 3.49–3.62 (m, 1 H), 4.25 (q, J = 
7.1 Hz, 2 H), 4.44 (s, 2 H), 6.63 (s, 1 H). 
13C NMR (63 MHz, CDCl3): δ = 12.4, 14.6, 18.8, 
23.6, 28.8, 34.5, 60.5, 110.9, 114.6, 148.3, 167.1, 
167.7. 
HRMS (EI) m/z calcd for C12H17O3Br: 288.0361, 
found: 288.0332. 
 
2-sec-Butyl-5-formylfuran-3-carboxylic acid ethyl 
ester (11) 
Bromide 10 (40 mg, 0.14 mmol) was dissolved in dry 
dimethylsulfoxide (5 mL) and the solution was heated 
under reflux at 190 °C for 10 min, then H2O (20 mL) 
was added and the mixture was extracted with CH2Cl2 
(3 × 20 mL). The combined organic phases were 
washed with H2O (60 mL) and brine (60 mL), dried 
over MgSO4, and concentrated in vacuo. The residue 
was purified by column chromatography on silicagel 
(hexane/AcOEt 5:1) to yield 11 as pale yellow oil (14 
mg, 45%). 
IR: 2968, 2930, 1721, 1688, 1586, 1535, 1459, 1216, 
1057 cm-1. 
1H NMR (400 MHz, CDCl3): δ = 0.86 (t, J = 7.6 Hz, 3 
H), 1.31 (d, J = 7.2 Hz, 3 H), 1.36 (t, J = 7.2 Hz, 3 H), 
1.61–1.86 (m, 2 H), 3.62–3.71 (m, 1 H), 4.32 (q, J = 
7.2 Hz, 2 H), 7.47 (s, 1 H), 9.57 (s, 1 H). 
13C NMR (100 MHz, CDCl3): δ = 12.3, 14.6, 18.5, 
28.7, 34.9, 60.8, 110.6, 116.2, 150.7, 163.0, 172.3, 
177.6. 
HRMS (EI) m/z calcd for C12H16O4: 224.1049, found: 
224.1047. 
 
2-sec-Butyl-5-vinylfuran-3-carboxylic acid ethyl 
ester (12) 
Ph3PCH3Br (96 mg, 0.27 mmol) was dissolved under 
Ar in dry THF (2 mL) and the suspension was cooled 
to 0 °C. n-BuLi (2.5 M, 0.1 mL, 0.25 mmol) was 
added, the mixture was warmed to 25 °C, and stirred 
for 1 h before aldehyde 11 (50 mg, 0.22 mmol) in 
THF (3 mL) was added. The reaction mixture was 
stirred for 12 h at 25 °C, and treated with sat. aq Na-
HCO3 soln (10 mL) and extracted with Et2O (3 × 10 
mL). The combined organic phases were dried over 
MgSO4 and concentrated in vacuo. The residue was 
purified by column chromatography on silicagel (hex-
ane/AcOEt 20:1) to give 12 as pale yellow oil (27 mg, 
55%). 
IR: 2961, 2930, 2877, 1717, 1588, 1535, 1451, 1375, 
1209, 1057 cm-1. 
1H NMR (250 MHz, CDCl3): δ = 0.89 (t, J = 7.5 Hz, 3 
H), 1.30 (d, J = 7.1 Hz, 3 H), 1.37 (t, J = 7.2 Hz, 3 H), 
1.56–1.89 (m, 2 H), 3.52–3.68 (m, 1 H), 4.30 (q, J = 
7.2 Hz, 2 H), 5.19 (d, J = 11.3 Hz, 1 H), 5.66 (d, J = 
17.5 Hz, 1 H), 6.45 (dd, J = 17.5, 11.3 Hz, 1 H), 6.51 
(s, 1 H). 
13C NMR (100 MHz, CDCl3): δ = 12.4, 14.7, 18.9, 
29.0, 34.4, 60.4, 108.7, 113.0, 114.6, 124.9, 151.1, 
164.3, 166.3. 
HRMS (ESI) m/z calcd for C13H18O3: 222.1256, 
found: 222.1245. 
 
(1SR,5RS,6SR)-Bicyclo[3.2.0]hept-2-en-6-benzoate 
(13) 
A suspension of NaBH4 (870 mg, 23.0 mmol) in 
MeOH (75 mL) at –78 °C was treated dropwise with 
racemic bicycloheptenone 6 (4.9 mL, 46.0 mmol) in 
MeOH (25 mL). The mixture was stirred for 1 h at –
78 °C, warmed to 25°C and diluted with Et2O and 2 N 
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HCl. The organic layer was dried over MgSO4, con-
centrated and diluted with CH2Cl2 (50 mL) and pyri-
dine (7.5 mL, 92.0 mmol). Benzoyl chloride (7.5 mL, 
64.4 mmol) was added dropwise and the mixture was 
stirred at 25 °C for 4 h, quenched with H2O and ex-
tracted with CH2Cl2. The organic layer was washed 
with brine, dried over MgSO4 and concentrated to 
give after chromatography (silicagel, hexane/AcOEt 
10:1) benzoate 13 (9.6 g, 97% over 2 steps) as a color-
less oil.   
IR: 3056, 2939, 2850, 1716, 1602, 1585, 1491, 1452, 
1347, 1314, 1271, 1176, 1113, 1070, 1046 cm-1.   
1H -NMR (CDCl3, 250 MHz): δ = 1.90–2.01 (m, 1 H, 
H-C(2)), 2.50 (dd, J = 17.1 Hz, 9.8, 1 H, H-C(6)), 
2.60–2.73 (m, 1 H, H-C(6)), 2.88 (dt, J = 8.0, 2.2 Hz, 
1 H, H-C(2)), 3.10–3.23 (m, 1 H, H-C(3)), 3.36–3.50 
(m, 1 H, H-C(7)), 5.41–5.52 (m, 1 H, H-C(1)), 5.88 (s, 
2 H, H-C(4), H-C(5)), 7.46 (t, J = 7.6 Hz, 2 H, Ph), 
7.59 (t, J = 7.6 Hz, 1 H, Ph), 8.07 (d, J = 7.6 Hz, 2 H, 
Ph).   
13C NMR (63 MHz, CDCl3): δ = 33.1, 37.1, 41.3, 
41.7, 69.8, 128.7, 130.0, 130.1, 132.6, 133.2, 134.6, 
144.4.   
EI-HR-MS: m/z calcd for 214.0994 (M+, C14H14O2+, 
found:. 214.0991. 
 
(1SR,2RS,3RS)-2-(2-Hydroxyethyl)-3-
hydroxymethyl-cyclobutyl-benzoate (14) 
Olefin 13 (4.60 g, 21.5 mmol) in CH2Cl2 (30 mL) was 
treated at –78 °C with ozone for 20 min, then warmed 
to 0°C and diluted with MeOH (30 mL). Solid NaBH4 
(3.25 g, 85.9 mmol) was added in small portions and 
the mixture was stirred for 2 h at 0° C, quenched with 
2 N HCl and extracted with CH2Cl2. The organic layer 
was washed with brine, dried over MgSO4, evaporated 
and purified by chromatography (silicagel, AcOEt) to 
give 14 (4.6 g, 85% over 2 steps) as a colorless oil.   
IR: 3339, 2944, 2874, 1720, 1699, 1278, 1177, 1115, 
1071, 1050, 1025 cm-1.  
1H NMR (250 MHz, CDCl3): δ = 1.70–2.07 (m, 3 H, 
H-C(2), H-C(6)), 2.38–2.59 (m, 2 H, H-C(2), H-C(3)), 
2.83–2.99 (m, 1 H, H-C(7)), 3.52–3.67 (m, 2 H, H-
C(4)), 3.73–4.00 (m, 4 H, H-C(5), OH), 5.25–5.37 (m, 
1 H, H-C(1)), 7.38–7.48 (m, 2 H, Ph), 7.51–7.60 (m, 1 
H, Ph), 7.99–8.06 (m, 2 H, Ph).   
13C NMR (63 MHz, CDCl3): δ = 26.4, 30.9, 34.4, 
40.6, 62.8, 62.9, 69.4, 128.8, 129.9, 130.5, 133.5, 
166.5.   
ESI-MS: 273.0 m/z calcd for C14H18O4Na+ (MNa+), 
273.1103, found 273.1105. 
 
(1SR,2RS,3RS)-2-(2-Hydroxyethyl)-3-trityloxy-
methyl-cyclobutyl-benzoate (15) and 
(1SR,2RS,3RS)-3-Hydroxymethyl-2-(2-
trityloxyethyl)-cyclobutyl-benzoate (16) 
Tritylchloride (4.66 g, 16.6 mmol) in CH2Cl2 (15 mL) 
at 0 °C was treated with NEt3 (5.1 mL, 36.8 mmol) 
and 4-dimethylamino-pyridine (22 mg, 0.18 mmol). 
Diol 14 (4.60 g, 18.4 mmol.) in CH2Cl2 (60 mL) was 
added dropwise and the mixture was stirred for 18 h at 
25 °C. the mixture was quenched with aqueous 
NH4Cl, extracted with Et2O the organic layer was 
washed with brine, dried over MgSO4 concentrated 
and purified by chromatography (silicagel, hex-
ane/AcOEt 5:1, then 1:1) to give 15 ((1.63 g, 35%) 
and 16 (600 mg, 9%) as colorless oils.   
15: IR: 1716, 1490, 1449, 1314, 1275, 1176, 1112,, 
1070, 1026 cm-1.   
1H NMR (400 MHz, CDCl3): δ = 1.31 (t, J = 5.1 Hz, 1 
H, OH), 1.77–2.01 (m, 3 H, H-C(2), H-C(6)), 2.23–
2.34 (m, 1 H, H-C(3)), 2.43–2.52 (m, 1 H, H-C(2)), 
2.78–2.86 (m, 1 H, H-C(7)), 3.02 (dd, J = 15.0, 7.7 
Hz, 1 H, H-C(5)), 3.13 (dd, J = 15.0, 7.7 Hz, 1 H, H-
C(5)), 3.52–3.60 (m, 1 H, H-C(4)), 3.63–3.71 (m, 1 H, 
H-C(4)), 5.17 (q, J = 7.0 Hz, 1 H, H-C(1)), 7.07–7.19 
(m, 9 H, C(Ph)3), 7.29–7.35 (m, 8 H, Ph, C(Ph)3), 7.47 
(t, J = 8.1, 1 H, Ph), 7.85 (d, J = 8.1 Hz, 2 H, Ph).   
13C NMR (100 MHz, CDCl3): δ = 25.1, 31.5, 34.0, 
39.2, 63.2, 63.7, 69.1, 87.1, 127.4, 128.1, 128.8, 
129.0, 130.0, 130.6, 133.3, 144.6, 166.3.   
ESI-HRMS: m/z calcd for C33H32O4Na+ (MNa+) 
515.2198 , found 515.2196. 
16.  IR: 3456, 3060, 2938, 1717, 1699, 1601, 1490, 
1451, 1314, 1276, 1113, 1069, 1026 cm-1.  
1H NMR (400 MHz, CDCl3): δ =  1.43 (t, J = 5.7 Hz, 
1 H, OH), 1.60–1.81 (m, 2 H, H-C(6)), 1.85–2.00 (m, 
1 H, H-C(2)), 2.57–2.71 (m, 2 H, H-C(2), H-C(3)), 
2.91–3.03 (m, 1 H, H-C(7)), 3.21 (dd, J = 9.4, 7.8 Hz, 
1 H, H-C(4)), 3.32 (dd, J = 9.4, 5.3, 1 H, H-C(4)), 
4.83–4.64 (m, 2 H, H-C(5)), 5.29–5.40 (m, 1 H, H-
C(1)), 7.20–7.38 (m, 9 H, C(Ph) 3), 7.39–7.51 (m, 8 H, 
Ph, C(Ph)3), 7.53–7.63 (m, 1 H, Ph), 7.90–7.96 (m, 2 
H, Ph).   
13C NMR (100 MHz, CDCl3): δ = 27.7, 31.7, 32.3, 
39.2, 62.3, 64.3, 69.8, 87.2, 127.4, 128.2, 128.8, 
129.0, 129.9, 130.5, 133.4, 144.4, 166.3.   
ESI-HRMS: m/z calcd for C33H32O4Na+ 515.2198 
(MNa+), found 515.2189. 
 
(1SR,2RS,3RS)-3-Formyl-2-(2-trityloxyethyl)-
cyclobutyl-benzoate (17) 
Alcohol 15 (1.63 g, 3.31 mmol.) was treated with 
NaHCO3 (1.3 g, 14.9 mmol) and Dess-Martin-
periodinane (2.1 g, 4.96 mmol) in CH2Cl2 (30 mL) for 
2 h. The mixture was quenched with aqueous dithio-
nite and extracted with ether. The organic layer was 
washed with brine, dried over MgSO4, concentrated 
and purified by chromatography (silicagel, hex-
ane/AcOEt 10:1) to give aldehyde 17 (1.41 g, 87%) as 
a colorless oil. 
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IR: 3060, 3032, 2937, 2870, 2723, 1716, 1601, 1490, 
1449, 1386, 1314, 1274, 1224, 1177, 1153, 1115, 
1070, 1026, 1002 cm-1. 
1H NMR (400 MHz, CDCl3): δ = 1.86–2.08 (m, 2 H, 
H-C(6)), 2.43–2.55 (m, 1 H, H-C(2)), 2.65–2.78 (m, 1 
H, H-C(2)), 3.03–3.16 (m, 3 H, H-C(3), H-C(5)), 
3.35–3.53 (m, 1 H, H-C(7)), 5.29–5.43 (m, 1 H, H-
C(1)), 7.18–7.36 (m, 9 H, C(Ph)3), 7.38–7.47 (m, 8 H, 
Ph, C(Ph)3), 7.55–7.61 (m, 1 H, Ph), 7.95–7.97 (m, 2 
H, Ph), 9.71 (d, J = 1.9 Hz, 1 H, CHO).   
13C NMR (100 MHz, CDCl3): δ = 25.9, 27.9, 42.0, 
43.0, 62.5, 68.3, 87.1, 127.4, 128.2, 128.8, 129.0, 
130.0, 130.3, 133.5, 144.5, 166.2, 202.0.   
ESI-HRMS: m/z calcd for C33H30O4Na+ (MNa+) 
513.2042, found 513.2053. 
 
(1SR,2RS,3SR)-3-Formyl-2-(2-trityloxyethyl)-
cyclobutyl-benzoate (5) 
Aldehyde 17 (290 mg, 0.59 mmol) in CH2Cl2 (2 mL) 
was treated with a 0.1 M soln of K2CO3 in MeOH (10 
mL) according to general procedure B. The residue 
was purified by column chromatography on silicagel 
(hexane/AcOEt 7:1) to furnish 5 as a colorless oil (252 
mg, 87%). 
IR: 3059, 2946, 1709, 1595, 1489, 1451, 1307, 1277, 
1178, 1155, 1110, 1072, 1027 cm-1. 
1H NMR (CDCl3, 250 MHz): δ = 1.84–2.19 (m, 2 H), 
2.24–2.37 (m, 1 H), 2.63–2.81 (m, 1 H), 2.98–3.16 
(m, 3 H), 3.17–3.24 (m, 1 H), 5.27–5.39 (m, 1 H), 
7.20–7.33 (m, 9 H), 7.41–7.48 (m, 8 H), 7.50–7.60 
(m, 1 H), 8.01–8.09 (m, 2 H), 9.64 (d, J = 1.6 Hz, 1 
H). 
13C NMR (CDCl3, 63 MHz): δ = 27.6, 29.0, 39.3, 
47.2, 61.3, 69.3, 86.7, 127.0, 127.8, 128.4, 128.6, 
129.6, 129.9, 133.1, 144.0, 165.8, 201.4. 
HRMS (ESI): m/z calcd for C33H30O4Na+ (MNa+): 
513.2042, found: 513.2053. 
 
(1SR,2RS,3SR)-3-(2-Ethoxycarbonyl-4-
oxopentanoyl)-2-(2-trityloxyethyl)-
cyclobutylbenzoate (18) 
SnCl2 (62 mg), methyl diazoacetate (206 μL, 1.96 
mmol) and aldehyde 5 (800 mg, 1.64 mmol) in 
CH2Cl2 (6 mL) were converted into the β-ketoester 
(690 mg, 73%) as described for the preparation of 7. 
The crude ester was transformed into diketone 18 as 
described for the preparation of 8. Purification of the 
crude product by chromatography (silicagel, hex-
ane/EtOAc 10:1, then 5:1) furnished 18 (138 mg, 
46%) as a colorless oil. 
IR: 3059, 2984, 2946, 2870, 1740, 1717, 1599w, 
1489, 1448, 1398, 1364, 1311, 1269, 1228, 1178, 
1155, 1114, 1068, 1023 cm-1.    
1H NMR (250 MHz, CDCl3): δ = 1.18–1.33 (m, 3 H, 
CH2CH3), 1.84–2.10 (m, 1 H, H-C(6)), 2.10–2.54 (m, 
2 H, H-C(2), H-C(6)), 2.18 (s, 3 H, H-C(11)), 2.66–
2.80 (m, 1 H, H-C(2)), 2.85–3.29 (m, 5 H, H-C(3), H-
C(5), H-C(7), H-C(9)), 3.38–3.57 (m, 1 H, H-C(9)), 
3.88–4.03 (m, 1 H, H-C(8)), 4.05–4.42 (m, 2 H, 
CH2CH3), 5.27–5.38 (m, 1 H, H-C(1)), 7.14–7.32 (m, 
9 H, C(Ph)3), 7.36–7.52 (m, 8 H, Ph, C(Ph)3), 7.56–
7.66 (m, 1 H, Ph), 7.99–8.09 (m, 2 H, Ph).   
13C NMR (63 MHz, CDCl3): δ = 14.4, 29.8, 30.0, 
31.0, 31.6, 40.8, 42.0, 47.6, 52.7, 62.1, 69.5, 87.1, 
127.3, 128.1, 128.8, 129.0, 130.0, 130.6, 133.4, 144.6, 
166.2, 168.9, 205.0, 205.5.   
 
2-[(1SR,2RS,3SR)-3-Benzoyloxy-2-(2-
hydroxyethyl)-cyclobutyl]-5-methylfuran-3-
carboxylic acid ethyl ester (19) 
Diketone 18 (63 mg, 0.1 mmol), MeOH (1 mL), 
CH2Cl2 (0.5 mL) and concd HCl (30 μL) were reacted 
according to the general procedure. The residue was 
purified by column chromatography on silicagel (hex-
ane/AcOEt 3:1) to afford 19 as pale yellow oil (27 mg, 
90%). 
IR: 3515, 2946, 1717, 1580, 1451, 1375, 1315, 1277, 
1209, 1110, 1057 cm-1. 
1H NMR (CDCl3, 400 MHz): δ = 1.33 (t, J = 7.1 Hz, 3 
H), 1.83 (br s, 1 H), 1.88–2.02 (m, 2 H), 2.29 (s, 3 H), 
2.51–2.62 (m, 1 H), 2.74–2.85 (m, 1 H), 3.02–3.12 
(m, 1 H), 3.66 (t, J = 6.4 Hz, 2 H), 4.16–4.23 (m, 1 H), 
4.26 (q, J = 7.1 Hz, 2 H), 5.55–5.61 (m, 1 H), 6.23 (s, 
1 H), 7.46 (t, J = 7.7 Hz, 2 H), 7.58 (t, J = 7.7 Hz, 1 
H), 8.08 (d, J = 7.7 Hz, 2 H). 
13C NMR (CDCl3, 100 MHz): δ = 13.7, 14.7, 32.3, 
32.6, 34.8, 43.8, 60.6, 61.1, 70.8, 106.9, 122.8, 128.8, 
130.0, 130.6, 133.5, 150.9, 161.4, 164.7, 166.7. 
HRMS (EI): m/z calcd for C21H24O6: 372.1573, found: 
372.1584. 
 
(S)-2-Trityloxymethyloxiran ((–)-20)9  
TrCl (2.46 g, 8.8 mmol) in CH2Cl2 (8 mL) was treated 
under Ar at 0 °C with NEt3 (2.2 mL, 16.0 mmol) and 
(R)-glycidol (+)-21 (540 μL, 8.0 mmol) in CH2Cl2 (4 
mL). 4-dimethylamino-pyridine (10 mg, 0.08 mmol) 
was added and the mixture was stirred for 24 h at 25 
°C. The mixture was quenched with NH4Cl and ex-
tracted with ether. The organic Phase was washed with 
brine, dried over MgSO4 and concentrated to give 
white crystals which were recrystallized from MeOH. 
Yield 2.5 g (quant.), mp. 94–96 °C (MeOH) (ref9: 100 
°C). [α]D25 = –9.7 (c = 1.0, CHCl3) ref9: [α]D25 = –10.5 
(c = 1, CHCl3)). 
 IR: 3023, 2925, 2874, 1595, 1490, 1448, 1158, 1071, 
1032, 1002 cm-1. 
1H NMR (250 MHz, CDCl3): δ = 2.68 (dd, J = 4.9, 2.2 
Hz, 1 H, H-C(3)), 2.82 (dd, J = 4.9, 3.9 Hz, 1 H, H-
C(3)), 3.17–3.28 (m, 2 H, H-C(1)), 3.38–3.48 (m, 1 H, 
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H-C(2)), 7.26–7.45 (m, 9 H, C(Ph) 3), 7.51–7.62 (m, 6 
H, C(Ph)3). 
 
(S)-4-Methyl-1-trityloxypent-4-en-2-ol ((–)-21)9  
CuI (121 mg, 0.63 mmol) under Ar in THF (2 mL) 
was treated dropwise at –78 °C with isopropenylmag-
nesiumbromide (0.5 M in THF, 13.3 mL, 6.64 mmol). 
After 30 min (-)-20 (1.0 g, 3.16 mmol) in THF (1 mL) 
was added and the mixture was stirred for 2 h at –40 
°C, quenched with NH4Cl and stirred for 30 min at 25 
°C. Workup with water and ether furnished after 
chromatography (silicagel, hexane/AcOEt 5:1) (-)-21 
(1.14 g, quant.).as a colorless oil with [α]D25 = –3.8 ° 
(c = 0.6, CHCl3). Ref9: [α]D25 = –3.0 (c = 1.15, 
CHCl3)).   
IR: 3058, 3020, 2926, 2875, 1595, 1489, 1449, 1220, 
1103, 1071 cm-1.  
1H NMR (250 MHz, CDCl3): δ = 1.74 (s, 3 H, H-
C(5)), 2.19 (d, J = 6.7 Hz, 2 H, H-C(3)), 2.25 (d, J = 
3.3 Hz, 1 H, OH), 3.11–3.24 (m, 2 H, H-C(1)), 3.87–
4.00 (m, 1 H, H-C(2)), 4.75 (s, 1 H, H-C(6)), 4.82 (s, 1 
H, H-C(6)), 7.23–7.38 (m, 9 H, C(Ph) 3), 7.44–7.50 
(m, 6 H, C(Ph)3). 
 
(S)-2-(4-Methoxybenzyloxy)-4-methylpent-4-en-1-
ol ((+)-23) 
NaH, (60% suspension in mineral oil, 633 mg, 15.8 
mmol) in THF (15 mL) was treated dropwise at 0 °C 
with (–)-21 (3.78 g, 10.6 mmol) in THF (5 mL).  The 
mixture was stirred at 25 °C for 1 h, then p-
methoxybenzyl chloride (2.14 mL, 15.8 mmol) and 
tetrabutylammonium bromide (68 mg, 0.21 mmol) 
were added and the mixture was stirred for 24 h at 
60°C. Usual workup with NH4Cl, water and ether 
furnished 22 after chromatography (silicagel, hex-
ane/AcOEt 20:1), which was detritylated in MeOH 
(20 mL) with TsOH•H2O (200 mg, 1.1 mmol) for 30 
min at 25°C. Usual workup and chromatography (sili-
cagel, hexane/AcOEt 5:1, then AcOEt) gave alcohol 
23 (1.77 g (71%, 2 steps) as a colorless oil.  [α]D25 = 
+14.7 (c = 0.3, CHCl3).   
IR: 3401, 2929, 1738, 1713, 1613, 1514, 1455, 1301, 
1249, 1173, 1103, 1035 cm-1.   
1H NMR (250 MHz, CDCl3): δ = 1.79 (s, 3 H, H-
C(5)), 1.94 (dd, J = 6.9, 5.6 Hz, 1 H, OH), 2.22 (dd, J 
= 14.1, 7.2 Hz, 1 H, H-C(3)), 2.42 (dd, J = 14.1, 5.6, 1 
H, H-C(3)), 3.47–3.59 (m, 1 H, H-C(2)), 3.64–3.76 
(m, 2 H, H-C(1)), 3.84 (s, 3 H, OCH3), 4.50, 4.64 (AB, 
J = 11.2 Hz, 2 H, CH2C6H4OCH3), 4.81 (s, 1 H, H-
C(6)), 4.85 (s, 1 H, H-C(6)), 6.91, 7.30 (AA'BB', J = 
8.5 Hz, 4 H, C6H4OCH3).   
13C NMR (63 MHz, CDCl3): δ = 23.2, 39.9, 55.7, 
64.7, 71.6, 78.1, 113.6, 114.3, 129.8.   
EI-HRMS: m/z calcd for M+, C14H20O3+, 236.1412, 
found 236.1417. 
 
(S)-2-(4-Methoxybenzyloxy)-4-methylpent-4-enal 
((–)-24) 
Oxalylchloride (100 μL, 1.18 mmol) under Ar in 
CH2Cl2 (3 mL) was treated at –78 °C with dimethyl-
sulfoxide (167 μL, 2.36 mmol) After 15 min (+)-23 
(254 mg, 1.07 mmol) in CH2Cl2 (2 mL) was added 
and the mixture was stirred for1 h at –78 °C. NEt3 
(748 μL, 5.37 mmol) was added and the mixture was 
warmed to 0 °C and stirred for 2 h. Usual workup with 
water and ether furnished after chromatography (sili-
cagel, hexane/AcOEt 5:1) aldehyde (-)-24 (220 mg, 
88%) as a colorless oil. [α]D25 = –44.9 (c = 2.0, 
CHCl3).   
IR: 3078, 2936, 2839, 1733, 1700, 1652, 1613, 1514, 
1464, 1456, 1375, 1303, 1250, 1174, 1103, 1035 cm-1.   
1H NMR (250 MHz, CDCl3): δ = 1.76 (s, 3 H, H-
C(5)), 2.43 (d, J = 6.6 Hz, 2 H, H-C(3)), 3.84 (s, 3 H, 
OCH3), 3.92 (dt, J = 6.6 Hz, 2.2, 1 H, H-C(2)), 4.55, 
4.63 (AB, J = 11.3 Hz, 2 H, CH2C6H4OCH3), 4.83 (s, 
1 H, H-C(6)), 4.89 (s, 1 H, H-C(6)), 6.91, 7.30 
(AA'BB', J = 8.5 Hz, 4 H, C6H4OCH3), 9.65 (d, J = 2.2 
Hz, 1 H, CHO).   
13C NMR (63 MHz, CDCl3): δ = 23.1, 38.8, 55.6, 
72.6, 82.0, 114.2, 114.3, 129.7, 129.9, 140.8, 160.0, 
203.6.   
EI-HRMS: m/z calcd for M+, C14H18O3+ 234.1261, 
found 234.1261. 
 
(1SR,2RS,3RS)-2-(2-Oxoethyl)-3-
trityloxymethylcyclobutylbenzoate (25) 
Alcohol 16 (600 mg, 1.22 mmol), NaHCO3 (460 g, 
5.48 mmol) and Dess-Martin-periodinane (776 mg, 
1.83 mmol) in CH2Cl2 (10 mL) were stirred at 25°C 
for 2 h. Usual workup and chromatography (silicagel, 
hexane/AcOEt 10:1) furnished aldehyde 25 (570 mg, 
95%) as a colorless oil. 
IR: 3060, 2935, 1721, 1601, 1490, 1450, 1314, 1275, 
1154, 1112, 1069, 1026 cm-1.  
1H NMR (250 MHz, CDCl3): δ = 1.88–2.05 (m, 1 H, 
H-C(2)), 2.59 (d, J = 9.1 Hz, 2 H, H-C(6)), 2.64–2.78 
(m, 2 H, H-C(2), H-C(3)), 3.02–3.17 (m, 1 H, H-C(4)), 
3.22–3.33 (m, 1 H, H-C(4)), 3.37–3.57 (m, 1 H, H-
C(7)), 5.33–5.46 (m, 1 H, H-C(1)), 7.21–7.37 (m, 9 H, 
C(Ph)3), 7.40–7.49 (m, 8 H, Ph, C(Ph)3), 7.54–7.63 
(m, 1 H, Ph), 7.86–7.93 (m, 2 H, Ph), 9.69 (t, J = 1.4 
Hz, 1 H, CHO).   
13C NMR (100 MHz, CDCl3): δ = 31.2, 31.6, 36.7, 
39.2, 64.0, 68.6, 87.2, 127.5, 128.2, 128.8, 129.0, 
129.9, 130.5, 133.5, 144.3, 166.1, 201.8.  
ESI-HRMS: m/z calcd for M+ C33H30O4Na+ 
513.2042, found 513.2028. 
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(1SR,2RS,3RS)-2-[3-(Dimethoxyphosphoryl)-2-
hydroxypropyl]-3-
trityloxymethylcyclobutylbenzoate (26) 
Dimethylmethanephosphonate (138 μl, 1.16 mmol) in 
THF (7 mL) was treated dropwise at –78 °C under Ar 
with n-BuLi (2.5 M in hexane, 464 μl, 1.16 mmol). 
After 30 min aldehyde (-)-24 (570 mg, 1.16 mmol) in 
THF (3 mL) was added and the mixture was stirred 
for 4 h at –78 °C. Workup with NaHCO3, water and 
ether furnished after chromatography (silicagel, hex-
ane/AcOEt 5:1, then AcOEt) 26 (380 mg, 84%, based 
on recovered starting material) as an inseparable di-
astereomeric mixture. The NMR data are provided for 
the major diastereomer. Rf 0.21 (hexane/AcOEt 5:1). 
IR: 3392, 3058, 3033, 2953, 2874, 1716, 1601, 1490, 
1450, 1449, 1360, 1314, 1275, 1223, 1178, 1154, 
1113s, 1064, 1032 cm-1.   
1H NMR (250 MHz, CDCl3): δ = 1.57–1.97 (m, 3 H, 
H-C(2), H-C(6)), 2.59–2.75 (m, 2 H, H-C(2), H-C(3)), 
3.02–3.42 (m, 4 H, H-C(4), H-C(5), H-C(7)), 3.57–
3.85 (m, 8 H, H-C(8), 2 × OCH3), 3.86–4.09 (br. s, 1 
H, OH), 5.30–5.42 (m, 1 H, H-C(1)), 7.20–7.36 (m, 9 
H, C(Ph) 3), 7.39–7.49 (m, 8 H, Ph, C(Ph) 3), 7.50–
7.65 (m, 1 H, Ph), 7.86–8.06 (m, 2 H, Ph).   
13C NMR (63 MHz, CDCl3): δ = 31.8, 32.7, 34.2, 
38.5, 39.0, 52.6, 52.7, 64.4, 65.5, 70.2, 87.1, 127.4, 
128.2, 128.8, 129.1, 129.9, 130.6, 133.3, 144.4, 166.2.  
ESI-HRMS: m/z calcd for C36H39O7PNa+ 637.2331, 
(MNa+), found 637.2344. 
 
(1SR,2RS,3RS)-2-[3-(Dimethoxyphosphoryl)-2-
oxopropyl]-3-trityloxymethylcyclobutylbenzoate 
(27) 
Alcohol 26 (472 mg, 0.77 mmol), NaHCO3 (291 mg, 
3.47 mmol) and Dess-Martin-periodinane (489 mg, 
1.15 mmol) in CH2Cl2 (20 mL) were stirred for 2 h at 
25°C. Workup as before including chromatography 
(silicagel, AcOEt) furnished ketophosphonate 27 (370 
mg, 78%) as a colorless oil. 
IR: 3058, 2953, 1716, 1600, 1490, 1449, 1399, 1314, 
1274, 1179, 1112, 1028 cm-1.   
1H NMR (250 MHz, CDCl3): δ = 1.83–1.96 (m, 1 H, 
H-C(2)), 2.59–2.77 (m, 2 H, H-C(2), H-C(3)), 2.87 (s, 
1 H, H-C(8)), 2.96 (s, 1 H, H-C(8)), 3.13 (dd, J = 9.6, 
8.4 Hz, 1 H, H-C(4)), 3.26 (dd, J = 9.6, 5.4 Hz, 1 H, 
H-C(4)), 3.34–3.46 (m, 1 H, H-C(7)), 5.32–5.42 (m, 1 
H, H-C(1)), 7.21–7.37 (m, 9 H, C(Ph)3), 7.39–7.48 
(m, 8 H, Ph, C(Ph)3), 7.53–7.62 (m, 1 H, Ph), 7.83–
7.89 (m, 2 H, Ph).   
13C NMR (63 MHz, CDCl3): δ = 31.3, 31.9, 37.2, 
39.7, 42.5, 64.3, 69.4, 88.0, 127.4, 128.2, 128.8, 
129.0, 129.9, 130.5, 133.4, 144.4, 166.1, 201.9.   
ESI-HRMS: m/z calcd for C36H37O7PNa+ (MNa+) 
635.2175, found 635.2182. 
 
(1SR,2RS,3RS)-2-[(E)-(5S)-5-(4-
Methoxybenzyloxy)-7-methyl-2-oxoocta-3,7-
dienyl]-3-trityloxymethylcyclobutylbenzoate (28) 
NaH, (60% suspension in mineral oil, 26 mg, 0.66 
mmol) in THF (6 mL) was treated dropwise at -10 °C 
with 27 (370 mg, 0.60 mmol) in THF (2 mL). After 10 
min aldehyde 25 (155 mg, 0.66 mmol) in  THF (2 mL) 
was added and the mixture was stirred for 2 h at 25 
°C. Usual workup with water and ether including 
chromatography (silicagel, hexane/AcOEt 5:1) fur-
nished 28 (400 mg, 92%, colorless oil) as an insepara-
ble diastereomeric mixture. The NMR data are pro-
vided for the major diastereomer. Rf 0.38 (hex-
ane/AcOEt 5:1). 
IR: 2934, 1718, 1684, 1654, 1560, 1512, 1448, 1274, 
1148, 1068 cm-1.  
Major diastereomer:  
1H NMR (400 MHz, CDCl3): δ = 1.65 (s, 3 H, H-
C(13)), 1.84–1.93 (m, 1 H, H-C(2)), 2.05–2.13 (m, 1 
H, H-C(11)), 2.25–2.34 (m, 1 H, H-C(11)), 2.60–2.76 
(m, 3 H, H-C(2), H-C(3), H-C(6)), 2.77–2.87 (m, 1 H, 
H-C(6)), 3.09 (t, J = 8.9 Hz, 1 H, H-C(4)), 3.26 (dd, J 
= 9.4, 5.0 Hz, 1 H, H-C(4)), 3.42–3.52 (m, 1 H, H-
C(7)), 3.80 (s, 3 H, OCH3), 3.95–4.01 (m, 1 H, H-
C(10)), 4.20, 4.39 (AB, J = 11.6 Hz, 2 H, CH2 
C6H4OCH3), 4.65 (s, 1 H, H-C(14)), 4.75 (s, 1 H, H-
C(14)), 5.34–5.40 (m, 1 H, H-C(1)), 6.13 (ddd, J = 
16.0, 4.5, 1.1 Hz, 1 H, H-C(8)), 6.51 (dt, J = 16.0, 6.0, 
1 H, H-C(9)), 6.81–6.86 (m, 2 H, C6H4OCH3), 7.13–
7.18 (m, 2 H, C6H4OCH3), 7.19–7.25 (m, 9 H, 
C(Ph)3), 7.33–7.39 (m, 2 H, Ph), 7.41–7.45 (m, 6 H, 
C(Ph)3), 7.48–7.53 (m, 1 H, Ph), 7.78–7.83 (m, 2 H, 
Ph).   
13C NMR (100 MHz, CDCl3): δ =  23.2, 31.5, 31.6, 
35.8, 37.2, 43.8, 55.7, 64.2, 69.3, 71.1, 76.9, 86.9, 
113.8, 114.2, 127.4, 128.2, 128.7, 129.0, 129.7, 129.9, 
130.3, 130.4, 130.6, 133.2, 141.6, 144.4, 145.8, 159.6, 
166.1, 198.8. 
ESI-HRMS: m/z calcd for C38H48O6Na+ (MNa+) 
743.3349, found 743.3343. 
 
(1SR,2RS,3RS)-2-[(E)-(5S)-2-Hydroxy-5-(4-
methoxybenzyloxy)-7-methylocta-3,7-dienyl]-3-
trityloxymethylcyclobutylbenzoate (29) 
Ketone 28 (91 mg, 0.13 mmol.) and CeCl3•H2O (48 
mg, 0.13 mmol) were stirred for 30 min in MeOH (4 
mL) at –78 °C. NaBH4 (6 mg, 0.14 mmol) was added 
and the mixture was stirred for 3 h at –78 °C. Usual 
workup with NH4Cl, water and ether gave after chro-
matography (silicagel, hexane/AcOEt 1:1) 29 (73 mg, 
78%, colorless oil) as an inseparable diastereomeric 
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mixture. The NMR data are provided for the major 
diastereomer. Rf 0.38 (hexane/AcOEt 1:1). 
IR: 3468, 3061, 2934, 2862, 1717, 1612, 1514, 1490, 
1450, 1368, 1314, 1276, 1249, 1174, 1111, 1069, 1033 
cm-1.   
1H NMR (250 MHz, CDCl3): δ = 1.58–1.76 (m, 2 H, 
H-C(6), OH), 1.70 (s, 3 H, H-C(13)), 1.76–1.96 (m, 2 
H, H-C(2), H-C(6)), 2.11–2.24 (m, 1 H, H-C(11)), 
2.29–2.45 (m, 1 H, H-C(11)),  2.59–2.78 (m, 2 H, H-
C(2), H-C(3)), 2.98–3.14 (m, 1 H, H-C(4)), 3.17–3.30 
(m, 1 H, H-C(4)), 3.31–3.41 (m, 1 H, H-C(7)), 3.82 (s, 
3 H, OCH3), 3.84–3.95 (m, 1 H, H-C(10)), 4.06–4.21 
(m, 1 H, H-C(5)), 4.31, 4.50 (AB, J = 11.4 Hz, 2 H, 
CH2 C6H4OCH3), 4.73 (s, 1 H, H-C(14)), 4.78 (s, 1 H, 
H-C(14)), 5.29–5.65 (m, 3 H, H-C(1), H-C(8), H-
C(9)), 6.83–6.93 (m, 2 H, C6H4OCH3), 7.17–7.38 (m, 
11 H, C6H4OCH3, C(Ph)3), 7.39–7.53 (m, 8 H, Ph, 
C(Ph)3), 7.54–7.64 (m, 1 H, Ph), 7.87–7.97 (m, 2 H, 
Ph).   
13C NMR (63 MHz, CDCl3): δ = 23.3, 31.8, 32.0, 
32.8,  38.5, 44.6, 55.7, 64.6, 70.2, 70.4, 71.3, 78.0, 
87.2, 113.1, 114.1, 127.4, 128.2, 128.8, 129.0, 129.7, 
129.9, 130.6, 131.2, 131.8, 133.4, 136.1, 142.5, 144.4, 
159.5, 166.3.   
ESI-HRMS: m/z calcd for C48H50O6Na+ (MNa+) 
745.3505, found 745.3489. 
 
(1SR,2RS,3RS)-2-[(E)-(5S)-2-Acetoxy-5-(4-
methoxybenzyloxy)-7-methylocta-3,7-dienyl]-3-
trityloxymethylcyclobutylbenzoate (30) 
Alcohol 29 (82 mg, 0.11 mmol.) in CH2Cl2 (5 mL) 
was treated with Ac2O (32 μl, 0.34 mmol), NEt3 (63 
μl, 0.45 mmol) and 4-dimethylamino-pyridine (3 mg, 
0.02 mmol) for 2 h at 25 °C. Usual workup and chro-
matography (silicagel, hexane/AcOEt 5:1) gave 30 (84 
mg, 97%, colorless oil) as an inseparable di-
astereomeric mixture. The NMR data are provided for 
the major diastereomer. Rf 0.32 (hexane/AcOEt 5:1). 
IR: 3061, 2934, 1737, 1717, 1612, 1514, 1490, 1450, 
1370, 1314, 1274, 1247, 1174, 1155, 1111, 1069, 1027 
cm-1.   
1H NMR (250 MHz, CDCl3): δ = 1.66–1.96 (m, 3 H, 
H-C(2), H-C(6)), 1.69 (s, 3 H, H-C(13)), 2.02 (s, 3 H, 
CH3CO), 2.07–2.21 (m, 1 H, H-C(11)), 2.28–2.43 (m, 
1 H, H-C(11)),  2.57–2.77 (m, 2 H, H-C(2), H-C(3)), 
2.84–3.00 (m, 1 H, H-C(4)), 3.17–3.39 (m, 2 H, H-
C(4), H-C(7)), 3.78–3.92 (m, 1 H, H-C(10)), 3.83 (s, 3 
H, OCH3), 4.24, 4.46 (AB, J = 11.6 Hz, 2 H, 
CH2C6H4OCH3), 4.71 (s, 1 H, H-C(14)), 4.77 (s, 1 H, 
H-C(14)), 5.25–5.58 (m, 4 H, H-C(1), H-C(5), H-
C(8), H-C(9)), 6.83–6.91 (m, 2 H, C6H4OCH3), 7.18–
7.38 (m, 11 H, C6H4OCH3, C(Ph)3), 7.40–7.54 (m, 8 
H, Ph, C(Ph)3), 7.55–7.64 (m, 1 H, Ph), 7.90–7.99 (m, 
2 H, Ph).   
13C NMR (63 MHz, CDCl3): δ = 21.6, 23.3, 29.5, 
31.7, 32.9, 38.4, 44.4, 55.7, 64.5, 70.2, 70.3, 73.4, 
77.7, 87.1, 113.2, 114.1, 127.4, 128.2, 128.8, 129.1, 
129.7, 130.0, 130.6, 131.0, 131.5, 133.3, 134.0, 142.4, 
144.5, 159.5, 166.3, 170.6.   
ESI-HRMS: m/z calcd for C50H52O7Na+ (MNa+) 
787.3611, found 787.3626. 
 
(1SR,2RS,3RS)-2-[(E)-(5S)-2-Acetoxy-5-(4-
methoxybenzyloxy)-7-methylocta-3,7-dienyl]-3-
hydroxymethylcyclobutylbenzoate (31) 
Trityl ether 30 (72 mg, 0.094 mmol) in MeOH (2 mL) 
was detritylated with p-TsOH (4 mg, 0.019 mmol) for 
2 h at 25 °C. Workup as described for 22 gave after 
chromatography (silicagel, hexane/AcOEt 1:2) 31 (40 
mg, 81%, colorless oil) as an inseparable di-
astereomeric mixture. The NMR data are provided for 
the major diastereomer. Rf 0.45 (hexane/AcOEt 1:2). 
IR: 3467, 2935, 2870, 1718, 1612, 1513, 1452, 
1371m, 1275, 1248, 1175, 1111, 1071, 1027 cm-1.   
1H NMR (250 MHz, CDCl3): δ = 1.70 (s, 3 H, H-
C(13)), 1.86–2.03 (m, 3 H, H-C(2), H-C(6)), 2.02 (s, 3 
H, CH3CO), 2.11–2.27 (m, 1 H, H-C(11)), 2.33–2.68 
(m, 3 H, H-C(2), H-C(3), H-C(11)), 2.81–2.96 (m, 1 
H, H-C(7)), 3.70–3.99 (m, 3 H, H-C(4), H-C(10)), 
3.82 (s, 3 H, OCH3), 4.31, 4.49 (AB, J = 11.4 Hz, 2 H, 
CH2C6H4OCH3), 4.72 (s, 1 H, H-C(14)), 4.78 (s, 1 H, 
H-C(14)), 5.28–5.40 (m, 1 H, H-C(1)), 5.41–5.53  (m, 
1 H, H-C(5)), 5.59–5.68 (m, 2 H, H-C(8), H-C(9)), 
6.83–6.92 (m, 2 H, C6H4OCH3), 7.20–7.31 (m, 2 H, 
C6H4OCH3), 7.42–7.52 (m, 2 H, Ph), 7.55–7.65 (m, 1 
H, Ph), 8.02–8.13 (m, 2 H, Ph).   
13C NMR (63 MHz, CDCl3): δ = 21.6, 23.3, 29.7, 
31.3, 34.3, 38.4, 44.4, 55.7, 63.5, 69.0, 70.4, 73.2, 
77.7, 113.3, 114.2, 126.9, 128.8, 129.7, 130.0, 130.5, 
131.2, 133.5, 134.0, 142.4, 159.5, 170.9.   
ESI-HRMS: m/z calcd for C31H38O7Na+ (MNa+) 
545.2515, found 545.2498. 
(1SR,2RS,3RS)-2-[(E)-(5S)-2-Acetoxy-5-(4-
methoxybenzyloxy)-7-methylocta-3,7-dienyl]-3-
formylcyclobutylbenzoate (32) 
Alcohol 31 (14 mg, 0.027 mmol) was oxidized with 
NaHCO3 (10 mg, 0.122 mmol) and Dess-Martin-
periodinane (17 mg, 0.040 mmol) in CH2Cl2 (1 mL) as 
described before to give after chromatography (sili-
cagel, hexane/AcOEt 2:1) aldehyde 32 (12 mg, 85%) 
as a colorless oil. 
IR: 2930, 2855, 1717, 1649, 1611, 1512, 1451, 1375, 
1315, 1277, 1246, 1178, 1118, 1072, 1027 cm-1.   
1H NMR (250 MHz, CDCl3): δ = 1.66 (s, 3 H, H-
C(13)), 1.88–1.99 (m, 2 H, H-C(6)), 2.04 (s, 3 H, 
CH3CO), 2.15 (dd, J = 13.9, 6.4 Hz, 1 H, H-C(11)), 
2.36 (dd, J = 13.9, 7.3 Hz, 1 H, H-C(11)), 2.46–2.68 
(m, 2 H, H-C(2)), 3.05–3.31 (m, 2 H, H-C(3), H-C(7)), 
75 PAPER  
 
75 
3.79 (s, 3 H, OCH3), 3.82–3.93 (m, 1 H, H-C(10)), 
4.27, 4.45 (AB, J = 11.5 Hz, 2 H, CH2C6H4OCH3), 
4.69 (s, 1 H, H-C(14)), 4.75 (s, 1 H, H-C(14)), 5.21–
5.32 (m, 1 H, H-C(1)), 5.33–5.44  (m, 1 H, H-C(5)), 
5.53–5.59 (m, 2 H, H-C(8), H-C(9)), 6.84, 7.20 
(AA'BB', J = 8.5 Hz, 4 H, C6H4OCH3), 7.40–7.50 (m, 
2 H, Ph), 7.53–7.63 (m, 1 H, Ph), 8.00–8.09 (m, 2 H, 
Ph), 9.99 (s, 1 H, CHO).   
13C NMR (63 MHz, CDCl3): δ = 21.6, 23.3, 28.1, 
30.1, 41.1, 43.3, 44.4, 55.7, 68.5, 70.4, 72.6, 77.7, 
113.3, 114.2, 128.9, 129.7, 130.0, 130.5, 130.9, 133.7, 
134.1, 142.3, 202.1.   
ESI-MS: m/z calcd for C31H36O7Na+ (MNa+) 
543.2359, found 543.2361. 
(1SR,2RS,3SR)-2-[(E)-(5S)-2-Acetoxy-5-(4-
methoxybenzyloxy)-7-methylocta-3,7-dienyl]-3-
formylcyclobutylbenzoate (33) 
Following general procedure B, aldehyde 32 (160 mg, 
0.31 mmol) in CH2Cl2 (3 mL) was stirred with K2CO3, 
0.1 M in MeOH/H2O 10:1, 5 mL) for 15 min at 25°C. 
Usual workup gave after chromatography (silicagel, 
hexane/AcOEt 5:1) aldehyde 33 (106 mg, 66%, color-
less oil) as an inseparable diastereomeric mixture. The 
NMR data are provided for the major diastereomer. Rf 
0.33 (hexane/AcOEt 5:1). 
IR: 2995, 2976, 2938, 1769, 1757, 1720, 1612, 1513, 
1452, 1375, 1247, 1112, 1057 cm-1.   
1H NMR (250 MHz, CDCl3): δ = 1.67 (s, 3 H, H-
C(13)), 1.91–2.08 (m, 2 H, H-C(6)), 2.04 (s, 3 H, 
CH3CO), 2.09–2.22 (m, 1 H, H-C(11)), 2.30–2.42 (m, 
2 H, H-C(2), H-C(11)), 2.65–2.81 (m, 1 H, H-C(2)), 
2.97–3.26 (m, 2 H, H-C(3), H-C(7)), 3.79 (s, 3 H, 
OCH3), 3.83–3.96 (m, 1 H, H-C(10)), 4.28, 4.47 (AB, 
J = 11.6 Hz, 2 H, CH2C6H4OCH3), 4.69 (s, 1 H, H-
C(14)), 4.75 (s, 1 H, H-C(14)), 5.24–5.44 (m, 2 H, H-
C(1), H-C(5)), 5.57–5.62 (m, 2 H, H-C(8), H-C(9)), 
6.85, 7.21 (AA'BB', J = 8.5 Hz, 4 H, C6H4OCH3), 
7.42–7.51 (m, 2 H, Ph), 7.54–7.64 (m, 1 H, Ph), 8.01–
8.09 (m, 2 H, Ph), 9.79 (d, J = 1.7 Hz, 1 H, CHO).   
13C NMR (100 MHz, CDCl3): δ = 21.5, 23.3, 28.4, 
33.7, 37.8, 44.4, 47.7, 55.7, 69.6, 70.5, 71.9, 77.7, 
113.4, 114.1, 128.9, 129.7, 130.0, 130.5, 130.6, 130.9, 
133.8, 134.1, 142.3, 159.5, 166.3, 170.5, 203.0.   
ESI-MS: m/z calcd for C31H36O7Na+ (MNa+) 
543.2359, found 543.2358. 
(1SR,2RS,3SR)-2-[(E)-(5S)-2-Acetoxy-5-(4-
methoxybenzyloxy)-7-methylocta-3,7-dienyl]-3-(2-
ethoxycarbonylacetyl)cyclobutylbenzoate (34) 
SnCl2 (8 mg, 0.04 mmol), ethyl diazoacetate (25 μl, 
0.24 mmol) and aldehyde 33 (106 mg, 0.20 mmol) in 
CH2Cl2 (8 mL) were treated as described for 5 to give 
after chromatography (silicagel, hexane/AcOEt 2:1) 
34 (96 mg, 79%, colorless oil) as an inseparable di-
astereomeric mixture. The NMR data are provided for 
the major diastereomer. Rf 0.29 (hexane/AcOEt 2:1). 
IR: 2976, 2938, 2862, 2839, 1740, 1717, 1650, 1611, 
1512, 1451, 1368, 1315, 1277, 1239, 1178, 1110, 
1072, 1034 cm-1.   
1H NMR (400 MHz, CDCl3): δ = 1.28 (t, J = 7.2 Hz, 3 
H, CH2CH3), 1.67 (s, 3 H, H-C(13)), 1.80–1.96 (m, 1 
H, H-C(6)), 2.04 (s, 3 H, CH3CO), 2.06–2.20 (m, 2 H, 
H-C(6), H-C(11)), 2.31–2.46 (m, 2 H, H-C(2), H-
C(11)), 2.58–2.69 (m, 1 H, H-C(2)), 2.91–3.14 (m, 1 
H, H-C(7)), 3.30–3.42 (m, 1 H, H-C(3)), 3.43, 3.48 
(AB, J = 15.4 Hz, 2 H, H-C(15)), 3.79 (s, 3 H, OCH3), 
3.85–3.92 (m, 1 H, H-C(10)), 4.20 (q, J = 7.2 Hz, 2 H, 
CH2CH3), 4.27, 4.47 (AB, J = 11.6 Hz, 2 H, 
CH2C6H4OCH3), 4.69 (s, 1 H, H-C(14)), 4.75 (s, 1 H, 
H-C(14)), 5.25–5.41 (m, 2 H, H-C(1), H-C(5)), 5.56–
5.63 (m, 2 H, H-C(8), H-C(9)), 6.84, 7.21 (AA'BB', J = 
8.0 Hz, 4 H, C6H4OCH3), 7.42–7.49 (m, 2 H, Ph), 
7.55–7.62 (m, 1 H, Ph), 8.01–8.10 (m, 2 H, Ph).   
13C NMR (100 MHz, CDCl3): δ = 21.5, 23.2, 31.3, 
33.7, 38.8, 44.3, 47.4, 48.4, 55.7, 61.9, 69.4, 70.4, 
71.9, 77.7, 113.3, 114.1, 128.9, 129.7, 130.0, 130.3, 
130.6, 130.9, 133.6, 134.5, 142.3, 159.5, 166.3, 167.4, 
170.5, 203.0.   
ESI-HRMS: m/z calcd for C35H42O9Na+ (MNa+) 
629.2727, found 629.2723. 
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Appendix 3 
 
Synthetic efforts towards the complex Diterpene Providencin 
Tanja Gaich, Harald Weinstabl and Johann Mulzer* 
Supporting Information 
1. Procedures 
General 
All reactions were carried out in oven-dried glassware under an argon atmosphere, unless otherwise 
stated. Anhydrous CH2Cl2 (DCM) was distilled from CaH2 under argon or reduced pressure, 
respectively. Anhydrous THF (tetrahydrofuran) was purchased (99.85%, water < 50 ppm). All other 
solvents were HPLC grade. Reactions were magnetically stirred and monitored by thin layer 
chromatography (TLC) with silica gel 60-F254 plates. Flash column chromatography was performed 
with silica gel (0.04-0.063mm, 240-400 mesh) under pressure. Yields refer to chromatographically and 
spectroscopically pure compounds, unless otherwise stated. NMR spectra were recorded on a 400 
MHz spectrometer. Unless otherwise stated, all NMR spectra were measured in CDCl3 solutions and 
referenced to the residual CHCl3 signal (1H, δ = 7.26 ppm; 13C, δ =77.00 ppm). All 1H and 13C shifts 
are given in ppm (s = singlet; d = doublet; t = triplet; q = quadruplet; m = multiplet; b = broad signal). 
Assignments of proton resonances were confirmed, when possible, by correlated spectroscopy. Optical 
rotations were measured at 20°C. High resolution mass spectra (HRMS) were performed with a 
resolution of 10000. Compound names were generated using AutoNom. 
 
(1S,4'R,5R,5'R)-4',5'-diphenylspiro[bicyclo[3.2.0]hept[2]ene-6,2'-[1,3]dioxolane] 17 
 
(R,R)-diphenyl ethandiol (2g, 9.3 mmol, 1eq), ketone 15 (1g, 9.3 mmol, 1eq) and p-toluolsulfonic acid 
(0.46 mmol, 88 mg, 5 mol%) were added to 90 mL benzene and heated at reflux with a Dean Stark 
trap for 50 minutes. The reaction was cooled to room temperature the solvents were removed in vacuo 
and the crude product was submitted to flash column chromatography leading to crystalline 17. 
1H-NMR (400MHz, CDCl3): δ= 7.37-7.33 p.p.m. (m, 6H), 7.28-7.24 (m, 4H), 5.88-5.82 (m, 2H), 4.73-
4.70 (m, 1H), 4.71 (d, J=8.3 Hz, 1H), 4.63 (d, J=8.3 Hz, 1H), 3.57-3.52 (m, 1H), 3.23-3.16 (m, 1H), 
2.92 (ddd, J=13.1, 8.8, 2.0 Hz, H), 2.80-2.73 (m, 1H), 2.58-2.50 (m, 1H), 2.42 (ddd, J=13.1, 4.0, 1.3 
Hz, 1H). 
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13C-NMR (100MHz, CDCl3): δ= 137.44 p.p.m., 137.15, 133.59, 132.27, 128.88, 128.85, 127.30, 
127.07, 110.62, 86.99, 85.26, 50.58, 44.70, 37.32, 33.21. 
HRMS (ESI) (m/z ): [M]+  calcd for C21H20O2 304.1463; found, 304.1457. 
 
(1S,5R,6S)-bicyclo[3.2.0]hept-2-en-6-yl 2-chloroacetate 19a 
 
Potassium dihydrogenphosphate buffer (50mM, 150 mL) 50 mL pentane and racemic 19 (58.4 mmol, 
10.9 g 58.4 mmol) dissolved in 50 mL tert-butyl methyl ether were vigorously stirred at room 
temperature. The pH was adjusted to 7.0 and SAM II amino lipase (60 mg) was added. The resolution 
was stopped after 55% conversion, the phases were separated and the aqueous phase was extracted 
two times with diethyl ether. The combined organic layers were dried over magnesium sulfate, the 
solvents were removed in vacuo and the crude product was submitted to flash column chromatography 
(pentane:diethyl ether 5:1) to give 4.9 g of acetate 19a, and 3.5 g of alcohol 19b.  
Acetate 19a: 
1H-NMR (CDCl3, 400 MHz): 1.83 (ddt, J = 13.1, 5.6, 1.2, 1 H, H-C(2)); 2.41–2.59 (m, 2 H, H-C(6)); 
2.78 (ddt, J = 13.1, 8.0, 2.0, 1 H, H-C(2)); 3.04–3.12 (m, 1 H, H-C(3)); 3.28–3.38 (m, 1 H, H-C(7)); 
4.06 (s, 2 H, CH2Cl); 5.25–5.33 (m, 1 H, H-C(1)); 5.79–5.85 (m, 2 H, H-C(4), H-C(5)).   
13C-NMR (CDCl3, 100 MHz): 32.9; 36.9; 41.0; 41.3; 41.5; 70.0; 132.7; 134.5; 167.1.   
EI-HR-MS: 186.0445 (M+, C9H11O2Cl+; Ber. 186.0448). 
IR: 2940m; 1757s; 1412w; 1347w; 1312m; 1287m; 1185m; 1047w; 1001w. 
[α]D
25
= –19.5 (c = 0.65g/100mL, CHCl3). 
Alcohol 19b:  
1H-NMR (CDCl3, 400 MHz): 1.60 (ddt, J = 13.0, 4.4, 1.1, 1 H, H-C(2)); 2.34–2.46 (m, 1 H, H-C(6)); 
2.67–2.78 (m, 2 H, H-C(2), H-C(6)); 2.98–3.06 (m, 1 H, H-C(3)); 3.12–3.20 (m, 1 H, H-C(7)); 3.28 
(br, 1 H, OH); 4.43 (ddt, J = 7.8, 4.7, 1.6, 1 H, H-C(1)); 5.83–5.87 (m, 2 H, H-C(4), H-C(5)).   
 
79 
13C-NMR (CDCl3, 100 MHz): 31.9; 40.2; 41.1; 42.5; 67.9; 132.9; 136.0.   
EI-HR-MS: 110.0735 (M+, C7H10O+; Ber. 110.0732). 
IR: 3351br; 3049m; 2933s; 2851m; 1733s; 1607w; 1411w; 1350m; 1319w; 1210m; 1168m; 1108s; 
1082m; 1048w; 1001w. 
[α]D
25
= –57.6 (c = 1.0, CHCl3) (Lit. [21]: [α]D
25
= –68.0 (c = 1.1, CHCl3)). 
 
(R)-((1S,5R,6S)-bicyclo[3.2.0]hept-2-en-6-yl) 3,3,3-trifluoro-2-methoxy-2-phenylpropanoate A 
 
19a was hydrolyzed with 30 % KOH in ethanol to give optical active alcohol 18 2.5 g in 87% yield. 
This alcohol ( 20 mg, 0.18 mmol, 1eq) was dissolved in 1 mL DCM and pyridine (50µL, 1 mmol, 5eq) 
was added. Then (S)-Mosher chloride (51µL, 0.27 mmol, 1.5eq) was added and the reaction was 
stirred for one hour at room temperature. The reaction was quenched with 1M HCl and diluted with 
diethyl ether. The phases were separated and the aqueous phase was extracted two times with diethyl 
ether. The combined organic layers were dried over magnesium sulfate, the solvents were removed in 
vacuo and the crude product was submitted to flash column chromatography (hexanes ethylacetate 
3:1) to give 60 mg 100% of compound A.  
The 19-F-NMR revealed 98% ee. 
1H-NMR (CDCl3, 400 MHz): 1.86 (ddt, J = 13.3, 5.2, 1.2, 1 H, H-C(2)); 2.34–2.43 (m, 1 H, H-C(6)); 
2.45–2.53 (m, 1 H, H-C(6)); 2.84 (ddt, J = 13.5, 8.0, 2.4, 1 H, H-C(2)); 3.05–3.14 (m, 1 H, H-C(3)); 
3.29–3.38 (m, 1 H, H-C(7)); 3.55 (d, J = 1.0, 3 H, OCH3); 5.39 (ddt, J = 8.1, 5.4, 1.0, 1 H, H-C(1)); 
5.73–5.80 (m, 2 H, H-C(4), H-C(5)); 7.37–7.42 (m, 3 H, C6H5); 7.53–7.57 (m, 2 H, C6H5).   
13C-NMR (CDCl3, 100 MHz): 32.9; 37.2; 41.3; 41.5; 55.8; 71.9; 123.7 (q, J = 288.8, CF3); 127.8; 
128.7; 129.9; 132.8; 132.9; 134.0; 166.3.   
19F-NMR (CDCl3, 376 MHz): –71.9.   
IR: 2947w; 1747m; 1451w; 1270m; 1169m; 1125w; 1017w.   
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EI-HR-MS: 326.1327 (M+, C17H17O3F3+; Ber. 326.1130). 
[α]D
25
=+58.4 (c = 1.0, CHCl3).  
((1S,5R,6S)-bicyclo[3.2.0]hept-2-en-6-yloxy)triisopropylsilane 18a 
 
Alcohol 18 (15.2 g, 138 mmol, 1eq) was dissolved in 100 mL DMF. To this solution imidazole (331 
mmol, 22.5 g, 2.4 eq) and TIPSCl (152 mmol, 29.2 g, 1.1 eq) were added. The reaction was stirred 
over night, quenched with water and diluted with diethyl ether. The phases were separated. The 
aqueous phase was extracted three times with diethyl ether, the combined organic layers were dried 
over magnesium sulfate, the solvents were removed in vacuo and the crude product was submitted to 
flash column chromatography (hexane:ethylacetate 20:1) to give 36.7 g 99% of compound 18a. 
1H-NMR (400MHz, CDCl3): δ= 5.83-5.81 p.p.m. (m, 1H), 5.79-5.76 (m, 1H), 4.53 (dd, J=14.0, 7.2 
Hz, 1H), 3.16-3.08 (m, 1H), 2.99-2.92 (m, 1H), 2.61 (dddd, J=12.1, 8.5, 7.2, 1.9 Hz, 2.31 (dddd, 
J=17.0, 10.2, 1.8, 1.8 Hz, 1H), 1.66-1.64 (m, 1H), 1.03 (s, 20H).  
13C-NMR (100MHz, CDCl3): δ= 134.49 p.p.m., 132.85, 65.46, 43.97, 40.93, 38.77, 31.27, 17.94, 
17.91, 12.05. 
HRMS (ESI) (m/z ): [M]+  calcd for C16H30OSi 266.2065; found, 266.2054. 
2-((1R,2R,4S)-2-(hydroxymethyl)-4-(triisopropylsilyloxy)cyclobutyl)ethanol 21 
 
Bicycle 18a ( 13.3 g, 50 mmol 1eq.) was dissolved in 300 mL DCM and 100 mL MeOH and cooled to 
-78°C. Ozone was bubbled through until the solution turned dark blue. Air was then bubbled through 
until the color deceased again and the cooling bath was removed. 200 mL MeOH  were added and 
NaBH4 (5.7g, 150 mmol, 3eq) was added. The reaction mixture was stirred at room temperature for 
two hours and quenched by slow addition of water (50 mL then 500 mL 1M HCl). The phases were 
separated and the water phase was further extracted three times with DCM. The combined organic 
layers were dried over magnesium sulfate, the solvents were removed under reduced pressure and 
submitted to flash column chromatography (hexane:ethylacetate 1:1) to yield 14.1 g diol 21 in 93% 
over two steps. 
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1H-NMR (400MHz, CDCl3): δ= 4.33 p.p.m. (dd, J=14.1, 7.3 Hz, 1H), 3.79 (ddd, J=10.4, 5.8, 4.6 Hz, 
1H), 3.70 (dd, J=11.0, 9.2 Hz, 1H), 3.66-3.62 (m, 1H), 3.57 (dd, J=11.1, 5.0 Hz, 1H), 2.70-2.58 (m, 
3H), 2.32-2.24 (m, 1H), 2.23-2.14 (m, 1H), 2.02-1.94 (m, 1H) 1.81 (ddd, J=14.8, 7.7, 4.9 Hz, 1H), 
1.68-1.61 (m, 1H), 1.05 (s, 20H). 
13C-NMR (100MHz, CDCl3): δ= 65.93 p.p.m.,63.48, 62.86, 42.91, 34.61, 32.27, 25.56, 18.12, 18.05, 
12.21. 
HRMS (ESI) (m/z ): [M]+  calcd for C16H34O3Si 302,2277; found, 302,2270. 
[α]D= +45.7 (c 0.7g/100mL, CHCl3). 
((1R,2R,3S)-2-(2-((4-methoxyphenyl)diphenylmethoxy)ethyl)-3-
(triisopropylsilyloxy)cyclobutyl)methanol 22 and 
2-((1R,2R,4S)-2-(((4-methoxyphenyl)diphenylmethoxy)methyl)-4-
(triisopropylsilyloxy)cyclobutyl)ethanol 23 
 
Diol 21 (14.1 g, 46.5 mmol, 1eq) was dissolved in 500 mL pyridine and cooled to -42°C. Dimethyl 
aminopyridine ( 284 mg, 2.3 mmol, 5 mol%) was added and MMTrCl ( 10.8 g, 34.8 mmol, 75 mol%) 
dissolved in 50 mL pyridine was added dropwise. The reaction was stirred over night, and was then 
concentrated. The residue was re-dissolved  in 200 mL DCM and extracted with 0.5M HCl. The 
phases were separated and the water phase was extracted two times with DCM. The combined organic 
layers were dried over magnesium sulfate, the solvents were removed under reduced pressure and the 
crude product was submitted to flash column chromatography (hexane:ethylacetate 5:1) to yield 14.7 g 
of 22 55% and 5.4 g of 23 20% yield. 
22: 
1H-NMR (400MHz, CDCl3): δ= 7.44-7.39 p.p.m. (m, 4H), 7.32-7.16 (m, 8H), 6.85-6.81 (m, 2H), 4.33 
(dd, J=14.6, 7.6 Hz, 1H), 3.79 (s, 3H), 3.63-3.49 (m, 2H), 3.14 (dd, J=9.3, 5.8 Hz, 1H), 2.98 (t, J=8.7 
Hz, 1H), 2.70-2.62 (m, 1H), 2.59 (dd, J=5.8, 4.5 Hz, 1H), 2.35-2.24 (m, 2H), 1.88-1.77 (m, 1H), 1.67 
(dd, J=17.7, 9.3 Hz, 1H), 1.48 (ddd, J=14.5, 9.9, 5.0 Hz, 1H), 1.03 (s, 20H). 
13C-NMR (100MHz, CDCl3): δ= 158.46 p.p.m., 144.56, 135.90, 130.28,  129.20, 128.39, 127.88, 
127.73, 127.18, 126.80, 113.02, 65.89, 63.82, 62.65, 55.18, 43.02, 35.43, 29.15, 26.45, 17.94, 17.85, 
12.04. 
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HRMS (ESI) (m/z ): [M]+  calcd for C36H50O4Si 574.3478; found, 574.3469. 
[α]D= 17.3 (c 1.05g/100mL, CHCl3). 
1H-NMR (400MHz, CDCl3): δ= 7.45-7.41 p.p.m. (m, 4H), 7.32-7.18 (m, 8H), 6.81 (d, J=9.1 Hz, 2H), 
4.25 (dd, J=13.3, 6.7 Hz, 1H), 3.79 (s, 3H), 3.67-3.61 (m, 1H), 3.59-3.53 (m, 1H), 3.21 (dt, J=8.8, 6.7 
Hz, 1H), 3.04 (dt, J=8.8, 6.8 Hz, 1H), 2.63 (ddd, J=14.7, 10.0, 7.3 Hz, 1H), 2.34-2.27 (m, 1H), 2.20-
2.11 (m, 1H), 2.07-1.98 (m, 1H), 1.85-1.74 (m, 2H), 1.68 (ddd, J=11.1, 8.5, 6.7 Hz, 1H), 0.96 (s, 20H.  
13C-NMR (100MHz, CDCl3): δ= 158.39 p.p.m., 144.84, 136.13, 130.35, 128.50, 127.73, 126.70, 
112.98, 66.44, 63.38, 63.05, 55.16, 40.64, 34.34, 32.98, 24.09, 17.94, 17.89, 11.95. 
HRMS (ESI) (m/z ): [M]+  calcd for C36H50O4Si 574.3478; found, 574.3471. 
[α]D= +19 (c 1.4g/100mL, CHCl3). 
(1R,2R,3S)-2-(2-((4-methoxyphenyl)diphenylmethoxy)ethyl)-3-
(triisopropylsilyloxy)cyclobutanecarbaldehyde 22a 
 
Alcohol 22 (14.7 g, 25.6 mmol, 1eq) was dissolved in ethylacetate and IBX (21.5g, 76.7 mmol, 3eq) 
was added. The suspension was vigorously stirred and heated at reflux for three hours. The reaction 
mixture was cooled to room temperature, the solids were filtered off and the solvents were removed in 
vacuo. The crude product was submitted to the next reaction without further purification. 
1H-NMR (400MHz, CDCl3): δ= 9.65 p.p.m. (d, J=2.3, 1H), 7.42-7.39 (m, 4H), 7.30-7.18 (m, 8H), 
6.81 (d, J=8.8 Hz, 2H), 4.36 (dd, J=14.3, 7.2 Hz, 1H), 3.79 (s, 3H), 3.15-3.02 (m, 3H), 2.81-2.74 (m, 
1H), 2.41 (ddd, J=11.7, 9.3, 7.9 Hz, 1H), 2.27-2.19 (m, 1), 2.10 (dt, J=13.9, 6.8 Hz, 1H), 1.79-1.68 
(m, 1H), 0.87 (s, 20H). 
13C-NMR (100MHz, CDCl3): δ= 202.94 p.p.m., 158.42, 144.83, 136.05, 130.26, 128.42, 127.77, 
126.74, 112.93, 65.26, 62.66, 55.13, 43.81, 41.70, 31.36, 24.75, 17.87, 11.97. 
HRMS (ESI) (m/z ): [M]+  calcd for C36H48O4Si 572.3322; found, 572.3314. 
(1S,2R,3S)-2-(2-((4-methoxyphenyl)diphenylmethoxy)ethyl)-3-
(triisopropylsilyloxy)cyclobutanecarbaldehyde 24 
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Crude aldehyde 22a was dissolved in a minimum of DCM and then diluted with 350 mL methanol. 
The solution was stirred at room temperature, and potassium carbonate (17.8 g, 127.8 mmol, 5eq.) was 
added. The reaction mixture was stirred for 1.5 hours, diluted with water and acidified. The water 
phase was extracted three times with diethyl ether, the combined organic layers were dried over 
magnesium sulfate, the solvents were removed in vacuo and the crude product was submitted to flash 
column chromatography (hexane: ethylacetate 10:1 ) to give 13.4 g, 92% of 24 over two steps. 
1H-NMR (400MHz, CDCl3): δ= 9.66 p.p.m. (d, J=1.5 Hz, 1H), 7.43-7.39 (m, 4H), 7.31-7.25 (m, 6H), 
7.22-7.18 (m, 2H), 6.81 (d, J=8.8 Hz, 2H), 4.36 (dd, J=12.8, 6.2, Hz, 1H), 3.78 (s, 3H), 3.18-3.12 (m, 
2H), 2.86-2.77 (m, 2H), 2.55-2.48 (m, 1H), 2.12-2.03 (m, 2H), 1.88-1.79 (m, 1H), 1.02 (s, 20H). 
13C-NMR (100MHz, CDCl3): δ= 202.41 p.p.m., 144.93, 130.46, 128.57, 127.89, 126.92, 113.21, 
66.10, 61.96, 55.35, 46.23, 41.35, 31.48, 28.71, 18.02, 12.09. 
HRMS (ESI) (m/z ): [M]+  calcd for C36H48O4Si 572.3322; found, 572.3313. 
[α]D= +23.3 (c 0.57g/100mL, CHCl3). 
Methyl-3-hydroxy-3-((1S,2R,3S)-2-(2-((4-methoxyphenyl)diphenylmethoxy)ethyl)-3-
(triisopropylsilyloxy)cyclobutyl)propanoate 24a 
 
Aldehyde 24 (13.4 g, 23.4 mmol, 1eq) and bromo methyl acetate (3.8 mL ,37.4 mmol, 1.6 eq) were 
dissolved in 25 mL THF and dropwise added to zinc powder (2.75 g, 42 mmol, 1.8 eq) under vigorous 
stirring. The reaction mixture was maintained at reflux for 10 minutes and quenched with water. The 
water phase was extracted three times with diethyl ether, the combined organic layers were dried over 
magnesium sulfate, the solvents were removed in vacuo and the crude product was submitted to flash 
column chromatography (hexane: ethylacetate 5:1 ) to give 14.4 g 95% of compound 24a. 
1H-NMR (400MHz, CDCl3): δ= 7.45-7.41 p.p.m. (m, 4H), 7.32-7.18 (m, 10H), 6.81 (d, J=9.1 Hz, 
2H), 4.40 (dd, J=13.1, 6.8 Hz, 1H), 3.93-3.84 (m, 1H), 3.78 (s, 3H), 3.72-3.70 (m, 1H), 3.67 (s, 1H), 
3.66 (s, 1H), 3.15-3.01 (m, 2H), 2.75 (d, J=3.5 Hz, 0.7H), 2.70 (d, J=3.0 Hz, 0.3H), 2.39-2.20 (m, 
2H), 2.15-1.66 (m, 4H), 0.99 (m, 11H), 0.98 (m, 8H). 
13C-NMR (100MHz, CDCl3): δ= 173.49, p.p.m., 173.23, 158.38, 144.85, 136.14, 130.31, 128.39, 
127.27, 126.58, 112.94, 86.43, 86.13, 70.92, 70.06, 66.15, 62.44, 61.86, 55.16, 51.68, 40.99, 40.72, 
40.44, 40.18, 39.25, 33.44, 31.96, 29.14, 28.84, 17.97, 17.92, 12.02. 
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HRMS (ESI) (m/z ): [M]+  calcd for C39H54O6Si 646.3689; found, 646.3678. 
Methyl-3-((1S,2R,3S)-2-(2-((4-methoxyphenyl)diphenylmethoxy)ethyl)-3-
(triisopropylsilyloxy)cyclobutyl)-3-oxopropanoate 11 
OTIPSMMTrO
O
CO2Me
 
Compound 24a (14.4 g, 22.2 mmol, 1eq), was dissolved in 70 mL ethylacetate. IBX (66.8 mmol, 
18.7g, 3eq) was added and the reaction mixture was heated at reflux for five hours, cooled to room 
temperature and the solids were filtered off. The solution was concentrated in vacuo and submitted to 
flash column chromatography (hexane: ethylacetate= 10:1). The yield was 93% 13.3g of compound 
11. 
1H-NMR (400MHz, CDCl3): δ= 7.40-7.42 p.p.m. (m, 4H, 7.30-7.19 (m, 10H), 6.83-6.79 (m, 2H) 4.41 
(dd, J=13.9, 6.6 Hz, 1H), 3.78 (s, 3H), 3.66 (s, 3H), 3.31 (d, J=15.7 Hz, 1H), 3.24 (d, J=15.7 Hz, 1H), 
3.21-3.11 (m, 2H), 2.95 (ddd, J=9.2, 4.5, 4.5 Hz, 1H), 2.82-2.74 (m, 1H), 2.51 (dddd, J=11.7, 4.3, 4.0, 
3.3 Hz, 1H), 2.17-2.06 (m, 2H), 1.90-1.74 (m, 1H). 
13C-NMR (100MHz, CDCl3): δ= 203.92, 167.52, 158.50, 144.60, 135.95, 130.24, 128.36, 127.75, 
126.83, 113.03, 86.30, 65.48, 61.96, 55.14, 52.19, 47.50, 45.62, 42.82, 32.99, 28.71, 17.82, 11.86. 
p.p.m., 
HRMS (ESI) (m/z ): [M]+  calcd for C39H52O6Si 644.3533; found, 644.3538. 
[α]D= +26 (c 0.55g/100mL, CHCl3). 
(6S)-6,7-bis(tert-butyldimethylsilyloxy)-1-(4-methoxybenzyloxy)-4-methylhept-2-yn-4-ol 28 
 
Literature known ester 26 (9.1 g, 24.1 mmol, 1eq) and weinreb-amine hydrochloride (36.5 mmol, 3.53 
g, 1.5 eq) were dissolved under argon in 50 mL THF at 0°C. Isopropyl magnesium chloride (2M in 
diethyl ether, 145 mL, 72.5 mmol, 3eq) was added slowly over 20 minutes. The reaction mixture was 
stirred for another 20 minutes at ambient temperature and was then carefully quenched with water. 
The phases were separated and the water phase was extracted three times with diethyl ether, the 
combined organic layers were washed with brine, dried over magnesium sulfate, the solvents were 
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removed in vacuo and the crude product was filtered over a short pad of silica gel to give 8.9 g 94% of 
the corresponding weinreb amide. 
This Weinreb Amide was dissolved in 60 mL diethyl ether and was cooled to 0°C under argon. 
Methyllithium (3M in diethyl ether, 24.1 mmol, 8 mL, 1eq) was added dropwise to the solution. The 
reaction was quenched with a saturated solution of ammonium chloride and diluted with diethyl ether. 
The phases were separated and the water phase was extracted three times with diethyl ether, the 
combined organic layers were washed with brine, dried over magnesium sulfate, the solvents were 
removed in vacuo. The crude ketone was added in 20 mL THF to the solution of 27 (28.9 mmol, 5.1 g, 
1.2eq) deprotonated at -78°C with LHMDS (28.9 mL, 28.9 mmol, 1.2eq). After 2.5 hours the reaction 
was quenched with a saturated solution of ammonium chloride and diluted with diethyl ether. The 
phases were separated and the water phase was extracted three times with diethyl ether, the combined 
organic layers were washed with brine, dried over magnesium sulfate, the solvents were removed in 
vacuo and the crude product was submitted to flash column chromatography (hexane: ethylacetate 5:1 
) to give 7.9 g 63% of alcohol 28. 
1H-NMR (400MHz, CDCl3): δ= 7.18-7.14 p.p.m. (m, 2H), 6.78-6.75 (m, 2H), 4.53 (s, 2H), 4.41 (s, 
2H), 4.19-4.13 (m, 1H), 4.06 (s, 3H), 3.57 (dd, J=10.0, 5.0 Hz, 1H), 3.51 (dd, J=10.0, 6.7 Hz, 1H), 
3.25 (s, 3H), 1.93-1.91 (m, 2H), 1.43 (s, 3H), 0.78 (s, 9H), 0.01 (s, 3H), 0.00 (s, 3H). 
13C-NMR (100MHz, CDCl3): δ= 159.04 p.p.m., 129.67, 129.58, 113.82, 96.62, 90.46, 79.03, 71.99, 
71.14, 69.99, 69.49, 57.06, 55.56, 55.29, 48.17, 31.12, 25.78, 18.00, -4.38, -4.77. 
HRMS (ESI) (m/z ): [M]+  calcd for C28H50O5Si2 522.3196; found, 522.3204. 
(6S)-6,7-bis(tert-butyldimethylsilyloxy)-1-(4-methoxybenzyloxy)-4-methylhept-2-yn-4-yl benzoate 
28a 
 
Triethylamine ( 1.7 ml, 12 mmol, 3eq), benzoic-anhydride (1.8 g, 8 mmol, 2 eq) and 
magnesiumbromide etherate (2 g, 8 mmol, 2eq) were added to 30 mL of THF at room temperature and 
stirred for 15 minutes. To this suspension was added alcohol xxx ( 2.1 g, 4.0 mmol, 1eq) in 5 mL THF. 
The reaction vessel became warm and was cooled with a water bath. After 20 minutes the reaction was 
quenched with 5M KOH and was vigorously stirred for 30 minutes at room temperature. The phases 
were separated and the water phase was extracted three times with diethyl ether, the combined organic 
layers were washed with brine, dried over magnesium sulfate, the solvents were removed in vacuo and 
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the crude product was submitted to flash column chromatography (hexane: ethylacetate 10:1 ) to give 
2.38 g 95% of benzoate 28a. 
1H-NMR (400MHz, CDCl3): δ= 8.06-8.02 p.p.m. (m, 2H), 7.57-7.53 (m, 1H), 7.46-7.41 (m, 2H), 7.32-
7.28 (m, 2H), 6.87-6.84 (m, 2H), 4.57 (a, 2H), 4.38-4.35 (m, 1H), 4.20 (s, 2H), 3.79 (s, 3H), 3.69-3.62 
(m, 1H), 3.49-3.46 (m, 1H), 2.56-2.51 (m, 1H), 2.07-2.01 (m, 1H), 1.92 (s, 3H), 0.90-0.89 (m, 18H), 
0.01 (m, 6H), -0.05 (m, 6H). 
13C-NMR (100MHz, CDCl3): δ= 164.51 p.p.m., 159.61, 132.91, 132.67, 131.04, 129.89, 129.54, 
128.26, 113.70, 87.16, 86.31, 82.39, 81.62, 74.85, 71.23, 70.81, 70.43, 67.65, 63.83, 56.81, 55.07, 
45.55, 42.74, 33.01, 29.29, 28.04, 27.38, 25.93, 25.89, 18.34, 18.02, -4.04, -4.58, -5.29, -5.32.  
HRMS (ESI) (m/z ): [M]+  calcd for C35H54O6Si2 626.3458; found, 626.3445. 
(6S)-6,7-bis(tert-butyldimethylsilyloxy)-1-hydroxy-4-methylhept-2-yn-4-yl benzoate 29 
 
Benzoate 28a (5.6 g, 8.9 mmol, 1eq) was dissolved in 60 mL DCM and 3 mL water were added. The 
solution was vigorously stirred when DDQ (3 g, 13.4 mmol, 1.5eq) were added. After stirring at room 
temperature for 2.5 hours the reaction was quenched with sodium thiosulfate and diluted with diethyl 
ether. The phases were separated and the water phase was extracted three times with diethyl ether, the 
combined organic layers were washed with brine, dried over magnesium sulfate, the solvents were 
removed in vacuo and the crude product was submitted to flash column chromatography (hexane: 
ethylacetate 5:1 ) to give 3.83 g 85% of the desired alcohol 29. 
1H-NMR (400MHz, CDCl3): δ= 8.01-7.99 p.p.m. (m, 2H), 7.56-7.52 (m, 1H), 7.43-7.39 (m, 2H), 4.32 
(s, 2H), 4.15 (dddd, J=10.8, 10.8, 5.4, 5.4 Hz, 1H), 3.66-3.64 (m, 2H), 2.49 (dd, J=14.9, 5.8 Hz, 1H), 
2.13 (s (br), 1H), 1.98 (dd, J=14.1, 5.6 Hz, 1H), 1.86 (s, 3H), 0.89 (s, 18H), 0.09 (s, 6H), 0.04 (s, 6H). 
13C-NMR (100MHz, CDCl3): δ= 164.67 p.p.m., 132.79, 130.85, 129.58, 128.26, 85.48, 84.71, 74.93, 
71.17, 67.69, 51.11, 45.53, 27.90, 25.97, 25.91, 18.41, 18.07, -3.97, -4.49, -5.21. 
HRMS (ESI) (m/z ): [M]+  calcd for C27H46O5Si2 506.2883; found, 506.2879. 
(6S)-6,7-bis(tert-butyldimethylsilyloxy)-1-iodo-4-methylhept-2-yn-4-yl benzoate 10 
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Alcohol 29 (3.83 g, 7.55 mmol, 1eq) was dissolved in 70 mL DCM and cooled to 0°C. Then imidazole 
(620 mg, 9.1 mmol, 1.2eq), triphenylphosphine (2.4 g, 9.1 mmol, 1.2 eq) and iodine (2.3 g, 9.1 mmol, 
1.2 eq) were added. The reaction mixture was stirred at that temperature for one hour. Then it was 
diluted with hexane. Triphenylphosphine oxide precipitated and was filtered off. The solution was 
concentrated in vacuo and submitted to flash column chromatography (hexane: ethylacetate= 10:1) to 
give 3.35 g 72% of iodide 10. 
1H-NMR (400MHz, CDCl3): δ= 7.93-7.90 p.p.m. (m, 2H), 7.46-7.42 (m, 1H), 7.34-7.30 (m, 2H), 4.09-
4.03 (m, 1H), 3.65 (s, 2H), 3.56-3.54 (m, 2H), 2.41 (dd, J=14.3, 5.9 Hz, 1H), 1.88 (dd, J=14.4, 5.8 Hz, 
1H), 1.75 (s, 3H), 0.81-0.79 (m, 18H), 0.04 (s, 3H), 0.03 (s, 3H), -0.04 (s, 6H). 
13C-NMR (100MHz, CDCl3): δ= 164.51 p.p.m., 132.89, 130.98, 129.68, 128.38, 84.81, 83.24, 74.84, 
71.02, 67.54, 45.68, 27.72, 26.00, 25.95, 18.43, 18.02, -3.90, -4.35, -5.22. 
HRMS (ESI) (m/z ): [M]+  calcd for C27H45IO4Si2 616.1901; found, 616.1894. 
1H-NMR (400MHz, CDCl3): δ= 7.41-7.39 p.p.m. 
13C-NMR (100MHz, CDCl3): δ= 201.78 p.p.m., 
(2S,4S)-1,2-bis(tert-butyldimethylsilyloxy)-9-methoxy-8-((1S,2R,3S)-2-(2-((4-
methoxyphenyl)diphenylmethoxy)ethyl)-3-(triisopropylsilyloxy)cyclobutanecarbonyl)-4-methyl-9-
oxonon-5-yn-4-yl benzoate 30 
OTIPSMMTrO
O
CO2Me
OBz
TBSO
TBSO
 
A solution of β-Ketoester 11 (9.9 g, 15.35 mmol, 1eq) in 30 mL THF was added to a suspension of 
NaH in 50 mL THF (490 mg, 12.28 mmol, 0.8 eq) at 0°C. The reaction mixture was stirred at that 
temperature for 30 minutes and was then stirred at room temperature for another 30 minutes. A 
solution of Iodide 10 ( 11.51 mmol, 7.1 g, 0.75eq) in 20 mL THF was added at room temperature and 
the mixture was stirred for one hour. The reaction was quenched with an ammonium chloride solution 
and the phases were separated. The water phase was extracted three times with diethyl ether, the 
combined organic layers were dried over magnesium sulfate, the solvents were removed in vacuo and 
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the crude product was submitted to flash column chromatography (hexane: ethylacetate 10:1 ) to give 
11.1 g 85% of compound 30. 
1H-NMR (400MHz, CDCl3): δ= 7.98-7.95 p.p.m. (m, 2H), 7.53-7.49 (m, 1H), 7.41-7.36 (m, 6H), 7.29-
7.17 (m, 10H), 6.81-6.78 (m, 2H), 4.41 (m, 1H), 4.11-4.01 (m, 1H), 3.78-3.77 (m, 3H), 3.68-3.45 (m, 
6H), 3.18-3.06 (m, 2H), 2.90-2.82 (m, 1H), 2.74-2.69 (m, 0.5H), 2.64-2.58 (m, 1.4H), 2.46-2.38 (m, 
2H), 2.16-1.99 (m, 3H), 1.80-1.76 (m, 4H), 0.98-0.94 (m, 20 H), 0.88-0.87 (m, 18H), 0.09-0.02 (m, 
12H). 
13C-NMR (100MHz, CDCl3): δ= 168.48 p.p.m., 158.25, 144.80, 135.84, 132.71, 130.25, 129.41, 
128.39, 128.23, 127.72, 126.69, 112.92, 71.14, 67.69, 65.51, 61.57, 55.10, 52.43, 46.05, 45.42, 44.79, 
42.16, 33.93, 32.98, 29.09, 28.86, 28.09, 25.92, 1836, 17.96, 11.89, -3.98, -5.29. 
HRMS (ESI) (m/z ): [M]+  calcd for C66H96O10Si3 1132.6311; found, 1132.6300. 
Methyl-5-((S,E)-4,5-bis(tert-butyldimethylsilyloxy)-2-methylpent-1-enyl)-2-((1S,2R,3S)-2-(2-((4-
methoxyphenyl)diphenylmethoxy)ethyl)-3-(triisopropylsilyloxy)cyclobutyl)furan-3-carboxylate 31 
 
30 (11.2 g, 9.7 mmol, 1eq) was dissolved in 80mL 10:1 acetonitrile:water, which was degassed before. 
The sequentially palladium diacetate (0.5 mmol, 124 mg, 5 mol%), diphenyl-phosphino ferrocene (0.7 
mmol, 380 mg, 7 mol%) and potassium carbonate (11.6 mmol, 1.61g, 1.2 eq) were added. The 
reaction mixture was heated at reflux for four hours, then cooled to room temperature and poured on 
0.5M HCl. The water phase was extracted three times with diethyl ether, the combined organic layers 
were dried over magnesium sulfate, the solvents were removed in vacuo and the crude product was 
submitted to flash column chromatography (hexane: ethylacetate 20:1 ) to give 8.8 g 90% of furan 31 
as double bond isomers, of which an analytical sample of the E-isomer was separated for 
spectroscopic analysis. 
1H-NMR (400MHz, CDCl3): δ= 7.37-7.33 p.p.m. (m, 4H), 7.24-7.14 (m, 9H), 6.76-6.73 (m, 2H), 6.36 
(s, 1H), 6.03 (s, 1H), 4.68 (dd, J=12.6, 6.1 Hz, 1H), 3.86-3.78 (m, 2H), 3.77 (s, 3H), 3.67 (s, 3H), 3.56 
(dd, J=9.8, 5.1 Hz, 1H), 3.42 (dd, J=9.8, 6.8 Hz, 1H), 3.08 (dd, J=(13.0, 6.2 Hz, 2H), 2.96-2.88 (m, 
1H), 2.48-2.41 (m, 2H), 2.36-2.29 (m, 1H), 2.17 (dd, J=13.1, 7.6 Hz, 1H), 2.13-2.07 (m, 1H), 1.99 (s, 
3H), 1.93-1.84 (m, 1H), 1.01 (s, 20H), 0.90 (s, 9H), 0.84 (s, 9H), 0.05 (s, 6H), 0.02 (s, 3H), -0.04 (s, 
3H). 
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13C-NMR (100MHz, CDCl3): δ= 164.26 p.p.m.,162.52, 158.38, 151.14, 144.88, 136.14, 130.18, 
128.37, 127.62, 126.58, 116.39, 113.52, 112.84, 108.10, 72.06, 67.24, 66.48, 61.66, 55.10, 45.90, 
44.85, 36.33, 32.94, 29.24, 26.00, 19.59, 18.31, 17.94, -4.52, -4.82. 
HRMS (ESI) (m/z ): [M]+  calcd for C59H90O8Si3 1010.5943; found, 1010.5929. 
Methyl-5-((S,Z)-4,5-bis(tert-butyldimethylsilyloxy)-2-methylpent-1-enyl)-2-((1S,2R,3S)-2-(2-
hydroxyethyl)-3-(triisopropylsilyloxy)cyclobutyl)furan-3-carboxylate 31a and 
Methyl-5-((S,E)-4,5-bis(tert-butyldimethylsilyloxy)-2-methylpent-1-enyl)-2-((1S,2R,3S)-2-(2-
hydroxyethyl)-3-(triisopropylsilyloxy)cyclobutyl)furan-3-carboxylate 31b 
 
Geometric isomers of furan 31 (8.8g, 8.7 mmol 1eq), were dissolved in 80 mL THF. 
Diphenyldiselenide (2.6 mmol,820 mg, 30 mol%) was added and the reaction mixture was refluxed for 
two days. The reaction was cooled to room temperature and the solvents removed in vacuo. The crude 
mixture was submitted to flash column chromatography (hexane: ethylacetate 20:1), and directly 
submitted to the next step. 
Furan 31 (8.8 g, 8.7 mmol, 1eq) was dissolved in 25 mL DCM. To this solution 25 mL of 1,1,1,3,3,3-
hexafluoro isopropanol were added dropwise. The solution turned yellow, and after stirring at room 
temperature for 20 minutes 3 mL methanol were added dropwise. The reaction mixture was stirred for 
16 hours and was quenched with sodium hydrogen carbonate. The water phase was extracted three 
times with diethyl ether, the combined organic layers were dried over magnesium sulfate, the solvents 
were removed in vacuo and the crude product was submitted to flash column chromatography 
(hexane: ethylacetate 5:1 ) to give 5.7 g 89% of alcohol 31a. A minor geometrical Z-isomer 31b could 
be easily separated on this step. 
Z-isomer: 
1H-NMR (400MHz, CDCl3): δ= 6.53 p.p.m. (s, 1H), 6.05 (s, 1H), 4.68 (dd, J=12.6, 6.3 Hz, 1H), 3.95-
3.89 (m, 1H), 3.78 (s, 3H), 3.72-3.66 (m, 2H), 3.59 (dd, J=10.0, 5.2 Hz, 1H), 3.44 (dd, J=9.8, 6.6 Hz, 
1H), 2.82-2.74 (m, 1H), 2.68-2.52 (m, 3H), 2.40-2.34 (m, 1H), 2.26-2.22 (m, 1H), 2.09-2.00 (m, 1H), 
1.92 (s, 3H), 1.89-1.83 (m, 1H), 1.07 (s, 20H), 0.89 (s, 9H), 0.81 (s, 9H), 0.05 (s, 6H), 0.03 (s, 3H), -
0.03 (s, 3H). 
 
90 
13C-NMR (100MHz, CDCl3): δ= 164.73 p.p.m., 162.11, 137.63, 116.08, 113.30, 108.15, 71.78, 67.98, 
66.95, 61.17, 51.18, 45.87, 38.82, 35.73, 32.88, 31.77, 25.98, 18.14, 12.28, -4.35, -4.83, -5.30. 
HRMS (ESI) (m/z ): [M]+  calcd for C39H74O7Si3 738.4742; found, 738.4734. 
[α]D= +23.5 (c 0.2g/100mL, CHCl3). 
E-isomer: 
1H-NMR (400MHz, CDCl3): δ= 6.36 p.p.m. (s, 1H), 6.06 (s, 1H), 4.76 (dd, J=9.5, 4.7 Hz, 1H), 3.80 
(s, 3H), 3.75-3.70 (m, 2H), 3.56 (dd, J=9.8, 5.0 Hz, 1H), 3.42 (dd, J=10.0, 6.8 Hz, 1H), 2.79-2.71 (m, 
1H), 2.63-2.56 (m, 1H), 2.48-2.41 (m, 2H), 2.33-2.28 (m, 1H), 2.18 (dd, J=13.4, 7.3 Hz, 1H), 2.08 
(dd, J=14.0, 7.2 Hz, 1H), 2.02 (s, 3H), 1.94-1.89 (m, 1H), 1.07 (s, 20H), 0.91 (s, 9H), 0.85 (s, 9H), 
0.06 (s, 6H), 0.04 (s, 3H), -0.01 (s, 3H). 
13C-NMR (100MHz, CDCl3): δ= 164.61 p.p.m., 162.52, 136.42, 115.92, 113.49, 108.03, 71.81, 67.09, 
66.62, 61.16, 51.31, 46.32, 45.78, 35.87, 32.23, 31.82, 26.03, 19.62, 17.93, 12.20, -4.31, -4.99, -5.33. 
HRMS (ESI) (m/z ): [M]+  calcd for C39H74O7Si3 738.4742; found, 738.4730. 
[α]D= -10 (c 0.35g/100mL, CHCl3). 
Methyl-5-((S,E)-4,5-bis(tert-butyldimethylsilyloxy)-2-methylpent-1-enyl)-2-((1S,2R,3S)-2-(3-
(dimethoxyphosphoryl)-2-oxopropyl)-3-(triisopropylsilyloxy)cyclobutyl)furan-3-carboxylate 32 
 
Oxallyl chloride (75 µL, 0.86 mmol, 2eq), was dissolved in 2 mL DCM and cooled to -78°C. Then 
DMSO (125 µL, 1.72 mmol, 4 eq) was added and the mixture was stirred for 15 minutes. Alcohol 31b 
(318 mg, 0.43 mmol, 1eq) dissolved in 2mL DCM was added and the reaction mixture was stirred for 
one hour. Then triethylamine (370µL, 2.58 mmol, 6eq) was added dropwise and after stirring at -78°C 
for 20 minutes the reaction was warmed to 0°C and stirred for 45 minutes before it was quenched with 
an ammonium chloride solution. The water phase was extracted three times with diethyl ether, the 
combined organic layers were dried over magnesium sulfate, the solvents were removed in vacuo and 
the crude product was directly submitted to the next step.  
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To a solution of 2.5M n-butyllithium (345µL, 0.86 mmol, 2eq) in 2mL THF was added methyl-
dimethylphosphonate (95µL, 0.86 mmol, 2 eq) at -78°C. The mixture was stirred at that temperature 
for one hour before the crude aldehyde in 2mL THF was added. The raction was quenched after 30 
minutes with water. The water phase was extracted three times with diethyl ether, the combined 
organic layers were dried over magnesium sulfate, the solvents were removed in vacuo and the crude 
product was directly submitted to the next step.  
Oxallyl chloride (75 µL, 0.86 mmol, 2eq), was dissolved in 2 mL DCM and cooled to -78°C. Then 
DMSO (125 µL, 1.72 mmol, 4 eq) was added and the mixture was stirred for 15 minutes. Phosphono-
alcohol dissolved in 2mL DCM was added and the reaction mixture was stirred for one hour. Then 
triethylamine (370µL, 2.58 mmol, 6eq) was added dropwise and after stirring at -78°C for 20 minutes 
the reaction was warmed to 0°C and stirred for 45 minutes before it was quenched with an ammonium 
chloride solution. The water phase was extracted three times with diethyl ether, the combined organic 
layers were dried over magnesium sulfate, the solvents were removed in vacuo and the crude product 
was submitted to flash column chromatography (hexane: ethylacetate 1:1 ) to give 255 mg 68% of the 
phosphonate 32. 
1H-NMR (400MHz, CDCl3): δ= 6.39 p.p.m. (s, 1H), 6.07 (s, 1H), 4.47 (dd, J=14.9, 7.4 Hz, 1H), 3.92-
3.87 (m, 1H), 3.80 (s, 3H), 3.69 (d, J=5.6 Hz, 3H), 3.68 (d, J=6.0 Hz, 3H), 3.56 (dd, J=10.0, 5.2 Hz, 
1H), 3.54-3.50 (m, 1H), 3.42 (dd, J=9.8, 6.8 Hz, 1H), 2.95-2.84 (m, 3H), 2.62-2.55 (m, 1H), 2.54-2.46 
(m, 3H), 2.19 (dd, J=13.6, 7.5 Hz, 1H), 2.01 (s, 3H), 1.04 (s, 20H), 0.91 (s, 9H), 0.86 (s, 9H), 0.06 (s, 
3H), 0.05 (s, 3H), 0.04 (s, 3H), 0.00 (s, 3H). 
13C-NMR (100MHz, CDCl3): δ= 200.62 p.p.m., 164.18, 158.43, 152.08, 137.10, 116.24, 115.41, 
108.21, 71.78, 67.11, 64.35, 52.73, 51.41, 45.78, 44.10, 41.70, 40.98, 39.30, 34.87, 27.08, 25.88, 
19.65, 17.97, 12.10, -4.19, -4.79, -5.27. 
HRMS (ESI) (m/z ): [M]+  calcd for C42H79O10PSi3 848.4718; found, 848.4709. 
[α]D= -43 (c 0.5g/100mL, CHCl3). 
Compound 34 
 
Phosphonate 32 (255 mg, 0.3 mmol, 1eq) was dissolved in 1.5 mL methanol. Ammonium fluoride (15 
mmol, 570 mg, 50 eq) was added and the reaction mixture was stirred for 24 hours. The mixture was 
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poured on a brine solution and the water phase was extracted three times with DCM, the combined 
organic layers were dried over magnesium sulfate, the solvents were removed in vacuo and the crude 
product was submitted to flash column chromatography (hexane: ethylacetate 1:1 ) to give 100 mg, 
45% of the primary alcohol which was directly submitted to the next reaction. 
Primary alcohol was dissolved in 1 mL DCM and Dess-Martin periodinane (0.27 mmol, 114 mg, 2eq) 
was added. The reaction mixture was stirred at room temperature for one hour and poured on a brine 
solution. The water phase was extracted three times with DCM, the combined organic layers were 
dried over magnesium sulfate, the solvents were removed in vacuo and the crude product was filtered 
over a short pad of silica gel and directly submitted to the macrocyclization, as the aldehyde 33 turned 
out to be very instable. 
10 mL 1,1,1,3,3,3-hexafluoro-isopropanol were dissolved in 50 mL THF and cooled to 0°C. n-
butyllithium (2.5M, 162 µL, 3eq) was added dropwise and the reaction mixture was stirred at 0°C for 
30 minutes. The crude aldehyde dissolved in 40 mL THF was then added via a syringe pump over 1 
hour. The reaction was stirred at room temperature for another 4 hours. The reaction was the quenched 
with water. The aqueous phase was extracted three times with DCM, the combined organic layers 
were dried over magnesium sulfate, the solvents were removed in vacuo and the crude product was 
submitted to flash column chromatography (hexane: ethylacetate 5:1 ) to give 37 mg 45% of 
macrocycle 34. 
1H-NMR (400MHz, CDCl3): δ= 6.74 p.p.m. (dd, J=16.0, 4.3 Hz, 1H), 6.42 (s, 1H), 6.07 (s, 1H), 6.06 
(dd, J=16.0, 1.3 Hz, 1H), 4.49-4.42 (m, 2H), 4.07-4.01 (m, 1H), 3.80 (s, 3H), 3.50-3.44 (m, 1H), 3.12 
(dd, J=18.9, 10.2 Hz, 1H), 2.87 (dd, J=18.5, 5.3 Hz, 1H), 2.50-2.45 (m, 2H), 2.41 (dd, J=12.8, 7.5 Hz, 
1H), 2.24 (dd, J=13.2, 6.4 Hz, 1H), 1.98 (s, 3H), 1.72-1.66 (m, 1H), 0.97 (s, 20H), 0.85 (s, 9H), 0.02 
(s, 3H), -0.01 (s, 3H). 
13C-NMR (100MHz, CDCl3): δ= 202.61 p.p.m., 164.18, 158.44, 152.11, 147.59, 128.49, 116.90, 
108.49, 70.19, 64.07, 51.20, 49.82, 43.54, 36.54, 34.57, 30.40, 26.10, 25.94, 19.34, 18.30, 11.86, -
5.49, -5.60. 
HRMS (ESI) (m/z ): [M]+  calcd for C34H56O6Si2 616.3615; found, 616.3608. 
[α]D= -76 (c 0.15g/100mL, CHCl3). 
 
Methyl-6-(methoxycarbonyloxy)-2-((1S,2R,3S)-2-(2-((4-methoxyphenyl)diphenylmethoxy)ethyl)-3-
(triisopropylsilyloxy)cyclobutanecarbonyl)hex-4-ynoate 45 
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A solution of β-Ketoester 11 (9.9 g, 15.35 mmol, 1eq) in 30 mL THF was added to a suspension of 
NaH in 50 mL THF (490 mg, 12.28 mmol, 0.8 eq) at 0°C. The reaction mixture was stirred at that 
temperature for 30 minutes and was then stirred at room temperature for another 30 minutes. A 
solution of Iodide ( 10.75 mmol, 2.9 g, 0.75eq) in 20 mL THF was added at room temperature and the 
mixture was stirred for one hour. The reaction was quenched with an ammonium chloride solution and 
the phases were separated. The water phase was extracted three times with diethyl ether, the combined 
organic layers were dried over magnesium sulfate, the solvents were removed in vacuo and the crude 
product was submitted to flash column chromatography (hexane: ethylacetate 10:1 ) to give 6.9 g 84% 
of compound 45. 
1H-NMR (400MHz, CDCl3): δ= 7.41-7.39 p.p.m. (m, 4H), 7.29-7.18 (m, (8H), 6.82-6.78 (m, 2H), 4.28 
(dd, J=15.6, 7.1 Hz, 1H), 3.78 (s, 3H), 3.69 (s, 3H), 3.28 (d, J=15.4 Hz, 1H), 3.18 (d, J=15.4 Hz, 1H), 
3.14-2.96 (m, 4H), 2.45 (dd, J=19.7, 10.9 Hz, 1H), 2.18-2.07 (m, 2H), 1.63-1.55 (m, 1H), 0.98 (s, 
20H). 
13C-NMR (100MHz, CDCl3): δ= 201.78 p.p.m., 167.94, 158.44, 144.83, 136.10, 130.37, 128.44, 
127.65, 126.68, 113.02, 64.08, 62.55, 55.29, 52.28, 48.99, 44.29, 40.09, 32.21, 24.61, 17.80, 11.85. 
HRMS (ESI) (m/z ): [M]+  calcd for C45H58O9Si 770.3850; found, 770.3842. 
Methyl-2-((1S,2R,3S)-2-(2-hydroxyethyl)-3-(triisopropylsilyloxy)cyclobutyl)-5-vinylfuran-3-
carboxylate 46 
 
45 (3 g, 3.8 mmol, 1eq) was dissolved in 130mL THF, which was degassed before. Then sequentially 
palladium diacetate (0.19 mmol, 49 mg, 5 mol%), diphenyl-phosphino ferrocene (0.26 mmol, 150 mg, 
7 mol%) and potassium carbonate (24.6 mmol, 3.4 g, 6.5 eq) were added. The reaction mixture was 
heated at reflux for four hours, then cooled to room temperature and poured on 0.5M HCl. The water 
phase was extracted three times with diethyl ether, the combined organic layers were dried over 
 
94 
magnesium sulfate, the solvents were removed in vacuo and the crude product was submitted to flash 
column chromatography (hexane: ethylacetate 20:1 ) to give 1.2 g 75% of furan 46 which was 
subsequently subjected to the deprotection reaction of the MMTr-group. 
1H-NMR (400MHz, CDCl3): δ= 7.39-7.19 p.p.m. (m, 12H), 6.78 (d, J=8.9 Hz, 1H), 6.51-6.40 (m, 
1H), 6.48 (s, 1H), 5.67 (d, J=17.4 Hz, 1H), 5.21 (d, J=11.3 Hz, 1H), 4.72-4.63 (m, 1H), 4.19 (ddd, 
J=14.3, 7.2, 7.2 Hz, 1H), 4.01-3.89 (m, 1H), 3.80 (s, 3H), 3.71 (s, 3H), 3.14-3.01 (m, 3H), 2.54-2.45 
(m, 1H), 2.38-2.28 (m, 1H), 2.10 (ddd, J=13.4, 13.4, 6.9 Hz, 1H), 1.97-1.83 (m, 1H), 1.06 (s, 20H). 
[α]D= +16.4 (c 0.48g/100mL, CH2Cl2). 
MMTr-protected Furan 46 (5.3 g, 7.6 mmol, 1eq) was dissolved in 25 mL DCM. To this solution 25 
mL of 1,1,1,3,3,3-hexafluoro isopropanol were added dropwise. The solution turned yellow and after 
stirring at room temperature for 20 minutes 3 mL methanol were added dropwise. The reaction 
mixture was stirred for 16 hours and was quenched with sodium hydrogen carbonate. The water phase 
was extracted three times with diethyl ether, the combined organic layers were dried over magnesium 
sulfate, the solvents were removed in vacuo and the crude product was filtered over a short pad silica 
gel to give 2.73 g, 85% of alcohol 46a.  
1H-NMR (400MHz, CDCl3): δ= 6.50-6.40 p.p.m. 6.47 (s, 1H), 5.68-5.62 (m, 1H), 5.21 (dt, J=11.5, 1.2 
Hz, 1H), 4.77-4.69 (m, 1H), 4.15-3.95 (m, 3H), 3.81 (d, J=1.5 Hz, 3H), 2.86-2.75 (m, 1H), 2.61-2.53 
(m, 1H), 2.41-2.31 (m, 1H), 2.18-2.09 (m, 1H), 2.06-1.97 (m, 1H), 1.07 (s, 20H). 
13C-NMR (100MHz, CDCl3): δ= 164.18 p.p.m., 163.28, 150.78, 124.30, 112.78, 108.61, 66.64, 66.39, 
51.50, 44.07, 38.27, 35.99, 33.21, 29.15, 17.99, 12.11. 
HRMS (ESI) (m/z ): [M]+  calcd for C23H38O5Si 422.2488; found, 422.2219. 
[α]D= +25.4 (c 0.5g/100mL, CHCl3). 
(5S)-5-(2-methylallyl)-3-(phenylselanyl)dihydrofuran-2(3H)-one 39 
 
Literature known alcohol 42 (11.73 g, 43.4 mmol, 1eq) was dissolved in 40 mL THF and added to a 
suspension of NaH (1.82 g, 45.5 mmol, 1.05 eq) at 0°C. The epoxide formed in situ was then added at 
-78°C to a solution of dianion B. The dianion was prior prepared as follows: Diisopropylamine (19 
mL, 134.5 mmol, 3.1eq) was added to 65 mL of THF and cooled to 0°C. Then n-butyllithium (2.5M, 
53.8 mL, 134.5 mmol, 3.1 eq) was added dropwise and the reaction mixture was stirred for 20 minutes 
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at 0°C followed by stirring at room temperature for 30 minutes. At -20°C phenylselenyl acetic acid (14 
g, 65.1 mmol, 1.5eq) in 65mL of THF is then added and the reaction mixture is stirred at that 
temperature for 2 hours. To this dianion is then added the epoxide 43.  
After the epoxide addition the reaction is warmed to room temperature over night. The reaction is 
quenched with 1M HCl and the aqueous phase is extracted three times with DCM. The combined 
organic layers were dried over magnesium sulfate, the solvents were removed in vacuo and the crude 
product was dissolved in benzene and catalytic amount of p-toluene sulfonic acid was added. The 
reaction is heated at reflux with a Dean-Stark trap for one hour. Then the reaction is cooled to room 
temperature and the solvents are removed under reduced pressure. The crude product was submitted to 
flash column chromatography (hexane:ethylacetate 5:1) to give 9.3 g 73% of lactone 39. 
1H-NMR (400MHz, CDCl3): δ= 7.69 p.p.m. (m, 2H), 7.35 (m, 1H), 7.34 (m, 2H), 4.84 (s, 1H), 4.73 (s, 
1H), 4.42 (dddd, J=7.0, 7.0, 6.8, 6.8 Hz, 1H), 3.94 (, dd, J=6.5, 4.5 Hz, 1H), 2.45 (dd, J=14.3, 6.9 Hz, 
1H), 2.35 (m, 1H), 2.23 (dd, J=14.3, 6.1 Hz, 1H), 1.71 (s, 3H). 
13C-NMR (100MHz, CDCl3): δ= 175.58 p.p.m., 140.08, 135.89, 129.89, 129.81, 129.22, 126.70, 
113.85, 77.61, 43.15, 36.91, 36.47, 22.70. 
HRMS (ESI) (m/z ): [M]+  calcd for C23H38O5Si 296.0315; found, 296.0301. 
Methyl-2-((1S,2R,3S)-2-(2-hydroxy-2-(5-(2-methylallyl)-2-oxo-3-(phenylselanyl)tetrahydrofuran-3-
yl)ethyl)-3-(triisopropylsilyloxy)cyclobutyl)-5-vinylfuran-3-carboxylate 47 
 
Oxallyl chloride (2 mL, 23.2 mmol, 2eq), was dissolved in 20 mL DCM and cooled to -78°C. Then 
DMSO (3.3 mL, 46.4 mmol, 4 eq) was added and the mixture was stirred for 15 minutes. Alcohol 46a 
(4.9 g, 11.6 mmol, 1 eq) dissolved in 20 mL DCM was added and the reaction mixture was stirred for 
one hour. Then triethylamine (9.8 mL, 69.6 mmol, 6eq) was added dropwise and after stirring at -78°C 
for 20 minutes the reaction was warmed to 0°C and stirred for 45 minutes before it was quenched with 
an ammonium chloride solution. The water phase was extracted three times with diethyl ether, the 
combined organic layers were dried over magnesium sulfate, the solvents were removed in vacuo and 
the crude product was filtered over a short pad silica gel to give the corresponding aldehyde 40 4.9g 
99% which was directly used in the next reaction. 
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LiHMDS (1M in THF, 33.5 mL, 33.5 mmol, 3eq) was added to 40 mL of THF at -78°C. Then lactone 
xxx (10g, 33.5 mmol, 3eq) dissolved in 20 mL THF was added dropwise to this solution at -78°C. The 
reaction was stirred at that temperature for one hour. Then aldehyde 40 (4.9 g, 11.6 mmol, 1eq) was 
added and the reaction was left for another hour at -78°C. Then it was quenched with a saturated 
ammonium chloride solution. The phases were separated and the aqueous phase was extracted three 
times with DCM. The combined organic layers were dried over magnesium sulfate, the solvents were 
removed in vacuo and the crude product was submitted to flash column chromatography 
(hexane:ethylacetate 5:1) to give 5.4 g 65% of seleno-lactone 47 as a mixture of diastereomers. An 
analytical sample of one diastereomer was separated by HPLC for spectroscopic analysis. 
1H-NMR (400MHz, CDCl3): δ= 7.70 p.p.m. (m, 2H), 7.40 (m, 1H), 7.30 (m, 2H), 6.45 (s, 1H), 6.43 
(dd, J=17.3, 12.5 Hz, 1H), 5.65 (d, J=17.3 Hz, 1H), 5.20 (d, J=12.5 Hz, 1H), 4.81 (s, 1H), 4.58 (dddd, 
J=9.0, 6.8, 6.8, 6.8 Hz, 1H), 4.57 (m, 1H), 3.91 (ddd, J=9.1, 5.8, 5.9 Hz, 1H), 3.85 ( (d, J=10.7 Hz, 
1H), 3.74 (s, 3H), 3.03 (m, 1H), 2.82 (m, 1H), 2.60 (m, 1H), 2.44 (dd, J=14.5, 7.0 Hz, 1H), 2.34 (m, 
1H), 2.21 (m, 1H), 2.20 (m,1 H), 2.19 (m, 1H), 2.17 (m, 1H), 1.64 (s, 3H), 1.09 (m, 20H). 
13C-NMR (100MHz, CDCl3): δ= 164.72 p.p.m., 163.84, 151.28, 140.47, 138.83, 130.17, 129.55, 
126.11, 124.81, 114.10, 113.43, 109.02, 76.63, 72.02, 67.45, 56.69, 45.57, 43.62, 38.59, 36.05, 33.82, 
32.15, 23.00, 18.44, 18.38, 12.57. 
HRMS (ESI) (m/z ): [M]+  calcd for C37H52O7SeSi 716.2647; found, 716.2639. 
Compounds 48a and 48b 
 
The diastereomeric mixture of 47 (1.55 g, 2.15 mmol, 1eq) was dissolved in 70 mL DCM and cooled 
to 0°C. 15 mL of a saturated ammonium chloride solution were added and the biphasic system was 
vigorously stirred. To this reaction mixture 75 mL of 30% hydrogen peroxide were added via a 
dropping funnel. After completion of addition the reaction mixture was stirred for another 20 minutes 
at room temperature before it was diluted with water and the phases were separated. The aqueous 
phase was extracted three times with DCM. The combined organic layers were dried over magnesium 
sulfate, the solvents were removed in vacuo and the crude product was submitted to filtration over a 
pad of silica gel to give 1.0 g 87% of metathesis precursor 38. 
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The diastereomeric mixture of 38 (1 g, 1.87 mmol, 1eq) was dissolved in 1L benzene prior degassed 
by two pump and freeze cycles. Grubbs II catalyst (0.28 mmol, 238 mg, 15mol%) was dissolved in 5 
mL benzene and added over two hours to the refluxing solution of xxx in benzene. After this time the 
reaction mixture was cooled to room temperature and the solvent was removed in vacuo. The crude 
product was submitted to flash column chromatography (hexane:ethylacetate 5:1) to give 310 mg 31% 
of compound 48a and 238 mg 24% of compound 48b. 
13-(R)-diastereomer 48a 
1H-NMR (400MHz, CDCl3): δ= 6.57 p.p.m. (s, 1H), 6.45 (s, 1H), 6.12 (s, 1H), 4.92 (dd, J=11.2, 3.8 
Hz, 1H), 4.41 (dd, 5.6, 5.6 Hz, 1H), 4.24 (m, 1H), 4.17 (ddd, J=9.2, 9.2, 9.2 Hz, 1H), 3.81 (s, 3H), 
3.03 ( (d,, J=12.2, 11.2 Hz, 1H), 2.75 (dd, J=12.2, 4.1 Hz, 1H), 2.47 (m, 1H), 2.38 (ddd, J=12.7, 12.7, 
4.0 Hz, 1H), 2.27 (m, 1H), 2.24 (m, 1H), 2.07 (m, 1H), 2.00 (s, 3H), 1.05 (d, J=7.1 Hz, 20H). 
13C-NMR (100MHz, CDCl3): δ= 171.79 p.p.m., 163.72, 162.24, 153.55, 149.72, 131.50, 129.78, 
117.10, 113.82, 111.48, 78.51, 68.34, 66.07, 51.57, 42.12, 40.28, 39.51, 37.75, 36.14, 26.37, 18.06, 
18.00, 12.13. 
HRMS (ESI) (m/z ): [M]+  calcd for C29H42O7Si 530.2699; found, 530.2687. 
[α]D= +69.3 (c 0.42/100mL, CH2Cl2). 
13-(S)-diastereomer 48b 
1H-NMR (400MHz, CDCl3): δ= 6.83 p.p.m. (s, 1H), 6.38 (s, 1H), 6.06 (s, 1H), 4.91 (dm, J=11.8 Hz, 
1H), 4.72 (m, 1H), 4.35 (dd, J=15.9, 5.9 Hz, 1H), 4.23 (ddd, J=9.3, 9.3, 9.3 Hz, 1H), 3.73 (s, 3H), 
3.05 (dd, J=11.7, 11.7 Hz, 1H), 2.68 (dd, J=11.7, 4.5 Hz, 1), 2.54 (m, 1H), 2.33 (m, 1H), 2.18 (m, 
1H), 2.11 (m, 1H), 2.04 (m, 1H), 1.95 (s, 3H), 1.00 (s, 20H). 
13C-NMR (100MHz, CDCl3): δ= 171.91 p.p.m., 164.41, 163.83, 152.51, 150.12, 143.43, 129.80, 
117.52, 113.90, 111.79, 69.44, 67.33, 51.80, 41.32, 40.81, 38.63, 38.35, 33.28, 26.62, 18.41, 18.21, 
17.49. 
HRMS (ESI) (m/z ): [M]+  calcd for C29H42O7Si 530.2699; found, 530.2682. 
Compound 49 
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Macrocycle 48a (310 mg, 0.58 mmol, 1eq) was dissolved in DCM and cooled to 0°C. Then 
sequentially pyridine ( 105µl, 0.93 mmol, 2 eq), dimethyl aminopyridine ( 3mg, 5mol%) and acetic 
anhydride (66µL, 0.7 mmol, 1.2 eq) were added and the reaction mixture was stirred at room 
temperature for three hours. The reaction was quenched with a saturated solution of ammonium 
chloride. The phases were separated and the aqueous phase was extracted three times with DCM. The 
combined organic layers were dried over magnesium sulfate, the solvents were removed in vacuo and 
the crude product was submitted to flash column chromatography (hexane:ethylacetate 7:1) to give 
282 mg 85% of compound 49. 
1H-NMR (400MHz, CDCl3): δ= 6.94 p.p.m. (s, 1H), 6.48 (s, 1H), 6.12 (s, 1H), 5.24 (dd, J=12.0, 5.2 
Hz, 1H), 4.97 (ddd, J=11.5, 4.5, 0.9 Hz, 1H), 4.46 (dd, J=5.9, 5.9 Hz, 1H), 4.18 (dd, J=18.8, 9.5 Hz, 
1H), 3.83 (s, 3H), 3.02 (dd, J=11.8, 11.8 Hz, 1H), 2.78 (dd, J=11.8, 4.5 Hz, 1H), 2.59-2.48 (m, 2H), 
2.32 (dd, J=11.6, 9.3 Hz, 1H), 2.24 (ddd, J=12.9, 12.9, 5.4 Hz, 1H), 2.12-2.05 (m, 1H), 2.03 (s, 3H), 
2.00 (s, 3H), 1.08 (s, 20H). 
13C-NMR (100MHz, CDCl3): δ= 171.62 p.p.m., 169.41, 163.53, 162.30, 158.38, 150.04, 129.69, 
128.47, 116.94, 113.76, 111.55, 78.21, 68.64, 66.93, 51.48, 41.17, 40.64, 37.97, 36.52, 29.89, 26.15, 
21.35, 18.14, 12.20. 
HRMS (ESI) (m/z ): [M]+  calcd for C31H44O8Si 572.2805; found, 572.2798. 
Compound 55 
 
Acetate 49 (282 mg, 0.48 mmol, 1eq) was dissolved in pyridine and cooled to -20°C. Sodium 
hypochlorite (1mL 5%chlorine ) was added dropwise to this solution. After 30 minutes the reaction 
was quenched with 1M HCl and diluted with water. The phases were separated and the aqueous phase 
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was extracted three times with DCM. The combined organic layers were dried over magnesium 
sulfate, the solvents were removed in vacuo and the crude product was submitted to flash column 
chromatography (hexane:ethylacetate 5:1) to give 245 mg 87% of epoxide 55. 
1H-NMR (400MHz, CDCl3): δ= 6.50 p.p.m. (s, 1H), 6.19 (s, 1H), 4.78 (dd, J=12.2, 4.9 Hz, 1H), 4.54 
(dd, J=12.8, 4.2 Hz, 1H), 4.50 (dd, J=6.4, 6.4 Hz1H), 4.08 (dd, J=17.7, 8.3 Hz, 1H), 3.82 (s, 3H), 
3.70 (s, 1H), 3.50 (dd, J=12.6, 12.6 Hz, 1H), 2.90-2.82 (m, 1H), 2.61-2.53 (m, 2H), 2.45 (ddd, J=12.0, 
10.0, 1.5 Hz, 1H), 2.33-2.19 (m, 2H), 2.11 (s, 3H), 2.00 (s, 3H), 1.07 (s, 20H). 
13C-NMR (100MHz, CDCl3): δ= 170.01 p.p.m., 168.37, 163.45, 161.80, 149.48, 129.19, 117.61, 
113.83, 111.35, 75.75, 67.90, 67.60, 65.32, 58.11, 51.60, 39.66, 38.02, 36.63, 35.99, 30.27, 25.55, 
21.02, 17.99, 12.07. 
HRMS (ESI) (m/z ): [M]+  calcd for C31H44O9Si 588.2754; found, 588.2743. 
[α]D= +96 (c 0.9g/100mL, CHCl3). 
Compound 53 
 
Acetate 49 (10 mg, 17.5µmol, 1eq) was dissolved in 500µL THF. Hydrogen peroxide (20µL, 0.2 
mmol, 12 eq) and tetrabutyl ammonium hydroxide (1M in water, 50µL, 2eq) were added. The reaction 
was stirred at ambient temperature for one hour, diluted with water and diethyl ether and the phases 
were separated. The aqueous phase was extracted three times with diethyl ether. The combined 
organic layers were dried over magnesium sulfate, the solvents were removed in vacuo and the crude 
product was submitted to flash column chromatography (hexane:ethylacetate 3:1) to give 8 mg, 87% 
of peroxide 53. 
1H-NMR (400MHz, CDCl3): δ= 8.90 p.p.m. (s, 1H), 6.48 (s, 1H), 6.21 (s, 1H), 4.57 (dd, J=12.5, 4.2 
Hz, 1H), 4.52-4.48 (m, 1H), 4.16-4.09 (m, 1H), 3.87 (dd, J=12.0, 4.4 Hz, 1H), 3.82 (s, 3H), 3.63-3.47 
(m, 1H), 3.56 (s, 1H), 2.84-2.76 (m, 1H), 2.61-2.49 (m, 2H), 2.24-2.34 (m, 2H), 2.23-2.16 (m, 1H), 
2.01 (s, 3H), 1.08 (s, 20H). 
13C-NMR (100MHz, CDCl3): δ= 163.49 p.p.m., 161.58, 149.72, 129.64, 117.66, 113.96, 111.22, 
80.22, 75.81, 67.94, 51.67, 40.35, 37.84, 36.65, 36.35, 28.78, 25.68, 18.00, 12.15. 
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HRMS (ESI) (m/z ): [M]+  calcd for C29H42O8Si 562.2598; found, 562.2587. 
Compound 51 
 
Peroxide 53 (50 mg, 91µmol, 1eq) were dissolved in 1 mL DCM. Then sequentially pyridine ( 150 µl, 
1.4 mmol, 15 eq), dimethyl aminopyridine ( 3mg, 5mol%) and acetic anhydride (20µL, 0.45 mmol, 5 
eq) were added and the reaction mixture was stirred at room temperature for three hours. The reaction 
was quenched with a saturated solution of ammonium chloride. The phases were separated and the 
aqueous phase was extracted three times with DCM. The combined organic layers were dried over 
magnesium sulfate, the solvents were removed in vacuo and the crude product was submitted to flash 
column chromatography (hexane:ethylacetate 4:1) to give 42 mg 85% of ketone 51 
1H-NMR (400MHz, CDCl3): δ= 6.47 p.p.m. (s, 1H), 6.18 (d, J=1.3 Hz, 1H), 4.69 (dd, J=12.6, 4.8 Hz, 
1H), 4.59 (dd, J=61., 6.1 Hz, 1H), 4.14 (dd, J=19.2, 10.0 Hz, 1H), 3.89 (s, 1H), 3.79 (s, 3H), 3.65 (dd, 
J=12.6, 4.7 Hz, 1), 3.46 (dd, J=12.6, 12.6 Hz, 1H), 3.19 (dddd, J=15.9, 6.4, 6.4, 2.9 Hz, 1H), 2.98 
(dd, J=12.7, 12.7 Hz, 1H), 2.68 (dd, J=12.6, 4.8 Hz, 1H), 2.43 (dd, J=12.1, 9.6 Hz, 1H), 2.18-2.15 (m, 
1H), 2.00 (d, J=0.9 Hz, 3H), 1.09-1.07 (m, 20H). 
13C-NMR (100MHz, CDCl3): δ= 197.07 p.p.m., 168.64, 163.73, 161.62, 150.11, 128.82, 118.44, 
114.50, 112.39, 76.13, 68.78, 67.22, 52.09, 43.98, 40.15, 38.04, 37.55, 37.23, 25.61, 18.37, 12.48. 
HRMS (ESI) (m/z ): [M]+  calcd for C29H40O8Si 544.2492; found, 544.2488. 
[α]D= +122 (c 0.7g/100mL, CHCl3). 
Compound 60 
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Acetate 49 (14 mg, 24 µmol, 1eq) was dissolved in 1 mL of wet THF. To this solution N-
bromsuccinimide (7 mg, 39 µmol, 1.6 eq) was added. The reaction mixture was stirred for one hour 
and diluted with water and diethyl ether. The phases were separated and the aqueous phase was 
extracted three times with DCM. The combined organic layers were dried over magnesium sulfate, the 
solvents were removed in vacuo and the crude product was submitted to flash column chromatography 
(hexane:ethylacetate 4:1) to give 14 mg 89% of bromohydrine 60. 
1H-NMR (400MHz, CDCl3): δ= 6.47 p.p.m. (s, 1H), 5.41 (d, J=2.5 Hz, 1H), 4.96 (dd, J=8.6, 2.5 Hz, 
1H), 4.89 (dd, J=7.8, 7.8 Hz, 1H), 4.52 (dd, J=5.7, 5.7 Hz, 1H), 3.90 (dd, J=18.0, 9.6 Hz, 1H), 3.80 
(s, 3H), 3.64 (s, 1H), 3.27-3.20 (m, 1H), 2.74 (ddd, J=15.4, 7.7,7.7 Hz, 1H), 2.68 (d, J=3.3 Hz, 1H), 
2.43-2.20 (m, 4H), 2.13 (s, 3H), 1.81 (s, 3H), 1.71 (dd, J=14.7, 3.4 Hz, 1H), 1.07 (s, 20H). 
13C-NMR (100MHz, CDCl3): δ= 169.91 p.p.m., 168.11, 165.64, 163.39, 162.32, 149.78, 113.91, 
110.59, 76.52, 74.21, 69.49, 68.76, 62.74, 59.15, 51.55, 42.95, 38.74, 37.72, 36.65, 29.01, 26.20, 
20.91, 17.93, 12.36. 
HRMS (ESI) (m/z ): [M]+  calcd for C31H45O10BrSi 684.1965; found, 684.1976. 
[α]D= +73 (c 0.43g/100mL, CHCl3). 
Compound 60b 
 
Bromohydrine 60 (14 mg, 20µmol, 1eq) was dissolved in THF. NaH (60% mineral oil suspension, 
40µmol, 2 mg, 2eq) was added at 0°C. The reaction was stirred at ambient temperature for 30 minutes 
before it was quenched with water. The phases were separated and the aqueous phase was extracted 
three times with DCM. The combined organic layers were dried over magnesium sulfate, the solvents 
were removed in vacuo and the crude product was submitted to flash column chromatography 
(hexane:ethylacetate 4:1) to give 11 mg 90% of bis-epoxide 60a. 
1H-NMR (400MHz, CDCl3): δ= 6.92 p.p.m. (s, 1H), 4.96 (dd, J=11.6, 4.7 Hz, 1H), 4.85 (dd, J=12.7, 
3.8 Hz, 1H), 4.54 (s, 1H), 4.45 (dd, J=12.8, 6.0 Hz, 1H), 3.82 (s, 3H), 3.68-3.64 (m, 1H), 3.65 (s, 1H), 
2.81-2.73 (m, 2H), 2.63-2.52 (m, 3H), 2.27 (s, 1H), 2.26 (dd, J=13.7, 4.5 Hz, 1H), 2.23-2.17 (m, 1H), 
2.14 (s, 3H), 1.57 (s, 3H), 1.03 (s, 20H). 
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13C-NMR (100MHz, CDCl3): δ= 170.45 p.p.m., 168.46, 163.59, 163.14, 146.36, 116.00, 114.37, 
75.95, 68.51, 66.45, 60.94, 57.31, 56.79, 51.80, 40.99, 37.79, 32.07, 30.48, 29.85, 29.67, 21.26, 18.07, 
12.10. 
HRMS (ESI) (m/z ): [M]+  calcd for C31H44O10Si 604.2703; found, 604.2695. 
[α]D= +56 (c 0.47g/100mL, CHCl3). 
Compound 60b 
 
To epoxide 55 (12 mg, 20µmol, 1eq) in 500 µl DCM was added meta-chlorperbenzoic acid (30 µmol, 
5 mg, 1.5eq). The reaction mixture was stirred for 8 hours. The reaction was quenched with a saturated 
sodium hydrogen carbonate solution and diluted with diethyl ether and water. The phases were 
separated and the aqueous phase was extracted three times with diethyl ether. The combined organic 
layers were dried over magnesium sulfate, the solvents were removed in vacuo and the crude product 
was submitted to flash column chromatography (hexane:ethylacetate 4:1) to give 12 mg 92% of bis-
epoxide 60b. 
1H-NMR (400MHz, CDCl3): δ= 6.84 p.p.m. (s, 1H), 4.54 (dd, J=11.6, 5.3 Hz, 1H), 4.46 (dd, J=13.0, 
3.1 Hz, 1H), 4.41 (dd, J=5.8, 5.8 Hz, 1H), 4.31 (dd, J=18.0, 9.3 Hz, 1H), 3.79 (s, 3H), 3.68 (s, 1H), 
2.61-2.52 (m, 2H), 2.56 (s, 1H), 2.48-2.41 (m, 1H), 2.35-2.20 (m, 3H), 2.14 (dd, J=11.8, 8.8 Hz, 1H), 
2.01 (s, 3H), 1.48 (s, 3H), 0.99 (s, 20H). 
13C-NMR (100MHz, CDCl3): δ= 170.39 p.p.m., 168.19, 163.27, 162.79, 146.61, 124.51, 115.16, 
115.02, 75.84, 68.33, 67.96, 63.64, 60.49, 58.44, 57.37, 52.31, 42.26, 37.67, 37.24, 35.86, 30.53, 
30.04, 23.21, 21.37, 18.34, 12.46. 
HRMS (ESI) (m/z ): [M]+  calcd for C31H44O10Si 604.2703; found, 604.2693. 
Compound 62 
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Oxallyl chloride (5 µL, 58 µmol mmol, 4eq), was dissolved in 0.5 mL DCM and cooled to -78°C. 
Then DMSO (9 µL, 116 µmol, mmol, 8 eq) was added and the mixture was stirred for 15 minutes. 
Alcohol 60 (10 mg, 14.6 µmol, 1 eq) dissolved in 0.5 mL DCM was added and the reaction mixture 
was stirred for one hour. Then triethylamine (25 µL, 175 µmol mmol, 12eq) was added dropwise and 
after stirring at -78°C for 20 minutes the reaction was warmed to 0°C and stirred for 45 minutes before 
it was quenched with an ammonium chloride solution. The aqueous phase was extracted three times 
with diethyl ether, the combined organic layers were dried over magnesium sulfate, the solvents were 
removed in vacuo and the crude product was filtered over a short pad silica gel to give the 
corresponding ketone 61 10 mg 99% which was directly used in the next reaction.  
Bromoketone 61 (10 mg, 14.6µmol, 1eq) was dissolved in 500 µL methanol and cooled to -20°C. 
Then sodium borohydride (73 µmol, 3 mg, 5 eq) was added in one portion. The reaction mixture was 
stirred at this temperature for one hour before it was quenched with water and diluted with diethyl 
ether. The phases were separated and the aqueous phase was extracted three times with diethyl ether, 
the combined organic layers were dried over magnesium sulfate, the solvents were removed in vacuo 
and the crude product was submitted to flash column chromatography (hexane:ethylacetate 4:1) to 
give 9 mg 88% of inverted bromohydrine 62. 
1H-NMR (400MHz, CDCl3): δ= 6.62 p.p.m. (s, 1H), 4.73 (dd, J=11.6, 4.5 Hz, 1H), 4.62 (d, J=4.8 Hz, 
1H), 4.47 (dd, J=6.2, 6.2 Hz, 1H), 4.10 (dd, J=18.1, 9.1 Hz, 1H), 3.78 (s, 3H), 3.12-3.05 (m, 2H), 
2.83-2.73 (m, 2H), 2.64 (s, 1H), 2.42-2.15 (m, 4H), 2.04 (s, 3H), 1.90 (s, 3H), 0.99 (s, 20H). 
13C-NMR (100MHz, CDCl3): δ= 169.73 p.p.m., 167.02, 162.45, 147.51, 128.40, 114.12, 111.74, 
76.30, 75.84, 69.03, 67.97, 67.50, 64.07, 58.58, 51.83, 40.92, 40.13, 37.35, 35.11, 29.22, 28.43, 21.02, 
18.05, 12.03. 
HRMS (ESI) (m/z ): [M]+  calcd for C31H45O10BrSi 684.1965; found, 684.1974. 
[α]D= +58(c 0.5g/100mL, CHCl3). 
Compound 64 
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Bromohydrine 62 (8 mg, 12µmol, 1eq) was dissolved in 1 mL THF. Sodium hydride (60% mineral oil 
suspension, (1 mg, 26µmol, 2 eq) was added in one portion. The reaction was quenched after 25 
minutes with water the aqueous phase was extracted three times with diethyl ether, the combined 
organic layers were dried over magnesium sulfate, the solvents were removed in vacuo and the crude 
product was submitted to flash column chromatography (hexane:ethylacetate 5:1) to give 5 mg, 72% 
of ketone 64 as amixture of diastereomers. 
1H-NMR (400MHz, CDCl3): δ= 7.42 p.p.m. (s, 1H), 4.61 (dd, J=12.0, 4.9 Hz, 1H), 4.42 (m, 1H), 3.97 
(s, 1H), 3.82 (m, 1H), 3.77 (s, 3H), 3.20 (m, 1H), 2.99 (m, 1H), 2.78 (m, 1H), 2.55 (ddd, J=14.7, 8.3, 
7.9), 2.48 (m, 1H), 2.46 (m, 1H), 2.39 (m, 1H), 2.11 (s, 3H), 1.92 (ddd, J=14.7, 5.7, 3.4 Hz, 1H), 1.88 
(s, 1H), 1.26 (d, J=7.6 Hz, 3H). 
13C-NMR (100MHz, CDCl3): δ= 189.48 p.p.m., 170.53, 168.11, 165.82, 162.81, 150.02, 119.01, 
116.66, 76.46, 70.27, 68.10, 62.13, 58.14, 52.43, 41.48, 36.54, 36.34, 35.94, 30.39, 21.29, 15.40. 
HRMS (ESI) (m/z ): [M]+  calcd for C31H44O10Si 604.2703; found, 604.2712. 
Compound 64a 
 
Epoxide 60a (7 mg, 11µmol, 1eq) was dissolved in 500µL ethanol. The solution was cooled to 0°C 
and diphenyl diselenide (14µmol, 4 mg, 1.2 eq) was added. Then in one portion sodium borohydride 
(28 µmol, 1mg, 2.4 eq) was added and the reaction mixture was stirred at 0°C for 1.5 hours. The 
reaction was quenched with water, diluted with diethyl ether and the phases were separated. The 
aqueous phase was extracted three times with diethyl ether, the combined organic layers were dried 
over magnesium sulfate, the solvents were removed in vacuo and the crude product was submitted to 
flash column chromatography (hexane:ethylacetate 5:1) to give 7 mg, 84% of alcohol 64a. 
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1H-NMR (400MHz, CDCl3): δ= 7.52-7.49 p.p.m. (m, 2H), 7.29-7.24 (m, 3H), 6.90 (s, 1H), 4.86 (dd, 
J=12.6, 5.2 Hz, 1H), 4.74-4.70 (m, 1H), 4.72 (s, 1H), 4.50-4.46 (m, 1H), 4.07 (dd, J=19.2, 9.8 Hz, 
1H), 3.83 (s, 3H), 3.10-3.03 (m, 1H), 2.98 (s, 1H), 2.93 (s, 1H), 2.60 (ddd, J=14.9, 9.1, 6.2 Hz, 1H), 
2.27-2.23 (m, 2H), 2.17 (d, J=2.2 Hz, 2H), 2.11 (s, 3H), 1.87 (ddd, J=14.5, 7.6, 2.8 Hz, 1H), 1.25 (s, 
3H), 1.06 (s, 20H). 
13C-NMR (100MHz, CDCl3): δ= 169.97 p.p.m., 168.27, 163.60, 161.77, 152.72, 133.40, 129.70, 
128.90, 128.43, 114.63, 112.21, 75.89, 73.39, 69.31, 68.63, 63.07, 59.12, 56.61, 51.77, 40.17, 39.71, 
37.29, 36.35, 29.22, 21.06, 18.09, 12.44. 
HRMS (ESI) (m/z ): [M]+  calcd for C37H50O10SSeSi 762.2338; found, 762.2327. 
(Bicyclo[3.2.0]hepta-2,6-dien-6-yloxy) (tert-butyl)dimethylsilane) 65 
 
To a solution of 15 (1.00 g, 9.24 mmol, 1eq.) in 40 mL dry THF at -78°C was slowly added TBSOTf 
(6.4 mL, 27.7 mmol, 3eq.). To this mixture at -78°C was rapidly added LiHMDS (1M in hexane, 46 
mL, 46 mmol, 5eq.). The reaction mixture was stirred for one hour at -78°C, and then quenched with 
saturated NH4Cl solution and extracted two times with diethylether (100 mL). The combined organic 
layers were dried over MgSO4 and the solvents were removed under reduced pressure. The crude 
product was filtered over silica gel with (hexane/ethylacetate 20:1 and 5% triethylamine) and was then 
further purified via a bulb to bulb distillation to yield 95% 1.95 g of pure 65.   
 
1H-NMR: δ 5.90-5.85 (m, 1H), 5.62-5.57 (m, 1H), 4.99 (s, 1H), 3.51-3.44 (m, 1H), 3.25-3.20 (m, 1H), 
2.46-2.17 (m, 2H), 0.95 (s, 9H), 0.19 (s, 6H).  
13C-NMR: δ 134.97, 130.52, 111.52, 49.09, 45.52, 30.77, 26.04, -4.17, -4.33.  
HRMS (EI) m/z calcd for C13H22OSi 222.3987, found 222.3982. 
 
(4,7-Methano-1H-indene-5,6-diol, 3a,4,5,6,7,7a-hexahydro-, (3aα,4β,5α,6α,7β,7aα) 68 
 
To a solution of 65 (743 mg, 3.3 mmol, 1eq.) in tBuOH:H2O (1:1, 30 mL) at 0°C was added OsO4 ( 4 
mg, 0.016 mmol, 0.5mol%) and N-morpholine-N-oxid (390 mg, 3.3 mmol, 1eq.). The reaction mixture 
was stirred for 20 hours, quenched with an aqueous sodium thiosulfate solution, and extracted two 
times with  diethylether (50 mL). The combined organic layers were washed with brine and dried over 
MgSO4. The solvents were removed under reduced pressure. Crude 68 was purified by 
chromatography (silica gel, hexane/ethyl acetate 1:1) to yield 488 mg 89% of pure 68.  
 
106 
 
1H-NMR: δ 5.45-5.37 (m, 2H), 3.61 (d, J = 5.38 Hz, 1H), 3.52 (d, J = 5.56 Hz, 1H), 2.94-2.88 (m, 
1H), 2.69-2.59 (m, 2H OH broad), 2.42-2.35 (m, 1H), 2.15-2.06 (m, 3H), 1.92 (d, J = 4.29 Hz, 1H), 
1.70-1.67 (m, 1H), 116-1.12 (m, 1H). 
13C-NMR: δ 131.33, 131.13, 71.81, 70.19, 51.29, 48.47, 46.87, 40.92, 35.35, 32.35.  
HRMS (EI) m/z calcd for C10H14O2 166.2170, found 166.2178. 
 
(7-(tert-butyldimethylsilyloxy)bicyclo[3.2.0]hept-3-en-6-ol) 70 
 
To a solution of 65 ( 743 mg, 3.3 mmol, 1eq.) in dry THF (7 mL) at 0°C was added 9-BBN (0.5M in 
THF 6.6 mL, 1eq.). The reaction mixture was warmed to room temperature and stirred for 14 hours. 
The reaction was quenched with 3mL 0.5M NaOH and 1mL H202 (30%), diluted with brine and 
extracted two times with diethylether (50 mL). The combined organic layers were dried over MgSO4 
and the solvents were removed under vacuum. Crude 70 was purified by flash column 
chromatography (hexane/ethylacetate 3:1) to yield 412 mg 52% of pure 70. 
1H-NMR: δ 5.79-5.72 (m, 2H), 4.11 (dd, J = 8.96, 4.92 Hz, 1H), 3.59-3.56 (m, 1H), 2.96-2.88 (m, 1H), 
2.67-2.60 (m, 2H), 2.25-2.17 (m, 1H), 0.83 (s, 9H), 0.01 (s, 3H), 0.00 (s, 3H).  
13C-NMR: δ 134.46, 131.79, 84.38, 74.59, 49.47, 37.69, 26.24, -4.47.  
HRMS (EI) m/z calcd for C13H24O2Si 240.4140, found 240.4133. 
 
(tert-butyl(-7-(4-methoxybenzyloxy)bicyclo[3.2.0]hept-2-en-6-yloxy)dimethylsilane) 71 
 
To a solution of alcohol 70 ( 2.1 g, 8.7 mmol, 1eq.) in dry DCM (10 mL) was added a solution of 
Bundles reagent ( 5 g, 17.5 mmol, 2eq.) in hexane (30 mL) and cooled to 0°C. Then 20 mg of camphor 
sulfonic acid were added and the reaction mixture was stirred over night. The reaction was quenched 
with saturated NaHCO3 solution, and extracted two times with diethylether (100 mL). The combined 
organic layers were washed with brine and dried over MgSO4. Solvents were removed under reduced 
pressure and crude 71 was purified by column chromatography (silicagel, hexane/ethylacetate 7:1) to 
yield 1.63 g 52% of pure 71.   
1H-NMR: δ 7.30-7.26 (m, 2H), 6.92-6.88 (m, 2H), 5.83-5.79 (m, 1H), 5.76-5.71 (m, 1H), 4.44 (s, 2H), 
3.83 (s, 3H), 3.49-3.45 (m, 1H), 3.09-2.96 (m, 1H), 2.81-2.69 (m, 2H), 2.38-2.24 (m, 1H), 0.94 (s, 
9H), 0.10 (s, 3H), 0.09 (s, 3H).  
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13C-NMR: δ 159.71, 134.31, 131.75, 129.82, 129.61, 114.27, 91.22, 74.59, 73.18, 55.86, 49.47, 37.69, 
26.24, 18.43, -4.51.  
HRMS (EI) m/z calcd for C21H32O3Si 360.5625, found 360.5620. 
 
2-(4-methoxybenzyl)oxy-4,9-dioxatricyclo[3.2.2.03,7]nonan-8-ol 73 
 
Ozone was bubbled through a solution of 71 (219 mg, 0.89 mmol, 1eq.) in DCM/MeOH 4:1 (5 mL) at 
-78°C for 10 minutes. To remove unreacted ozone, air was subsequently bubbled through the reaction 
mixture at the same temperature for 5 minutes. Then thiourea (71 mg, 0.93 mmol, 1.05 eq.) was added 
and the reaction was warmed to room temperature. The solid was filtered off, the solvents were 
removed under reduced pressure and crude 73 was submitted to flash column chromatography 
(silicagel, hexane/ethyl acetate 2:1) to yield 200 mg 81% of pure 73. 
1H-NMR: δ 7.30-7.21 (m, 2H), 6.90-6.82 (m, 2H), 5.67-5.54 (m, 1H), 5.17 (s, 1H), 4.63-4.35 (m, 3H), 
3.78 (s, 3H), 3.51-3.22 (m, 1H), 3.06-2.91 (m, 1H), 2.75-2.69 (m, 1H), 2.64-2.55 (m, 1H), 1.55-1.45 
(m, 1H).  
HRMS (EI) m/z calcd for C15H18O5 278.3004, found 278.2999. 
 
2-(4-methoxybenzyl)oxy-4,9-dioxatricyclo[3.2.2.03,7]nonan-3-one 74 
 
Lactol 73 ( 200 mg, 0.72 mmol, 1eq.) was dissolved in dry DCM (12 mL) at 0°C. The PCC (170 mg, 
0.8 mmol, 1.2 eq.) was added. After 30 minutes another portion of PCC (240 mg, 1.21 mmol, 1.7 eq.) 
was added and a last portion of PCC ( 240 mg, 1.21 mmol, 1.7 eq.) was added after 2 hours. The 
reaction was then stirred for 24 hours, quenched with saturated NaHCO3 solution, and extracted two 
times with diethylether (50 mL). The combined organic layers were washed with brine and dried over 
MgSO4. Solvents were removed under reduced pressure and crude 74 was purified by column 
chromatography (silicagel, hexane/ethyl acetate 2:1) to yield 70 mg 35% of pure 74.   
1H-NMR: δ 7.32-7.26 (m, 2H), 6.94-6.89 (m, 2H), 5.99 (dd, J=3.08, 1.03 Hz, 1H), 4.62-4.46 (m, 3H), 
3.93 (s, 1H), 3.83 (s, 3H), 3.66-3.59 (m, 1H), 3.28-3.24 (m, 1H), 2.11-2.04 (m, 1H), 2.00-1.91 (s, 1H). 
HRMS (EI) m/z calcd for C15H16O5 276.2845, found 276.2855. 
 
(1S,3S,5S,6S,7R)-7-ethynyl-3-methoxy-6-(4-methoxybenzyloxy)-2-oxabicyclo[3.2.0]heptane xxx and 
(1S,3S,5S,6S,7S)-7-ethynyl-3-methoxy-6-(4-methoxybenzyloxy)-2-oxabicyclo[3.2.0]heptanes xxx 
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Aldehyde 76 (152 mg, 0.5 mmol, 1eq) was dissolved in 12 mL methanol and potassium carbonate 
(145 mg, 1.04 mmol, 2eq) was added. After stirring at room temperature for 10 minutes Ohira-
Bestmann reagent (120 mg, 0.62 mmol, 1.2 eq) was added and the reaction mixture was stirred over 
night. The reaction was diluted with diethyl ether and quenched with brine. The phases were 
separated. The aqueous phase was extracted three times with diethyl ether, the combined organic 
layers were washed with brine, dried over magnesium sulfate, the solvents were removed in vacuo and 
the crude product was purified by flash column chromatography (hexane:ethylacetate 10:1) to give 
acetylene 77 and 78 116 mg 81% combined yield. 
77: 
1H-NMR (400MHz, CDCl3): δ= 7.14 p.p.m. (d, J=8.3 Hz, 2H), 6.72 (d, J=8.3 Hz, 2H), 5.06 (dd, 5.7, 
1.6 Hz, 1H), 4.36-4.30 (m, 3H), 4.04 (dd, J=5.9, 3.4 Hz, 1H), 3.64 (s, 3H), 3.18 (s, 3H), 2.91-2.83 (m, 
1H), 2.68 (ddd, J=9.4, 6.6, 2.6 Hz, 1H), 2.15 (d, J=2.5 Hz, 1H), 2.10-2.00 (m, 1H). 
13C-NMR (100MHz, CDCl3): δ= 159.83 p.p.m., 130.10, 130.01, 114.28, 109.97, 85.31, 83.74, 72.74, 
71.03, 55.75, 55.50, 36.44, 34.37, 30.19. 
HRMS (EI) m/z calcd for C17H20O4 288.1361, found 288.1354. 
78: 
1H-NMR (400MHz, CDCl3): δ= 7.34 p.p.m. (d, J=8.6 Hz, 2H), 6.90 (d, J=8.6 Hz, 2H), 5.19 (d, J=4.0 
Hz, 1H), 4.69 (ddd, J=7.8, 3.2, 1.1 Hz, 1H), 4.63 (d, J=11.4 Hz, 1H), 4.47 (d, J=11.4 Hz, 1H), 3.91 
(dd, J=7.3, 2.5 Hz, 1H), 3.82 (s, 3H), 3.32 (s, 3H), 3.09-3.02 (m, 1H), 2.97-2.93 (m, 1H), 2.35 (d, 
J=2.5 Hz, 1H), 2.27 (dd, J=13.5, 9.2 Hz, 1H). 
13C-NMR (100MHz, CDCl3): δ= 159.74 p.p.m., 130.08, 129.97, 114.19, 109.25, 83.52, 78.01, 73.37, 
70.91, 55.69, 55.04, 40.09, 39.44, 32.24. 
HRMS (EI) m/z calcd for C17H20O4 288.1361, found 288.1356. 
(5,5-Dichloro-2,9-dioxatricyclo[3.2.2.03,7]nonan-3-ol) 73a 
 
See procedure for compound 73. 
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1H-NMR: δ 5.70 (dd, J = 3.48, 0.50 Hz, 1H), 5.41 (s, 1H), 4.76-4.73 (m, 1H), 3.62-3.58 (m, 1H), 3.26-
3.22 (s, 1H OH, broad), 3.19 (ddd, J = 7.39, 4.47, 1.57 Hz, 1H), 2.78 (d, J = 12.28 Hz, 1H), 1.70 (ddd, 
J = 12.14, 4.16, 4.16 Hz, 1H)   
13C-NMR: δ 101.60, 90.31, 88.38, 82.36, 56.06, 35.22, 31.26.  
HRMS (EI) m/z calcd for C7H8Cl2O3 211.0426, found 211.0420. 
 
((3-(tert-butyldimethylsilyloxy)-2-(triisopropylsilyloxy)-4-(2-(trityloxy)ethyl)- cyclobutyl)methanol) 
80 
2-((1R,2R,3R,4R)-2-(tert-butyldimethylsilyloxy)-3-(triisopropylsilyloxy)-4-
(trityloxymethyl)cyclobutyl)ethanol 81 
 
Ozone was bubbled through a solution of 65 (385 mg, 1.0 mmol, 1eq.) in DCM/MeOH 4:1 (7 mL) at -
78°C for 10 minutes. To remove unreacted ozone air was bubbled through the reaction mixture at the 
same temperature for 5 minutes. Then NaBH4 (71 mg, 2.0 mmol, 2 eq.) was added and the reaction 
was warmed to room temperature. The reaction was then stirred for 2 hours, quenched with saturated 
NH4Cl solution, and extracted two times with diethylether (50 mL). The combined organic layers were 
washed with brine and dried over MgSO4. Solvents were removed under reduced pressure and crude 
79 (330 mg, 0.76 mmol, 1eq.) was directly used in the next step. 79 was dissolved in dry DCM (15 
mL) cooled to 0°C and pyridine (250µl, 2.28 mmol, 3eq.) was added at that temperature. To this 
solution was added dropwise tritylchloride in dry DCM (2 mL) and the reaction was stirred over night. 
The mixture was quenched with brine and extracted two times with diethylether (50 mL). The 
combined organic layers were washed with brine and dried over MgSO4. Solvents were removed 
under reduced pressure and crude product was purified by flash column chromatography (silicagel, 
hexane/ethyl acetate 7:1) to yield 267 mg 52% of 81 and 41 mg 8% of 80.   
 
1H-NMR: δ 7.54-7.25 (m, 15H), 4.00-3.62 (m, 4H), 3.37-3.14 (m, 2H), 2.34 (ddd, J = 16.9, 8.79, 4.23 
Hz, 1H), 2.08-1.94 (m, 2H), 1.76-1.61 (m, 1H), 1.69 (s, broad 1H), 1.12 (s, 21H), 0.95 (s, 9H), 0.11 (s, 
3H), 0.05 (s, 3H). HRMS (EI) m/z calcd for C41H62O4Si2 675.0996, found 675.0989. 
 
(3-(tert-butyldimethylsilyloxy)-2-(triisopropylsilyloxy)-4-(2-(trityloxy)ethyl)- 
cyclobutanecarbaldehyde) 81a 
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Alcohol 81 (175 mg, 0.26 mmol, 1eq.) was dissolved in ethyl acetate (3 mL) and IBX (218 mg, 0.78 
mmol, 3eq.) was added. The suspension was refluxed for 2 hours, and then cooled to room 
temperature and the solid was filtered off. The organic layer was concentrated, re-dissolved in MeOH 
(10 mL) and K2CO3 (361 mg, 2.6 mmol, 10eq.) was added to the solution. The reaction was stirred for 
1.5 hours, diluted with diethylether, the solids filtered off, and extracted with saturated NH4Cl 
solution. The combined organic layers were washed with brine and dried over MgSO4. Solvents were 
removed under reduced pressure and crude 81a was purified by flash column chromatography 
(silicagel, hexane/ethyl acetate 7:1) to yield 152 mg 87% of pure 81a. 
1H-NMR: δ 9.74 (t, J = 1.37 Hz, 1H), 4.13-4.05 (m, 1H), 3.77-3.71 (m, 1H), 3.53 (dd, J = 9.50, 4.23 
Hz, 1H), 3.17-3.05 (m, 1H), 2.86 (t, J = 10.16 Hz, 1H), 2.46-2.18 (m, 2H), 1.02 (s, 21H), 0.89 (s, 9H), 
0.10 (s, 3H), 0.07 (s, 3H).  
HRMS (EI) m/z calcd for C22H45O3Si2 413.7619, found 413.7611. 
Aldol adduct 69 
 
Commercially available ketone 15 in 10 mL THF (250 mg, 2.3 mmol, 1eq) was added to a solution of 
LHMDS in 7 mL THF (1 M in THF, 3.5 mL, 3.5 mmol, 1.5 eq) at -78°C under argon. After stirring 
the mixture for 30 minutes at that temperature Davis-oxaziridine ( 1.1 g, 3.5 mmol, 1.5eq) was added 
in 5 mL THF. After stirring for 45 minutes the reaction was quenched with a saturated solution of 
ammonium sulfate and diluted with diethyl ether. The phases were separated. The aqueous phase was 
extracted three times with diethyl ether, the combined organic layers were washed with brine, dried 
over magnesium sulfate, the solvents were removed in vacuo and the crude product was purified by 
flash column chromatography (hexane:ethylacetate 3:1) to give 69a and 69b 228 mg 92% combined 
yield. 
Cis-isomer 69a 
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1H-NMR (400MHz, CDCl3): δ= 5.79-5.75 p.p.m. (m, 3H), 5.70-5.68 (m, 1H), 3.70-3.64 (m, 1H), 3.32-
3.27 (m, 1H), 2.98-2.91 (m, 3H), 2.63-2.51 (m, 3H), 2.46-2.35 (m, 2H), 1.83 (s, 1H), 1.66 (dd, J 
=13.4, 3.3 Hz, 1H). 
13C-NMR (100MHz, CDCl3): δ= 215.26 p.p.m., 135.88, 133.01, 132.83, 132.43, 77.62, 75.01, 66.25, 
61.26, 45.66, 42.95, 40.63, 39.74, 35.43, 33.08. 
HRMS (EI) m/z calcd for C14H16O2 216.1150, found 216.1143. 
Trans-isomer 69a 
1H-NMR (400MHz, CDCl3): δ= 5.72-5.67 p.p.m. (m, 3H), 5.62 (m, 1H), 3.62-3.56 (m, 1H), 3.25-3.20 
(m, 1H), 2.94-2.86 (m, 3H), 2.55-2.46 (m, 3H), 2.42-2.28 (m, 2H), 1.78 (d, J =1.0 Hz, 1H), 1.57 (dd, J 
=13.0, 2.9 Hz, 1H). 
13C-NMR (100MHz, CDCl3): δ= 214.92 p.p.m., 136.00, 132.96, 132.93, 132.48, 75.45, 66.24, 61.34, 
45.80, 42.95, 40.68, 39.89, 35.39, 32.95. 
HRMS (EI) m/z calcd for C14H16O2 216.1150, found 216.1141. 
tert-butyl(-3-ethynyl-2-(triisopropylsilyloxy)-4-(2-(trityloxy)ethyl)cyclobutyl)dimethylsilane 82 
 
Aldehyde 81a (1.54 g, 2.28 mmol, 1eq) was dissolved in 20 mL methanol. To this solution potassium 
carbonate (770 mg, 5.5 mmol, 2.4 eq) was added and stirred for 10 minutes before the Ohira-
Bestmann reagent (530 mg, 2.75 mmol, 2.4eq) was added at room temperature. The reaction was 
stirred for 6 hours diluted with diethyl ether and quenched with a saturated ammonium chloride 
solution. The aqueous phase was extracted three times with diethyl ether, the combined organic layers 
were dried over magnesium sulfate, the solvents were removed in vacuo and the crude product was 
purified by flash column chromatography (hexane:ethylacetate 20:1) to give 1.3 g 89% of acetylene 
82. 
1H-NMR (400MHz, CDCl3): δ= 7.46-7.43 p.p.m., (m, 6H), 7.32-7.21 (m, 9H), 4.32 (ddd, J=8.5, 6.5, 
1.1 Hz, 1H), 4.13 (ddd, J=7.8, 7.3, 0.7 Hz, 1H), 3.22-3.16 (m, 1H), 3.13-3.07 ( m, 1H), 2.85-2.81 (m, 
1H), 2.44-2.37 (m, 1H), 2.16 (d, J=2.8 Hz,1H), 1.97-1.89 (m, 1H), 1.51-1.41 (m, 1H), 1.09 (d, J=2.8 
Hz, 20H), 0.88 (s, 9H), 0.06 (s, 3H), 0.03 (s, 3H). 
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13C-NMR (100MHz, CDCl3): δ= 144.34 p.p.m., 128.70, 127.73, 126.88, 86.63, 84.46, 75.22, 74.32, 
71.32, 62.31, 39.54, 32.37, 29.20, 25.83, 17.91, 12.06, -4.81, -4.93. 
HRMS (ESI) (m/z ): [M]+  calcd for C42H60O2Si2 652.4131; found, 652.4127. 
tert-butyldimethyl(-3-(3-((S)-oxiran-2-yl)prop-1-ynyl)-2-(triisopropylsilyloxy)-4-(2-
(trityloxy)ethyl)cyclobutyl)silane 84 
 
Acetylene 82 ( 1.1 g, 1.64 mmol, 1eq) was dissolved in 6 mL THF and cooled to -78°C. n-butyllithium 
(1.6M in hexane, 1.45 mL, 2.3 mmol, 1.4 eq) was added and the mixture was stirred at 0°C for 30 
minutes before it was cooled again to -78°C. tosyl-glycidol 83 ( 600 mg, 2.63 mmol, 1.6 eq) was 
added in 1 mL THF followed by the dropwise addition of borontrifluor etherate (290 µL, 2.3 mmol, 
1.4 eq). The reaction was stirred at -78°C for one hour before it was quenched with water. The phases 
were separated and the aqueous phase was extracted three times with diethyl ether, the combined 
organic layers were dried over magnesium sulfate, the solvents were removed in vacuo and the crude 
product 84 939 mg was directly submitted to the next reaction.  
Crude product was dissolved in 15 mL methanol and cooled to 0°C. Potassium carbonate (145 mg, 
1.05 mmol) was added and the reaction mixture was stirred at room temperature for 45 minutes. The 
reaction was quenched with ammonium chloride diluted with diethyl ether and the phases were 
separated. The aqueous phase was extracted three times with diethyl ether, the combined organic 
layers were washed with brine, dried over magnesium sulfate, the solvents were removed in vacuo and 
the crude product was purified by flash column chromatography (hexane:ethylacetate 7:1) to give 697 
mg 60% of epoxide 84a. 
1H-NMR (400MHz, CDCl3): δ= 7.45-7.42 p.p.m. (m, 7H), 7.31-7.20 (m, 8H), 4.28-4.23 (m, 1H), 4.15-
4.11 (m, 1H), 3.19-3.13 (m, 1H), 3.12-3.08 (m, 1H), 3.07-3.03 (m, 1H), 2.79 (d, J=7.6 Hz, 1H), 2.71 
(t, J=4.4 Hz, 1H), 2.68-2.65 (m, 1H), 2.62 (ddd, J=15.4, 5.0, 2.5 Hz, 1H), 2.40-2.28 (m, 2H), 1.95-
1.87 (m, 1H), 1.50-1.41 (m, 1H), 1.07 (s, 20H), 0.87 (s, 9H), 0.05 (s, 3H), 0.02 (s, 3H). 
13C-NMR (100MHz, CDCl3): δ= 144.41 p.p.m., 128.71, 127.76, 126.85, 86.65, 82.48, 75.35, 74.21, 
62.48, 50.33, 46.65, 39.58, 32.64, 29.22, 25.86, 23.06, 22.96, 17.91, 12.05, -4.82, -4.98. 
HRMS (ESI) (m/z ): [M]+  calcd for C45H64O3Si2 708.4397; found, 708.4389. 
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(S)-6-(-3-(tert-butyldimethylsilyloxy)-2-(triisopropylsilyloxy)-4-(2-(trityloxy)ethyl)cyclobutyl)hex-1-
en-5-yn-3-yl benzoate 86 
 
Trimethylsulfonium iodide (900 mg, 4.4 mmol, 4.4eq) was added to 4 mL THF under argon at -10°C. 
n-Butyllithium (1.6M in hexane, 2.75 mL, 4.4 mmol, 4.4eq) was added dropwise and the mixture was 
stirred at that temperature for 40 minutes. Epoxide 84a (770 mg, 1mmol, 1eq) was added in 2 mL THF 
and the reaction was stirred for 45 minutes and then at room temperature for 20 minutes. The reaction 
was quenched with brine and diluted with diethyl ether. The phases were separated and the aqueous 
phase was extracted three times with diethyl ether, the combined organic layers were washed with 
brine, dried over magnesium sulfate, the solvents were removed in vacuo and the crude product 85 
was directly submitted to the next reaction.  
Crude 85 was dissolved in 5 mL pyridine and catalytic DMAP and benzoyl chloride (170µL, 1.5 
mmol, 1.4 eq) were added. The reaction was stirred over night, quenched with 1M HCl diluted with 
diethyl ether and the phases were separated. The aqueous phase was extracted three times with diethyl 
ether, the combined organic layers were washed with brine, dried over magnesium sulfate, the solvents 
were removed in vacuo and the crude product was purified by flash column chromatography 
(hexane:ethylacetate 7:1) to give 749 mg 89% of 86. 
1H-NMR (400MHz, CDCl3): δ= 8.17-8.15 p.p.m. (m, 2H), 8.05-8.03 (m, 2H), 7.69-7.65 (m, 1H), 7.54-
7.20 (m, 15H), 6.04 (dddd, J=17.2, 10.7, 6.1, 2.0 Hz, 1H), 5.58-5.53 (m, 1H), 5.40-5.34 (m, 1H), 5.21-
5.18 (m, 1H), 4.26 (dd, J=7.7, 7.7 Hz, 1H), 4.12 (dd, J=7.6, 7.6 Hz1H), 3.21-3.05 (m, 2H), 2.78 (d, 
J=8.3 Hz, 1H), 2.75-2.61 (m, 2H), 2.30-2.25 (m, 1H), 1.95-1.87 (m, 1H), 1.50-1.41 (m, 1H), 1.07 (s, 
20H), 0.86 (s, 9H), 0.03 (s, 3H), 0.00 (s, 3H). 
13C-NMR (100MHz, CDCl3): δ= 166.06 p.p.m., 144.78, 135.88, 135.00, 133.40,  131.08, 130.80, 
130.19, 129.30, 129.15, 128.71, 128.13, 12727, 117.59, 87.04, 83.20, 78.25, 75.68, 75.01, 73.86, 
73.77, 62.89, 40.23, 33.07, 29.62, 26.27, 25.81, 18.32, 12.47, -4.40, -4.58. 
HRMS (ESI) (m/z ): [M]+  calcd for C53H70O5Si2 842.4761; found, 842.4755. 
(S)-6-(-3-(tert-butyldimethylsilyloxy)-2-(2-hydroxy-2-((S)-5-(2-methylallyl)-2-oxo-3-
(phenylthio)tetrahydrofuran-3-yl)ethyl)-4-(triisopropylsilyloxy)cyclobutyl)hex-1-en-5-yn-3-yl 
benzoate 87 
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Benzoate 86 (0.5g, 0.59 mmol, 1eq) was dissolved in 10 mL DCM and cooled to -78°C. To this 
solution was slowly added diethyl aluminum chloride (1M hexane, 1.2 mL, 1.18 mmol, 2eq). The 
mixture was stirred at -78°C for 50 minutes before it was quenched with a saturated solution of 
sodium hydrogen carbonate. The aqueous phase was extracted three times with diethyl ether, the 
combined organic layers were washed with brine, dried over magnesium sulfate, the solvents were 
removed in vacuo and the crude product 306 mg was dissolved in 2 mL DCM at room temperature. 
Dess-Martin periodinane (431 mg, 1.02 mmol, 2eq) was added together with sodium hydrogen 
carbonate (260 mg, 3.06 mmol, 6eq). The reaction was quenched after one hour with water and diluted 
with diethyl ether. The aqueous phase was extracted three times with diethyl ether, the combined 
organic layers were washed with brine, dried over magnesium sulfate, the solvents were removed in 
vacuo and the crude aldehyde was filtered over a short pad of silica gel before it was directly used in 
the next reaction. 
Diisopropylamine (240µL, 1.71 mmol, 3.35eq) was dissolved in 0.5 mL THF and cooled to 0°C. n-
butyllithium (1.6M in hexane, 1 mL, 1.71 mmol, 3.35 eq) was added dropwise and the mixture was 
stirred at 0°C for 30 minutes. The LDA solution was then cooled to -78°C and lactone 39 (425 mg, 
1.71 mmol, 3.35eq) was added in 1 mL THF. The reaction mixture was stirred at -78° for 1.25 hours 
before the aldehyde was added in 1 mL THF. The reaction was quenched after stirring at that 
temperature for 45 minutes with water and diluted diethyl ether. The aqueous phase was extracted 
three times with diethyl ether, the combined organic layers were washed with brine, dried over 
magnesium sulfate, the solvents were removed in vacuo and the crude product was purified by flash 
column chromatography (hexane:ethylacetate 5:1) to give products 87a and 87b each as 
diastereomeric mixtures in 189 mg 44% yield respectively.  
1H-NMR (400MHz, CDCl3): δ= 808-8.05, p.p.m. (m, 2H), 7.631-7.53 (m, 3H), 7.46-7.40 (m, 3), 7.38-
7.33 (m, 2H), 6.07-6.00 (m, 1H), 5.59-5.55 (m, 1H), 5.43-5.38 (m, 1H), 5.28-5.24 (m, 1H), 4.86-4.71 
(m, 2H), 4.56-4.49 (m, 1H), 4.36-4.23 (m, 1H), 4.19-4.07 (m, 1H), 3.82-3.78 (m, 1H), 2.71-2.59 (m, 
1H), 2.51-2.30 (m, 2H), 2.25-2.07 (m, 2H), 2.01-1.79 (m, 2H), 1.66 (s, 3H), 1.05 (s, 20H), 0.86 (s, 
9H), 0.04 (s, 3H), 0.01 (s, 3H). 
13C-NMR (100MHz, CDCl3): δ= 175.73 p.p.m., 140.53, 137.25, 133.26, 132.77, 130.44, 130.08, 
129.67, 129.23, 129.11, 128.36, 117.07, 113.79, 82.11, 76.18, 75.84, 75.74, 75.02, 74.53, 74.28, 
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73.87, 73.36, 43.88, 40.75, 40.39, 39.44, 37.85, 37.01, 35.80, 33.19, 32.53, 30.96, 29.73, 25.94, 25.76, 
25.40, 23.27, 22.71, 17.94, 11.96, -4.56, -5.02. 
HRMS (ESI) (m/z ): [M]+  calcd for C48H70O7SSi2 846.4380; found, 846.4371. 
 
1H-NMR (400MHz, CDCl3): δ= 8.08-8.05 p.p.m., (m, 2H), 7.57-7.53 (m, 3H), 7.45-7.38 (m, 3H), 
7.36-7.32 (m, 2H), 6.05-5.98 (m, 1H), 5.61-5.57 (m, 1H), 5.40 (dt, J=17.4, 1.3 Hz, 1), 5.26 (dt, 
J=10.6, 1.3 Hz, 1H), 4.81 (t, J=1.5 Hz, 1H), 4.65 (s, 1H), 4.58-4.52 (m, 1H), 4.29-4.26 (m, 1H), 4.17-
4.12 (m, 1H), 3.92 (ddd, J=10.5, 4.4, 1.4 Hz, 1H), 2.81-2.76 (m, 1H), 2.70-2.59 (m, 2H), 2.38-2.34 
(m, 1H), 2.33-2.28 (m, 1H), 2.17 (s, 3H), 2.03-1.96 (m, 1H), 1.86 (dd, J=14.3, 4.9 Hz, 1H), 1.05 (s, 
20H), 0.90 (s, 9H), 0.07 (s, 3H), 0.06 (s, 3H). 
13C-NMR (100MHz, CDCl3): δ= 171.47 p.p.m., 140.53, 137.01, 136.80, 135.37, 133.26, 130.06, 
129.67, 129.18, 128.53, 117.54, 114.02, 75.91, 75.79, 74.99, 74.75, 74.14, 73.46, 73.26, 72.95, 70.80, 
43.71, 41.19, 33.17, 32.78, 29.75, 25.87, 25.43, 22.67, 17.84, 14.18, 12.17, 12,02, -4.67, -4.82.  
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The fall armyworm (Spodoptera frugiperda) is native to the 
tropical regions of the western hemisphere from the United States 
to Argentina and its larvae cause enormous damage by consuming 
foliage of a variety of field crops, including barley, buckwheat, 
cotton, corn, oat, rice, sugarcane, soybean, tobacco, wheat and 
others.1 In Florida, for example, fall armyworm is the most 
significant pest of corn. As resistance to pesticides has been noted 
and is expected to become increasingly problematic from year to 
year, a way out of this dilemma would be the introduction of new 
environmentally benign pesticides. In this respect we were 
intrigued by a recent paper2 in which Gloer and co-workers 
described a novel sesquiterpenoid named penifulvin A (1), 
isolated from the fungus Penicillium griseofulvum (syn. P. 
patulum Bain.; P. urticae bain). This metabolite, which belongs to 
a larger family of penifulvins A - E (Figure 1),3 not only shows 
significant antiinsectan activity in assays against the fall 
armyworm, it also appeared, due to its unusual and complex 
molecular architecture, an attractive target for total synthesis. 
Furthermore, for procuring larger quantities, acquiring SAR data 
and elucidating the full bioprofile of the compound, a rational 
non-biological access was of the essence.  
Figure 1. Structures of Penifulvins A-E  
 
 
The overall structure of 1, which has been secured by X-ray 
crystallographic analysis,2 reveals a highly complex oxa-
fenestrane4 structure in which four rings share a central 
quaternary carbon. Additionally there are two more quaternary 
carbons, a γ-and a δ-lactone sharing the acylal center and a total 
of five stereogenic centers congested on a fifteen carbon skeleton. 
This ring system, whose absolute configuration is unknown, has 
not been described previously in literature. Herein we report the 
first total synthesis of racemic and optically active 1 from 
inexpensive o-tolylacetic acid (2) (Scheme 1).  
Scheme 1. Retrosynthetic Overview 
 
 
For our key transformation, we focused on Wender’s 
marvelous photo-induced cyclization of arene olefins5 such as 3a 
(racemic) and 3b (optically active) (Scheme 3), both readily 
available from 2 (Scheme 2). Racemic carboxylic acid 3a was 
obtained from the alkylation of the dianion.. The stereogenic 
center in 3b was introduced via Myers’ alkylation6 in 95% ee 
leading to amide 5 in two steps. As 5 undergoes racemization on 
basic hydrolysis, it was reduced to the alcohol. The photo-
reaction of 3a,b (Scheme 3) starts with a formal [3+2] 
cycloaddition to generate exciplex E which undergoes 1,3-bond 
formation to deliver a 1:1-mixture of the allylic regioisomers 6 
and 7. The stereochemical course of the addition is controlled by 
the stereogenic center in compound 3. According to the A1,3-strain 
model7 steric interactions between the aromatic methyl and the R-
group are minimized. This effect strongly disfavors 
conformations such as syn-3, so that anti-3 can be assumed to be 
the preferred conformation in the photocyclization. 
Scheme 2. Preparation of photocyclization precursors 3a and 3b 
 
Reagents and conditions: (a) 2 LDA, -78 °C, THF, 4; (b) (R,R)-
N-MPE, DIC, DMAP, DCM; (c) LiCl (6eq.) LDA, 5-bromo-2-
methyl-2-pentene (4), THF, rt, 24 h; (d) LDA, BH3NH3, THF. 
(R,R)-N-MPE = (R,R)-N-methylpseudoephedrine, DIC = 
diisopropyl carbodiimide, DMAP = dimethyl aminopyridine, 
DCM = dichloromethane, LDA = lithium diisopropyl amide. 
"Scheme 3. Photo-cyclization of 3a,b 
  
 
Conditions: hν, pentane, 22 °C, 2 h. (Series a: R = CH2OH, 
optically active, 70% yield. Series b: R = CO2H, racemic, 62% 
yield). 
 
The synthesis was completed in parallel for both the racemic 
and the optically active series (Scheme 4). Thus, the regioisomers 
6a and 7a were separated by chromatography and the 
cyclopropane was selectively reduced under Birch conditions to 
give triquinanyl alcohol 8, which was oxidized to carboxylic acid 
9. Ozonolytic cleavage of the double bond generated the non-
isolable dialdehyde 10 which immediately cyclized to lactol 11.8 
Oxidation gave 1, whose spectral data were in full accord with 
those of an authentic sample (see Supporting Information). The 
optical rotation of our material was [α]D20 =-127 (c 0.35, CHCl3) 
compared to a value of [α]D20 =-133 (c 0.50, CHCl3) of the 
authentic sample.9,10,11 This result also confirms the absolute 
configuration (1S, 4R, 7S, 8S, 9R) of 1. In the racemic series, the 
mixture of 6b and 7b was carried through the sequence without 
separation, and rac-1 was finally obtained in pure form by 
column chromatography and crystallization. 
In conclusion we have disclosed a concise synthesis of the 
antiinsectan agent penifulvin A in racemic and optically active 
form from o-tolylacetic acid in altogether 5 steps (14% overall 
yield) and 8 steps (8% overall yield), respectively. Apart from the 
photocyclization which leads to readily separable regioisomers, 
the synthesis is stereo- and regiocontrolled, does not require 
protecting groups or purification of intermediates and is scalable. 
Precursor 2 can be modified by introducing substituents onto the 
aromatic ring and/or the aliphatic sidechain, so that a variety of 
analogs, among them penifulvins B–E, should be available for 
performing SAR tests in the antiinsectan role. 
"Scheme 4. Completion of the Synthesis 
 
Reagents and conditions: (a) EtNH2, Li, THF, -78 °C 7 h; (b) 
IBX, DMSO, 22 °C, 20 min, then NaClO2, 2-methyl-2-butene, 
tert-BuOH, NaH2PO4, 1 h; (c) O3, DCM, -78 °C, 2 min, then 
thiourea, 22°C, 40 min; (d) PDC (4 eq.), DCM, 22 °C, 20 min, 
then AcOH (20 eq.), 20 min. IBX = 2-iodoxybenzoic acid, 
DMSO= dimethylsulfoxide, DCM = dichloromethane, PDC = 
pyridinium chlorochromate. 
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Herein we report the first total synthesis of Penifulvin A, a sesquiterpenoid with a novel dioxa-fenestrane structure. Penifulvin 
A is a potent antiinsectan against the fall armyworm spodoptera frugiperda which causes enormous damage in the US by 
consuming foliage of a variety of field crops. A five step racemic and an eight step enantioselective route to the natural 
product, and the determination of its absolute configuration are described. The key step involves a meta-photo cycloaddition, 
giving rapid access to the carbon skeleton of penifulvin A in a stereoselective fashion. Finally an oxidation cascade leads to 
the natural product The synthetic route is free from protecting groups, scalable and flexible so that a variety of analogs, among 
them penifulvins B–E, should be available for performing SAR tests in the antiinsectan role.  
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Total Synthesis of (‐)‐Penifulvin A, an Antiinsectan with a 
Dioxafenestrane Skeleton. 
Tanja Gaich* and Johann Mulzer* 
Supporting Information 
1. Procedures 
General 
All reactions were carried out in oven‐dried glassware under an argon atmosphere, unless otherwise 
stated. Anhydrous CH2Cl2 (DCM) was distilled from CaH2 under argon or reduced pressure, 
respectively. Anhydrous THF (tetrahydrofuran) was purchased (99.85%, water < 50 ppm). All other 
solvents were HPLC grade. Reactions were magnetically stirred and monitored by thin layer 
chromatography (TLC) with silica gel 60‐F254 plates. Flash column chromatography was performed 
with silica gel (0.04‐0.063mm, 240‐400 mesh) under pressure. Yields refer to chromatographically 
and spectroscopically pure compounds, unless otherwise stated. NMR spectra were recorded on a 
400 MHz spectrometer. Unless otherwise stated, all NMR spectra were measured in CDCl3 solutions 
and referenced to the residual CHCl3 signal (
1H, δ = 7.26 ppm; 13C, δ =77.16 ppm). All 1H and 13C shifts 
are given in ppm (s = singlet; d = doublet; t = triplet; q = quadruplet; m = multiplet; b = broad signal). 
Assignments of proton resonances were confirmed, when possible, by correlated spectroscopy. 
Optical rotations were measured at 20°C. High resolution mass spectra (HRMS) were performed with 
a resolution of 10000. Compound names were generated using AutoNom. 
 
N‐((1R,2R)‐1‐hydroxy‐1‐phenylpropan‐2‐yl)‐N‐methyl‐2‐o‐tolylacetamide (A) 
 
o‐Tolylacetic acid (1.00 g, 6.7 mmol, 1 eq.), (R,R)‐pseudoephedrine (1.20 g, 7.3 mmol, 1.1 eq.), and 
N,N‐dimethyl‐4‐amino pyridine were dissolved in DCM (40 mL) at room temperature. After the 
starting materials had dissolved, the solution was cooled to 0°C in an ice bath and diisopropyl 
carbodiimide (1.1 mL, 7.3 mmol, 1.1 eq.) was added dropwise. After 20 min a precipitate was formed, 
and the reaction was warmed to room temperature and stirred for 3 h. The reaction mixture was 
concentrated on the rotatory evaporator and directly submitted to flash column chromatography 
(hexane:ethylacetate=3:1) yielding 1.95 g (98%) of the desired amide A. 
1H‐NMR (400MHz, CDCl3): δ= 7.39‐7.26 p.p.m. (m, 5H), 7.20‐7.04 (m, 4H), 4.65 (t, J=7.3 Hz, 1H), 4.55‐
4.48 (m, 1H), 4.34 (s, br 1H), 3.64 (d, J=2.3 Hz, 2H), 2.86 (s, 3H), 2.25 (s, 3H), 1.18 (d, J=6.8 Hz, 3H).  
13C‐NMR (100MHz, CDCl3): δ= 173.70 p.p.m., 142.83, 136.84, 133.81, 130.63, 129.28, 128.79, 128.04, 
127.42, 126.72, 126.65, 76.88, 75.97, 59.09, 39.83, 20.02, 14.85. IR (film): 3383, 2971, 1699, 1617, 
1558, 1452, 1404, 1118, 1051, 743, 702, 610 cm‐1. HRMS (ESI) (m/z ): [M]+ c alcd for C19H23NO2 
297.1729; found, 297.1715. [α]D= ‐96 (c 1.05g/100mL, CHCl3). 
(R)‐N‐((1R,2R)‐1‐hydroxy‐1‐phenylpropan‐2‐yl)‐N,6‐dimethyl‐2‐o‐tolylhept‐5‐enamide (5) 
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A solution of n‐butyllithium (5.9 mL, 2.5M, 2.2 eq.) was added to a suspension of LiCl (1.65 g, 39.9 
mmol, 6 eq.) and diisopropylamine (2 mL, 14.6 mmol, 2.2 eq.) in THF. (7 mL) at ‐78°C. The resulting 
suspension was briefly warmed to 0°C and then cooled to ‐78°C. Amide A (1.95 g, 6.5 mmol, 1 eq.) 
was added to this mixture via cannula and stirred at that temperature for 1 h, then at 0°C for 15 min 
and at 23°C for 5 min. The mixture was cooled to 0°C and 5‐bromo‐2‐methyl‐2‐pentene (1.44 g, 8.9 
mmol) was added neat to this reaction mixture. After stirring at room temperature for 24 h the 
mixture was quenched with saturated aqueous ammonium chloride and extracted with 
dichloromethane (3x100 mL). The combined organic phases were dried over magnesium sulfate and 
concentrated in vacuo. Purification of the residue by flash column chromatography 
(hexane:ethylacetate=3:1) afforded 1.47 g (58%)of amide 5. 
1H‐NMR (400MHz, CDCl3): δ= 7.38‐7.04 p.p.m. (m, 9H), 5.18‐5.10 (m, 1H), 4.59‐4.50 (m, 1H), 4.47‐
4.26 (s br, 1H), 3.71‐3.66 (m, 1H), 2.92 (s, 1H minor rotamer), 2.54 (s, 1H major rotamer), 2.36 (s, 1H 
minor rotamer), 2.30 (s,  2H major rotamer), 2.24‐2.21 (m, 1H), 2.11‐2.04 (m, 1H), 1.98‐1.89 (m, 1H), 
1.69 (s, 2H major rotamer), 1.68 (s, 1H minor rotamer), 1.59 (s, 1H minor rotamer), 1.56 (s, 2H major 
rotamer), 1.51‐1.41 (m, 1H), 1.13 (d, J=4.9 Hz, 2H major rotamer), 0.39 (d, J=6 Hz, 1H). 13C‐NMR 
(100MHz, CDCl3): δ= 138.67p.p.m., 134.82, 132.60, 130.70, 128.78, 128.44, 127.65, 127.00, 126.90, 
126.64, 126.45, 124.45, 124.08, 76.60, 75.68, 58.06, 45.28, 34.50, 34.23, 27.58, 26.74, 25.84, 19.35, 
17.81, 14.19. IR (film): 3383, 2924, 1713, 1621, 1454, 1404, 1376, 1228, 1119, 1051, 895, 838, 757, 
726, 702, 610 cm‐1. HRMS (ESI) (m/z ): [M]+ calcd for C25H33NO2 379.2511; found, 379.2510 [α]D= ‐137° 
(c 0.75g/100mL, CHCl3). 
(R)‐6‐Methyl‐2‐o‐tolylhept‐5‐en‐1‐ol (3a) 
 
A solution of n‐butyllithium (5.9 mL, 2.5M, 14.8 mmol, 4 eq.) in hexanes was added to a solution of 
diisopropylamine (2.1 mL, 14.8 mmol, 4 eq.) in THF. (10 mL) at ‐78°C. The resulting solution was 
stirred at this temperature for 10 min, then warmed to 0°C and held at that temperature for 10 min. 
Borane‐ammonia complex (456 mg, 14.8 mmol, 4 eq.) was added in one portion. The suspension was 
stirred at 0°C for 15 min, then at 23°C for 15 min, cooled again to 0°C and a solution of amide 5 (1.40 
g, 3.7 mmol, 1 eq.) in THF.(6 mL ) was added via cannula. The reaction mixture was warmed to room 
temperature and stirred for 2 h before it was cooled to 0°C again and carefully quenched with 1M 
hydrochloric acid (40 mL). The mixture was diluted with water (100 mL) and extracted with ether (3x 
100 mL). The combined organic phases were dried over magnesium sulfate and the solvents were 
removed in vacuo to give 3a (734 mg, 91%) as a yellow oil which was directly used in the next step. 
An analytical sample was purified by chromatography (hexane:ethyl acetate 5:1). 
1H‐NMR (400MHz, CDCl3): δ= 7.21‐7.10 p.p.m. (m, 4H), 5.07 (dt, J=6.9,0.6 Hz, 1H), 3.76‐3.69 (m, 2H), 
3.19‐3.15 (m, 1H), 2.33 (s, 3H), 1.89 (dd, J=14.9, 7.3 Hz, 2H), 1.78‐1.72 (m, 1H), 1.69‐1.61 (m, 1H), 
1.66 (d, J=1.1 Hz, 3H), 1.44 (s, 3H).  13C‐NMR (100MHz, CDCl3): δ= 140.73 p.p.m., 137.71, 132.32, 
130.90, 126.74, 126.62, 126.27, 124.66, 67.78, 42.66, 32.55, 26.12, 25.98, 20.29, 17.97. IR (film): 
3241, 2928, 2857, 1653, 1559, 1463, 1256, 1101, 836, 775, 610 cm‐1. HRMS (ESI) (m/z ): [M]+ calcd for 
C15H22O 218.1671; found, 218.1665. [α]D= +18 (c 1.05g/100mL, CHCl3). 
 
((1aS,4R,4aR,6bS,6cS)‐1,1,6c‐Trimethyl‐1,1a,2,3,4,6a,6b,6c‐octahydro‐
cyclopenta[g]cyclopropa[cd]pentalen‐4‐yl)‐methanol (6a) 
((2aS,3aS,6R,6bS,6cR)‐3,3,6c‐Trimethyl‐2a,3,3a,4,5,6,6b,6c‐octahydro‐
cyclopenta[a]cyclopropa[gh]pentalen‐6‐yl)‐methanol (7a) 
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Compound 3a (1.00 g, 3.0 mmol) in pentane (100 mL) was irradiated with a Hannovia 700W medium 
pressure mercury lamp with a quartz filter at room temperatur for 2 h. The reaction mixture was 
concentrated and the crude residue was submitted to flash column chromatography (hexane) 
yielding 6a and 7a (350 mg each, total 70%) in a 1:1 ratio. 
6a : 1H‐NMR (400MHz, CDCl3): δ= 5.76 p.p.m. (dd, J=5.3, 2.0 Hz, 1H), 5.44 (d, J=5.3 Hz, 1H), 3.68‐3.61 
(m, 1H), 3.58‐3.48 (m, 1H), 2.47‐2.38 (m, 1H), 2.01‐1.85 (m, 2H), 1.84‐1.74 (m, 1H), 1.67 (d J=1.3 Hz, 
1H), 1.63‐1.50 (m, 3H), 1.48‐1.43 (m, 1H), 1.34 (s, 3H), 1.31 (d, J=7.6 Hz, 1H), 1.11 (s, 3H), 1.02 (s, 3H).  
13C‐NMR (100MHz, CDCl3): δ= 133.61 p.p.m., 130.69, 70.95, 66.14, 64.83, 60.47, 49.77, 48.55, 42.50, 
38.42, 31.09, 29.64, 29.36, 28.51, 19.15. IR (film): 3332, 3053, 2950, 1701, 1684, 1653, 1636, 1591, 
1559, 1540, 1507, 1458, 1361, 1025, 957, 887, 745, 610 cm‐1. HRMS (ESI) (m/z ): [M]+  calcd for 
C15H22O 218,1671; found, 218,1679. [α]D= ‐79 (c 1.35g/100mL, CHCl3). 
7a:  1H‐NMR (400MHz, CDCl3): δ= 5.66 p.p.m. (dd, J=5.6, 2.2 Hz, 1H), 5.46 (dd, J=5.6, 2.5 Hz, 1H), 3.44 
(dd J=10.6, 4.3 Hz, 1H), 3.36 (dd, J=9.3. 4.3 Hz, 1H), 2.40, (d, J=2.5 Hz, 1H), 2.07 (s, br, 1H), 1.90 (dd, 
J=9.5, 3.4 Hz, 1H), 1.86‐1.77 (m, 3H), 1.72‐1.59 (m, 2H), 1.51 (d, J=2.3 Hz, 1H), 1.49‐1.42 (m, 1H), 0.94, 
(s, 3H), 0.74 (s, 3H).  13C‐NMR (100MHz, CDCl3): δ= 131.70 p.p.m., 129.84, 68.40, 64.77, 55.25, 50.85, 
50.75, 46.71, 41.22, 38.16, 31.25, 23.78, 23.14, 23.03, 16.02. IR (film): 3332, 3053, 2950, 1701, 1684, 
1653, 1636, 1591, 1559, 1540, 1507, 1458, 1361, 1025, 957, 887, 745, 610 cm‐1. HRMS (ESI) (m/z ): 
[M]+  calcd for C15H22O 218,1671; found, 218,1681 [α]D= +58 (c 2.56g/100mL, CHCl3). 
 
((1R,3aS,5aS,8aR)‐4,4,5a‐Trimethyl‐1,2,3,3a,4,5,5a,6‐octahydro‐cyclopenta[c]pentalen‐1‐
yl)‐methanol (8) 
 
A solution of 6a (120 mg, 0.36 mmol, 1 eq.) in absolute THF (500µL) was cooled to ‐78°C and 
ethylamine (3 mL) was condensed in. Small pieces of lithium (15 mg, 2.16 mmol, 6 eq.) were added 
and the reaction mixture was stirred for 7 h until a deep blue color formed. The excess lithium was 
quenched with saturated ammonium chloride solution and the suspension was warmed to room 
temperature. Diethyl ether was added and the water phase was extracted with diethyl ether (3x 100 
mL). The combined organic phases were dried over magnesium sulfate and the solvents were 
removed in vacuo to give 8 (118 mg, 97%) as a yellow oil which was directly subjected to the next 
step. A purified sample was obtained by chromatography (hexanes:ethyl acetate 10:1). 
1H‐NMR (400MHz, CDCl3): δ= 5.68 p.p.m. (dt, J=5.7. 2.2 Hz, 1H), 5.54 (dt, J=5.6. 2.4 Hz, 1H), 3.55 (dd, 
J=11.0, 7.2 Hz, 1H), 3.49‐3.42 (m, 2H), 2.36 and 2.24 (AB dt, J=17.0 2.2 Hz, 2H), 1.95‐1.87 (m, 2H), 
1.69 (dd, J=4.8. 2.2 Hz, 3H), 1.67‐1.62 (m, 3H), 1.15 (s, 3H), 0.98 (m, 3H), 0.92 (s, 3H).  13C‐NMR 
(100MHz, CDCl3): δ= 137.51 p.p.m., 127.87, 65.31, 63.90, 58.52, 53.82, 51.12, 46.78, 42.12, 39.58, 
32.20, 30.77, 28.43, 28.02, 27.57. HRMS (ESI) (m/z ): [M]+  calcd for C15H24O 220,1827; found, 
220,1820. 
6-Methyl-2-o-tolyl-hept-5-enoic acid (3b) 
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Diisopropyl amine (1.5 mL, 10.5 mmol, 2.1 eq) was dissolved in 4 mL THF and cooled to 0°C. n‐
Butyllithium ( 2.5M, 4.2 mL 10.5 mmol, 2.1 eq) was added dropwise and the solution was stirred for 
30 min at that temperature. The reaction mixture was cooled to ‐78°C and o‐tolyl acetic acid (750 
mg, 5 mmol) in THF (1 mL) was added at‐78°C. The reaction was moved to a NaCl/ice bath and stirred 
at ‐20°C for 2h. After this time the reaction was cooled to ‐78°C and 5‐bromo‐2‐methyl‐pent‐2‐ene 
(1.21 g, 7.5 mmol) was added crude to this solution. The reaction was warmed to rt over night and 
quenched with aqueous sodium hydrogen carbonate solution. The aqueous phase was extracted two 
times with Et2O (50 mL). Then the aqueous phase was acidified to pH 2 and extracted four times with 
100 mL of DCM. The combined DCM fractions were dried over MgSO4 and the solvent was removed 
in vacuo. Crude 3b was used without any further purification. Yield 1.16g (quant). 
 
1H‐NMR (400MHz, CDCl3): δ= 11.01 p.p.m. (s,br 1H), 7.38‐7.35 (m, 1H), 7.26‐7.18 (m, 3H), 5.14 (dd, J= 
7.1Hz, 1H), 3.91 (t, J= 7.3Hz, 1H), 2.41 (s, 3H), 2.20 (ddd, J= 14.1, 7.1Hz, 1H), 2.04 (dd, J= 14,4, 7.1Hz, 
2H), 1.90‐1.81 (m, 1H), 1.73 (s, 3H), 1.55 (s, 3H). 
(1aS,4R,6cS)‐1,1,6c‐Trimethyl‐1,1a,2,3,4,6a,6b,6c‐octahydro‐
cyclopenta[g]cyclopropa[cd]pentalene‐4‐carboxylic acid (9) 
 
 
Acid 3b (1.14 g, 4.9 mmol) in pentane (100 mL) was irradiated with a Hanovia 700W medium 
pressure mercury lamp with a quartz filter at room temperatur for 1 h. The reaction mixture was 
concentrated and the crude mixture of 6b/7 b was dissolved in THF (1 mL), cooled to ‐78°C and 
ethylamine (3 mL) was condensed in. Small lithium pieces (15 mg, 2.16 mmol, 6 eq.) were added and 
the reaction mixture was stirred for 7 h as a deep blue color formed. The excess lithium was 
destroyed with saturated ammonium chloride solution and the suspension was warmed to room 
temperature. Diethyl ether was added and the water phase was extracted with diethyl ether (3x 100 
mL). The combined organic phases were dried over magnesium sulfate and the solvents were 
removed in vacuo to give 9 (along with its regioisomer, 707 mg, 62 %) as a yellow oil.  
(1R,3aS,5aS,8aR)‐4,4,5a‐Trimethyl‐1,2,3,3a,4,5,5a,6‐octahydro‐cyclopenta[c]pentalene‐1‐
carboxylic acid (9) 
 
Alcohol 8 was dissolved in DMSO (1 mL) and IBX (302 mg, 1.1 mmol, 3 eq.) was added in one portion. 
The reaction mixture was stirred at room temperature for 20 min until TLC control revealed full 
consumption of the starting material. The reaction mixture was diluted with diethyl ether (20 mL) 
and the solids were filtered off through a silica pad. The solvents were removed in vacuo and the 
crude aldehyde was dissolved in tert‐butanol (5 mL) and 2‐methyl‐2‐butene (500 µL) was added. A 
solution of sodium chlorite (537 mg, 5.4 mmol, 15 eq.) and sodium dihydrogenphosphate (537 mg) in 
water (2 mL) was added dropwise under vigorous stirring. The reaction mixture was stirred at room 
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temperature for 1 h and quenched with a 1M solution of potassium hydrogen sulfate in brine. The 
mixture was extracted with methylene chloride (3 x 50 mL), dried over magnesium sulfate and the 
solvents were removed in vacuo. Flash column chromatography (hexane:ethyl acetate=5:1) furnished 
73 mg (86%) of 9 as a viscous oil. 
1H‐NMR (400MHz, CDCl3): δ= 5.60‐5.47 p.p.m. (m, 2H), 2.98 (dd, J=10.7, 7.0 Hz, 1H), 2.48‐2.42 (m, 
1H), 2.32‐2.25 (m, 1H), 2.03‐1.81 (m, 4H), 1.77‐1.67 (m, 3H), 1.23 (s, 3H), 1.00 (s, 3H), 0.93 (s, 3H). 
13C‐NMR (100MHz, CDCl3): δ= 180.32 p.p.pm., 137.28, 128.60, 63.39, 58.51, 54.06, 61.32, 50.10, 
45.96, 39.74, 31.29, 30.82, 28.84, 28.42, 27.95. IR (film): 3332, 3053, 2950, 1701, 1684, 1653, 1636, 
1591, 1559, 1540, 1507, 1458, 1361, 1025, 957, 887, 745, 610 cm‐1. HRMS (ESI) (m/z ): [M]+  calcd for 
C15H22O 218,1671; found, 218,1681. [α]D= ‐76 (c 1.05g/100mL, CHCl3). 
Lactol 11 
 
Acid 9 (25 mg, 0.11mmol, 1 eq) was dissolved in dichloromethane (50 mL) in a three necked round 
bottom flask equipped with a gas outlet and a gas inlet‐tube. The solution was cooled to ‐78°C and 
ozonized for 2 min (flow 100mL/min) until the solution was dark blue. The excess ozone was driven 
out with air until the solution became colorless again. Then thiourea (9 mg, 0.12 mmol, 1.1 eq.) was 
added in one portion and the suspension was warmed to room temperature and stirred for 40 min 
giving a cloudy solution. The solvent was removed in vacuo and the crude product was submitted to 
flash column chromatography (hexane:ethyl acetate=3:1) yielding 15 mg (56%) of lactol 11. 
1H‐NMR (400MHz, CDCl3): δ= 5.69 p.p.m. (s, 1H), 5.37 (dd, J=8.9, 5.8 Hz, 1H), 3.24 (s, br 1H), 2.93 (d, 
J= 7.5 Hz, 1H) 2.25 (dd, J=9.3, 1.3 Hz, 1H) 2.16 (dd, J=13, 7.0 Hz, 1H), 2.01 (dd, J=14.2, 8.9 Hz, 1H), 
1.89‐1.85 (m, 2H), 1.76‐1.65 (m, 1H), 1.74 (d, J=14 Hz, 1H), 1.54‐1.47 ( m, 1H), 1.47 (d, J=13.6 Hz, 1H), 
1.22 (s, 3H), 1.08 (s, 3H), 0.96 (s, 3H).  13C‐NMR (100MHz, CDCl3): δ= 179.83 p.p.pm., 101.09, 91.81, 
66.90, 60.10, 58.16, 46.56, 42.39, 41.06, 40.06, 34.50, 31.21, 29.37, 28.33, 28.00. IR(film): 3449, 
2958, 1792, 1559, 1457, 1132, 997, 884, 738, 610 cm‐1. HRMS (ESI) (m/z ): [M]+  calcd for C15H22O4 
266,1518; found, 266,1509. [α]D= ‐65 (c 0.6g/100mL, CHCl3) 
Penifulvin A (1) 
 
Lactol 11 (15 mg, 56 µmol, 1eq) was dissolved in dichloromethane (0.5 mL) at room temperature. 
PDC (84 mg, 0.22 mmol, 4 eq.) was added in one portion. After 20 min concentrated acetic acid (67 
µL, 1.12 mmol, 20 eq.) was added dropwise. The reaction mixture was stirred for another hour and 
then diluted with diethyl ether. The suspension was filtered through a silica pad and concentrated in 
vacuo. Flash column chromatography (hexanes:ethyl acetate 5:1) gave 12 mg (80%) of pure 
penifulvin A (1).  
1H‐NMR (400MHz, CDCl3): δ= 5.96 p.p.m. (s, 1H), 2.97 (dd, J=8.0, 1.0 Hz, 1H), 2.79 (d, J=15 Hz, 1H), 
2.46 (dd, J=15 Hz, 1H), 2.32 (dd, J=9.7, 5.0 Hz, 1H), 2.23 (ddd, J=13.3, 8.0, 3.9, 1.8 Hz, 1H), 1.91 (ddt, 
J=14.0, 8.1, 8.2 Hz, 1H), 1.82 (m, 1H), 1.78 (d, J=14 Hz, 1H), 1.73 (d, J=14 Hz, 1H), 1.24 (s, 3H), 1.10 (s, 
3H), 1.03 (s, 3H). 13C‐NMR (100MHz, CDCl3): δ= 178.04 p.p.m., 168.65, 103.88, 66.73, 60.86, 55.62, 
46.43, 44.10, 42.07, 40.32, 32.83, 30.11, 28.18, 27.58, 27.42. IR (film): 2960, 1799, 1771, 1653, 1559, 
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1507, 1458, 1367, 1115, 1043, 995, 905, 738, 610 cm‐1. HRMS (ESI) (m/z ): [M]+  calcd for C15H20O4 
264,1362; found,, 264,1368. [α]D= ‐127 (c 0.35g/100mL, CHCl3). [α]D= ‐97 (c 0.35g/100mL, MeOH). 
In the racemic series, the operations from 9 to 1 were performed without isolation of the 
intermediates. The chromatography (hexanes:ethyl acetate 5:1) of the final mixture gave pure 
crystalline rac‐1 (23% from the 6b/7b‐ mixture). 
 
2. NMR Spectra 
 
Natural Penifulvin A2 
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Natural Penifulvin A2 
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  COMPARISON of 1H‐NMR DATA  COMPARISON of 13C‐NMR DATA 
  natural  synthetic  natural  synthetic 
Position  δH (mult, J in Hz)    δC  δC 
         
1  5.95 (s)  5.96 (s)  103.7  103.88 
2      168.3  168.65 
3α  2.77 (d, 16)  2.79 (d, 15)  43.9  44.10 
3β  2.43 (d, 16)  2.46 (d, 15)     
4      41.9  42.07 
5α  1.76 (d, 14)  1.78 (d, 14)  55.4  55.62 
5β  1.71 (d, 14)  1.73 (d, 14)     
6      40.2  40.32 
7  2.30 (dd, 5.1, 9.8)  2.32 (dd, 5.0, 9.7)  60.7  60.86 
8      66.7  66.73 
9  2.95 (dd, 1.2, 8.0)  2.97 (dd, 1.0, 8.0)  46.2  46.43 
10α  2.20 (dddd, 2.0, 
3.4, 8.0, 14) 
2.23 (dddd, 1.8, 
3.9, 8.0, 13.6) 
29.9  30.11 
10β  1.90 (ddt, 8.0, 
8.0, 14) 
1.91 (ddt, 8.1, 8.1, 
13.6) 
   
11α  1.71 (m)  1.74 (m)  28.0  28.18 
11β  1.83 (m)  1.83 (m)     
12  1.22 (s)  1.24 (s)  32.6  32.83 
13  1.00 (s)  1.03 (s)  27.4  27.58 
14  1.07 (s)  1.10 (s)  27.2  27.42 
15      177.8  178.04 
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Appendix 6 
Total Synthesis of (-)-Penifulvin B and C, a new Structure Type with a Dioxafenestrane 
Skeleton. 
Tanja Gaich* and Johann Mulzer* 
Supporting Information 
1. Procedures 
General 
All reactions were carried out in oven-dried glassware under an argon atmosphere, unless otherwise 
stated. Anhydrous CH2Cl2 (DCM) was distilled from CaH2 under argon or reduced pressure, 
respectively. Anhydrous THF (tetrahydrofuran) was purchased (99.85%, water < 50 ppm). All other 
solvents were HPLC grade. Reactions were magnetically stirred and monitored by thin layer 
chromatography (TLC) with silica gel 60-F254 plates. Flash column chromatography was performed 
with silica gel (0.04-0.063mm, 240-400 mesh) under pressure. Yields refer to chromatographically and 
spectroscopically pure compounds, unless otherwise stated. NMR spectra were recorded on a 400 
MHz spectrometer. Unless otherwise stated, all NMR spectra were measured in CDCl3 solutions and 
referenced to the residual CHCl3 signal (1H, δ = 7.26 ppm; 13C, δ =77.00 ppm). All 1H and 13C shifts 
are given in ppm (s = singlet; d = doublet; t = triplet; q = quadruplet; m = multiplet; b = broad signal). 
Assignments of proton resonances were confirmed, when possible, by correlated spectroscopy. Optical 
rotations were measured at 20°C. High resolution mass spectra (HRMS) were performed with a 
resolution of 10000. Compound names were generated using AutoNom. 
 
(Z)-2-Methyl-5-(tetrahydro-pyran-2-yloxy)-pent-2-en-1-ol 213a 
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To a stirred solution of KHMDS in 30 mL THF (0.5 M in toluene, 23.6 mL, 11.8 mmol, 1.1 eq.) at -
78°C phosphonate A (1.1 eq. 11.8 mmol, 4.1 g, in 10 mL THF)was added dropwise. After stirring at 
this temperature for 45 minutes, aldehyde 212 ( 1.0 eq, 10.7 mmol, 1.8 g ) was added crude to this 
mixture. The reaction was quenched after stirring at -78°C for one hour with saturated NH4Cl solution. 
The mixture was extracted two times with ether. The combined organic layers were washed with brine 
and dried over MgSO4. The solvents were removed in vacuo. The crude material was submitted to the 
next reaction without further purification. 
Compound 213( 1.6 g, 6.6 mmol, 1 eq) was dissolved in 20 mL diethylether and cooled to -78°C. 
diisobutylaluminum hydride ( 1M in hexane, 2.25eq, 14.85 mmol, 14.85mL) was added dropwise to 
this cooled solution and the reaction mixture was stirred for one hour at that temperature. The reaction 
was quenched by addition of 1mL methanol and warmed to room temperature. Then it was diluted 
with Na/K tartrate and stirred over night. The phases were separated and the aquaeous phase was 
extracted two times with ether. The combined organic layers were washed with brine and dried over 
MgSO4. The solvents were removed in vacuo. Purification of crude 213a by flash column 
chromatography (hexane: ethylacetate = 3:1) afforded 918 mg of 213a as a 6:1 = Z:E mixture of 
doublebond isomers ( 798 mg of the Z-isomer and 120 mg of the E-isomer) in 43% over two steps. 
 
1H-NMR (400MHz, CDCl3): δ= 5.34 p.p.m. (dt, J=8.3, 0.4 Hz, 1H), 4.60-4.58 (m, 1H), 4.09-4.00 (m, 
2H), 3.87-3.73 (m, 2H), 3.52-3.34 (m, 2H), 2.39-2.33 (m, 2H), 1.82 (d, J= 1.26 Hz, 3H), 1.81-1.68 (m, 
2H), 1.60-1.48 (m, 4H). 
13C-NMR (100MHz, CDCl3): δ= 138.35 p.p.m., 125.05, 99.11, 67.11, 62.50, 61.84, 30.79, 28.84, 
25.76, 22.83, 19.82. 
IR (film): 3423, 2941, 1441, 1201, 1120, 1032, 870, 815, 610 cm-1. 
HRMS (ESI) (m/z ): [M]+  calcd for C11H20O3 200,1412; found, 200,1430. 
Triisopropyl-[(Z)-2-methyl-5-(tetrahydro-pyran-2-yloxy)-pent-2-enyloxy]-silane 213b 
 
 
 
Alcohol 213a (798 mg, 4 mmol, 1eq.) was dissolved in 2 mL DMF at room temperature. Imidazole 
(652 mg, 9.6 mmol, 2.4 eq.) was added in one portion to the stirred solution. Then 
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triisopropylchlorosilane (940 µl, 4.4 mmol, 1.1 eq. ) was added dropwise and the reaction mixture was 
stirred over night. The reaction was diluted with diethylether and quenched with water. The mixture 
was extracted twice with diethylether. The combined organic layers were washed with brine and dried 
over MgSO4. The solvents were removed in vacuo. Purification of crude 213b by flash column 
chromatography (hexane: ethylacetate = 10:1) afforded pure 213b, 1.4 g in 98% yield. 
1H-NMR (400MHz, CDCl3): δ= 5.23 p.p.m. (ddt, J=7.3, 2.4, 1.1 Hz, 1H), 4.58-4.56 (m, 1H), 4.25 (m, 
2H), 3.88-3.82 (m, 1H), 3.73-3.66 (m, 1H), 3.51-3.46 (m, 1H), 3.37 (ddd, J= 8.5, 8.5, 7.2 Hz, 1H), 
2.32 (dd, J= 13.7, 6.9 Hz, 2H), 1.86-1.79 (m, 1H), 1.78 (d, J= 1.1 Hz, 3H), 1.74-1.66 (m, 1H), 1.59-
1.48 (m, 4H), 1.07 (s, 20H). 
13C-NMR (100MHz, CDCl3): δ= 137.71 p.p.m., 122.03, 99.21, 67.68, 62.72, 62.47, 31.13, 28.65, 
25.90, 21.37, 20.01, 18.43, 12.42. 
IR (film): 2942, 1463, 1260, 1120, 1034, 986, 682, 610 cm-1. 
HRMS (ESI) (m/z ): [M]+  calcd for C20H30O3Si 356,2747; found, 356,2753. 
(Z)-4-Methyl-5-triisopropylsilanyloxy-pent-3-en-1-ol 213c 
 
 
 
To a stirred solution of compound 213b ( 2.6 g, 7.3 mmol) in 40 mL MeOH were added 500 mg 
Montmorillionite K10 at room temperature. The reaction mixture was stirred for 6 hours. Then it was 
quenched with saturated NaHCO3 solution. The mixture was extracted two times with diethylether. 
The combined organic layers were washed with brine and dried over MgSO4. The solvents were 
removed in vacuo. Purification of crude 213c by flash column chromatography (hexane: ethylacetate = 
3:1) afforded pure 213c, 1.36g in 68% yield. 
1H-NMR (400MHz, CDCl3): δ= 5.25 p.p.m. (ddt, J=7.7, 2.1, 0.9 Hz, 1H), 4.23 (s, 2H), 3.61 (dd, 
J=11.6, 6.1 Hz, 2H), 2.31 (dd, J=12.9, 6.3 Hz, 2H), 1.82 (d, J=1.26 Hz, 3H), 1.77 (t,  J=5.4 Hz, 1H), 
1.08 (s, 20H). 
13C-NMR (100MHz, CDCl3): δ= 138.97 p.p.m., 122.88, 62.43, 31.53, 22.08, 18.41, 6.20.  
HRMS (ESI) (m/z ): [M]+  calcd for C15H32O2Si 272,2172; found, 272,2170. 
Methanesulfonic acid (Z)-4-methyl-5-triisopropylsilanyloxy-pent-3-enyl ester 213d 
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Alcohol 213c (1.1 g, 4 mmol, 1eq.) was dissolved in 10 mL dichloromethane and the solution was 
cooled to 0°C. Pyridine ( 500µL, 6 mmol, 1.5eq.) and methanesulfonylchloride ( 345 µL, 4.4 mmol, 
1.1eq.) were added sequentially and dropwise to this solution. The mixture was warmed to room 
temperature and stirred another two hours at this temperature. Saturated NH4Cl solution was added 
and the mixture was extracted two times with diethylether. The combined organic layers were washed 
with brine and dried over MgSO4. The solvents were removed in vacuo. Crude 213d 1.4 g  was 
directly submitted to the next reaction without further purification. 
1H-NMR (400MHz, CDCl3): δ= 5.18 p.p.m. (ddt, J=7.4, 2.1, 0.8 Hz, 1H), 4.23 (s, 2H), 4.18 (t, J=6.8 
Hz, 2H), 2.99 (s, 3H), 2.50 (dd, J=13.8,6.8 Hz, 2H), 1.80 (d, J=1.2 Hz), 1.07 (s, 20 Hz). 
((Z)-5-Iodo-2-methyl-pent-2-enyloxy)-triisopropyl-silane 214 
 
 
 
Mesylate 213d (1.4 g, 4 mmol, 1eq.) was dissolved in 8 mL acetone at room temperature. Sodium 
iodide (3.02 g, 20 mmol, 5eq.) was added to this mixture and stirred over night. The reaction was 
diluted with water and the resulting mixture was extracted two times with diethylether. The combined 
organic layers were washed with brine and dried over MgSO4. The solvents were removed in vacuo. 
Purification of crude 214 by flash column chromatography (hexane: ethylacetate = 20:1) afforded pure 
214, 1.5g in 98% yield. 
1H-NMR (400MHz, CDCl3): δ= 5.16 p.p.m. (ddt, J=7.3, 2.4, 1.2 Hz, 1H), 4.21 (s, 2H), 3.11 (t, J=7.4 
Hz), 2.61 (dd J=14.3, 7.1 Hz, 2H), 1.78 (d, J=1.2 Hz, 3H), 1.07 (s, 20H). 
13C-NMR (100MHz, CDCl3): δ= 138.51 p.p.m., 124.66, 62.59, 32.33, 21.58, 18.44, 122.41, 6.20. 
IR (film): 2940, 882, 739, 610 cm-1. 
HRMS (ESI) (m/z ): [M]+  calcd for C15H32IOSi 382,1189; found, 382,1178. 
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 N-((1R,2R)-1-hydroxy-1-phenylpropan-2-yl)-N-methyl-2-o-tolylacetamide 210 
 
o-Tolylacetic acid (1.00 g, 6.7 mmol, 1 eq.), (R,R)-pseudoephedrine (1.20 g, 7.3 mmol, 1.1 eq.), and 
N,N-dimethyl-4-amino pyridine were dissolved in DCM (40 mL) at room temperature. After the 
starting materials had dissolved, the solution was cooled to 0°C in an ice bath and diisopropyl 
carbodiimide (1.1 mL, 7.3 mmol, 1.1 eq.) was added dropwise. After 20 min a precipitate was formed, 
and the reaction was warmed to room temperature and stirred for 3 h. The reaction mixture was 
concentrated on the rotatory evaporator and directly submitted to flash column chromatography 
(hexane:ethylacetate=3:1) yielding 1.95 g (98%) of the desired amide 210. 
1H-NMR (400MHz, CDCl3): δ= 7.39-7.26 p.p.m. (m, 5H), 7.20-7.04 (m, 4H), 4.65 (t, J=7.3 Hz, 1H), 
4.55-4.48 (m, 1H), 4.34 (s, br 1H), 3.64 (d, J=2.3 Hz, 2H), 2.86 (s, 3H), 2.25 (s, 3H), 1.18 (d, J=6.8 
Hz, 3H).  13C-NMR (100MHz, CDCl3): δ= 173.70 p.p.m., 142.83, 136.84, 133.81, 130.63, 129.28, 
128.79, 128.04, 127.42, 126.72, 126.65, 76.88, 75.97, 59.09, 39.83, 20.02, 14.85.  
IR (film): 3383, 2971, 1699, 1617, 1558, 1452, 1404, 1118, 1051, 743, 702, 610 cm-1.  
HRMS (ESI) (m/z ): [M]+ c alcd for C19H23NO2 297.1729; found, 297.1715.  
[α]D= -96 (c 1.05g/100mL, CHCl3). 
(Z)-(R)-6-Methyl-2-o-tolyl-7-triisopropylsilanyloxy-hept-5-enoic acid ((1R,2R)-2-hydroxy-1-
methyl-2-phenyl-ethyl)-methyl-amide 214a 
 
 
A solution of n-butyllithium (3.45 mL, 2.5M, 8.6 mmol, 2.2 eq.) was added to a suspension of LiCl 
(1.0 g, 23.5 mmol, 6 eq.) and diisopropylamine (1.2 mL, 8.6 mmol, 2.2 eq.) in THF. (5 mL) at -78°C. 
The resulting suspension was briefly warmed to 0°C and then cooled to -78°C. Amide 210 (1.16 g, 3.9 
mmol, 1 eq.) was added to this mixture via cannula and stirred at that temperature for 1 h, then at 0°C 
for 15 min and at 23°C for 5 min. The mixture was cooled to 0°C and iodide 214 (1.5 g, 3.9 mmol, 
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1eq.) was added neat to this reaction mixture. After stirring at room temperature for 24 h the mixture 
was quenched with saturated aqueous ammonium chloride and extracted with dichloromethane (3x100 
mL). The combined organic phases were dried over magnesium sulfate and concentrated in vacuo. 
Purification of the residue by flash column chromatography (hexane:ethylacetate=3:1) afforded 1.50 g 
(70%)of amide 214a. 
1H-NMR (400MHz, CDCl3): δ= 7.41-6.92 p.p.m. (m, 9H), 5.38 (t, J=7.5 Hz, 0.45H), 5.26 (t, J=7 Hz 
0.6 Hz), 4.50-4.35 (m, 2.5H), 4.29-4.25 (m, 0.5H), 4.19-4.10 (m, 1.27H), 3.74-3.68 (m, 0.45H), 3.55-
3.51 (m, 0.6H), 2.86 (s, 1H), 2.55-2.45 (m, 0.43H), 2.37 (s, 1H), 2.34-2.21 (m, 3H), 2.13-2.11 (m,6H), 
1.96-1.92 (m, 3H), 1.60-1.51 (m, 1.35H), 1.32-1.24 (m, 0.8H), 1.18-1.12 (m, 20H). 
13C-NMR (100MHz, CDCl3): δ= 173.70 p.p.m., 137.44, 130.73, 128.33, 127.68, 126.96, 126.87, 
76.41, 62.61, 35.19, 26.70, 20.85, 19.03, 18.25, 14.00, 12.68. 
IR (film):3421, 2941, 1624, 1457, 1242, 882, 738, 610 cm-1. 
HRMS (ESI) (m/z ): [M]+  calcd for C34H53O3Si 551,3795; found, 551,3801. 
[α]D= -93° (c 0.55g/100mL, CHCl3). 
(Z)-(R)-6-Methyl-2-o-tolyl-7-triisopropylsilanyloxy-hept-5-en-1-ol 215 
 
 
A solution of n-butyllithium (4.25 mL, 2.5M, 10.6 mmol, 4 eq.) in hexanes was added to a solution of 
diisopropylamine (1.6 mL, 11.4 mmol, 4.2 eq.) in THF. (9 mL) at -78°C. The resulting solution was 
stirred at this temperature for 10 min, then warmed to 0°C and held at that temperature for 10 min. 
Borane-ammonia complex (335mg, 10.9 mmol, 4 eq.) was added in one portion. The suspension was 
stirred at 0°C for 15 min, then at 23°C for 15 min, cooled again to 0°C and a solution of amide 214a 
(1.50 g, 2.7 mmol, 1 eq.) in THF.(6 mL ) was added via cannula. The reaction mixture was warmed to 
room temperature and stirred for 2 h before it was cooled to 0°C again and carefully quenched with 
1M hydrochloric acid (40 mL). The mixture was diluted with water (100 mL) and extracted with ether 
(3x 100 mL). The combined organic phases were dried over magnesium sulfate and the solvents were 
removed in vacuo to give 215 (904 mg, 91%) as a yellow oil which was directly used in the next step. 
An analytical sample was purified by chromatography (hexane:ethyl acetate 5:1). 
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1H-NMR (400MHz, CDCl3): δ= 7.41-6.92 p.p.m. 5.08 (ddt, J=7.4, 2.0, 0.9 Hz, 1H), 3.92 (dd,  J=18.0, 
11.8 Hz), 3.68-3.61 (m, 2H), 3.12-3.05 (m, 1H), 2.25 (s, 3H), 1.84 (dd, J=14.8, 7.3 Hz, 2H), 1.75-1.68 
(m, 1H), 1.67 (d, J=1.25 Hz, 3H), 1.61-1.51 (m, 1H), 1.19 (t J=1.2 Hz, 1H), 0.94 (s, 20H). 
13C-NMR (100MHz, CDCl3): δ= 140.01 p.p.m., 137.21, 135.74, 130.59, 126.38, 125.80, 125.53, 
67.33, 61.80, 42.37, 32.34, 25.16, 21.05, 19.87, 18.05, 11.99. 
IR (film): 3356, 2941, 2865, 1458, 1383, 1063, 882, 610 cm-1. 
HRMS (ESI) (m/z ): [M]+  calcd for C24H42O2Si 390,2954; found, 390,2946. 
[α]D= -11° (c 0.55g/100mL, CHCl3). 
((1R,1aR,4R,4aR,6cS)-1,6c-Dimethyl-1-triisopropylsilanyloxymethyl-1,1a,2,3,4,6a,6b,6c-
octahydro-cyclopenta[g]cyclopropa[cd]pentalen-4-yl)-methanol 216 
 
 
 
Compound 215 (638 mg, 1.64 mmol) in pentane (90 mL) was irradiated with a Hannovia 700W 
medium pressure mercury lamp with a quartz filter at room temperatur for 2 h. The reaction mixture 
was concentrated and the crude residue was submitted to flash column chromatography 
(hexane:ethylacetate = 10:1) yielding 170 mg 216 and 238 mg 217 total 64% yield) in a 1:1.4 ratio. 
 
1H-NMR (400MHz, CDCl3): δ= 5.78 p.p.m. (dd, J= 5.3, 2.7 Hz, 1H), 5.47-5.45 (m, 1H), 3.69-3.62 (m, 
1H), 3.59-3.52 (m, 1H), 3.56 (d, J= 9.3 Hz, 1H), 3.49 (d, J= 9.3 Hz, 1H), 2.48-2.36 (m, 1H), 1.98-1.88 
(m, 1H), 1.76-1.58 (m, 2H), 1.56 (s, 1H), 1.53-1.44 (m, 2H), 1.34 (s, 3H), 1.17 (s, 3H), 1.06 (s, 20H). 
13C-NMR (100MHz, CDCl3): δ= 133.49 p.p.m., 130.64, 70.92, 69.17, 66.07, 48.12, 47.01, 45.50, 
41.93, 37.80, 31.29, 28.51, 27.16, 24.38, 18.98, 18.18, 12.22. 
IR (film): 3355, 2955, 1471, 1255, 1093, 836, 774, 610 cm-1. 
HRMS (ESI) (m/z ): [M]+  calcd for C24H42O2Si 390,2954, found, 390.2943. 
[α]D= -36° (c 0.30g/100mL, CHCl3). 
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((1R,3aR,4S,5aS,8aR)-4,5a-Dimethyl-4-triisopropylsilanyloxymethyl-1,2,3,3a,4,5,5a,6-octahydro-
cyclopenta[c]pentalen-1-yl)-methanol 216a 
 
 
A solution of 216 (170 mg, 0.43 mmol, 1 eq.) in absolute THF (200µL) was cooled to -78°C and 
ethylamine (5 mL) was condensed in. Small pieces of lithium (18 mg, 2.60 mmol, 6 eq.) were added 
and the reaction mixture was stirred for 7 h until a deep blue color formed. The excess lithium was 
quenched with saturated ammonium chloride solution and the suspension was warmed to room 
temperature. Diethyl ether was added and the water phase was extracted with diethyl ether (3x 100 
mL). The combined organic layers were dried over magnesium sulfate and the solvents were removed 
in vacuo. Crude 216a was subjected to flash column chromatography (hexanes:ethyl acetate 10:1) to 
give 145 mg, in 86% yield as a yellow oil.  
1H-NMR (400MHz, CDCl3): δ= 5.70 p.p.m. (dt, J= 5.6, 2.2 Hz, 1H), 5.58 (dt, J= 5.6, 2.3 Hz, 1H), 
3.59-3.54 (m, 1H), 3.52-3.45 (m, 1H), 3.50 (d, J= 9.1 Hz, 1H), 3.40 (d, J= 9.3 Hz, 1H), 2.54 (dt, J= 
17.4, 2.3 Hz, 1H), 2.29 (dt, J= 17.4, 2.2 Hz, 1H), 2.28-2.11 (m, 1H), 1.80-1.75 (m, 1H), 1.70-1.50 (m, 
3H), 1.14 (s, 3H), 1.07 (s, 3H), 1.05 (s, 20H). 
13C-NMR (100MHz, CDCl3): δ= 137.32 p.p.m., 128.31, 71.02, 65.22, 61.86, 53.71, 53.21, 51.35, 
49.85, 46.34, 45.06, 31.75, 28.54, 27.89, 25.53, 18.10, 12.09. 
IR (film): 3355, 2955, 1471, 1255, 1093, 836, 738, 610 cm-1. 
HRMS (ESI) (m/z ): [M]+  calcd for C24H42O2Si 392,3111; found,392,3100. 
[α]D= -16° (c 0.25g/100mL, CHCl3). 
Compound 225 
 
Alcohol 216a ( 145 mg, 0.37 mmol, 1 eq.) was dissolved in 3 mL dimethylsulfoxide. IBX ( 130mg, 
0.46 mmol, 1.5 eq.) was added to this stirred solution at room temperature. The mixture was stirred for 
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one hour, diluted with diethyl ether and water and extracted two times with ether. The combined 
organic phases were dried over magnesium sulfate and concentrated in vacuo. The crude aldehyde was 
dissolved in3 mL tert-butanol and 1 mL 2,3-dimthyl-2-butene was added. Sodium chlorite (370 mg, 
3.7 mmol, 10 eq.) and 370 mg sodium dihydrogen phosphate were dissolved in 1.5 mL water. The 
solution was added dropwise to the aldehyde at room temperature, and the mixture was stirred for 
another 30 minutes. The reaction mixture was quenched with brine and extracted four times with 
dichloromethane. The combined organic layers were dried over magnesium sulfate and the solvents 
were removed in vacuo.  
Crude acid 223 (110 mg, 0.27 mmol, 1 eq) was dissolved in dichloromethane (6 mL) in a three necked 
round bottom flask equipped with a gas outlet and a gas inlet-tube. The solution was cooled to -78°C 
and ozonized for 2 min (flow 100mL/min) until the solution was dark blue. The excess ozone was 
driven out with air until the solution became colorless again. Then thiourea (25 mg, 0.33 mmol, 1.2 
eq.) was added in one portion and the suspension was warmed to room temperature and stirred for 40 
min giving a cloudy solution. The solvent was removed in vacuo and the crude product was submitted 
to flash column chromatography (hexane:ethyl acetate=5:1) yielding 62 mg 38% of lactol 225 over 3 
steps. 
1H-NMR (400MHz, CDCl3): δ= 5.68 p.p.m. (s, 1H), 5.38 (ddd, J= 8.6, 5.8, 2.5 Hz, 1H), 3.48 (d, J= 
9.8 Hz, 1H), 3.44 (d, J= 9.8 Hz, 1H), 2.93 (d, J= 7.6 Hz, 1H), 2.90 (d, J= 2.8 Hz, 1H (OH)), 2.28 (dd, 
J= 9.6, 2.0 Hz, 1H), 2.20-2.14 (m, 1H), 2.12-2.03 (m, 2H), 1.95 (dd, J= 14.4, 5.5 Hz, 1H), 1.83-1.73 
(m, 1H), 1.57 (s, 2H), 1.27 (s, 3H), 1.09 (s, 3H), 1.06 (s, 20H). 
13C-NMR (100MHz, CDCl3): δ= 179.42 p.p.m., 101.44, 91.46, 68.94, 66.52, 58.94, 52.66, 46.75, 
45.64, 42.50, 41.39, 31.22, 29.56, 27.71, 26.42, 17.92, 12.01. 
IR (film): 3629, 2956, 1791, 1464, 1251, 1094, 857, 739, 610 cm-1. 
HRMS (ESI) (m/z ): [M]+  calcd for C24H42O5Si 438.2802, found 438.2798. 
[α]D= -66° (c 0.85g/100mL, CHCl3). 
Compound 225a 
 
Lactol 225 (31 mg, 71 µmol, 1eq) was dissolved in dichloromethane (0.5 mL) at room temperature. 
PDC (160 mg, 0.42 mmol, 6 eq.) was added in one portion. After 20 min acetic acid (9 µL, 28 µmol, 
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0.4 eq.) was added dropwise. The reaction mixture was stirred for another 24 hours and then diluted 
with diethyl ether. The suspension was filtered through a silica pad and concentrated in vacuo. Flash 
column chromatography (hexanes:ethyl acetate 5:1) gave 20 mg (65% yield) of acylal 225a. 
1H-NMR (400MHz, CDCl3): δ= 5.95 p.p.m., (s, 1H), 3.51 (s, 2H), 2.96 (d, J= 7.3 Hz, 1H), 2.83 (d, J= 
15.1 Hz, 1H), 2.49 (d, J= 15.0 Hz, 1H), 2.38 (dd, J= 10.0, 7.3 Hz, 1H), 2.27-2.21 (m, 1H), 2.05-1.97 
(m, 1H), 1.95-1.87 (m, 1H), 1.80-1.73 (m, 1H), 1.77 (d, J= 13.9 Hz, 1H), 1.62 (d, J= 13.9 Hz, 1H), 
1.29 (s, 3H), 1.11 (s, 3H), 1.06 (s, 20Hz). 
13C-NMR (100MHz, CDCl3): δ= 168.42 p.p.m., 167.86, 103.60, 68.89, 66.14, 59.23, 50.56, 46.35, 
45.78, 44.32, 41.84, 30.04, 28.16, 27.36, 27.27, 18.02, 11.95. 
IR (film): 2960, 1799, 1771, 1653, 1559, 1507, 1458, 1367, 1115, 1043, 995, 905, 738, 610 cm-1. 
HRMS (ESI) (m/z ): [M]+  calcd for C24H40O5Si 436.4645, found 436. 4637. 
[α]D= -72° (c 1.00g/100mL, CHCl3). 
Penifulvin C 139 
 
Acylal 225a ( 10 mg, 23 µmol, 1 eq.) was dissolved in 0.5 mL tetrahydrofuran. To this solution 200 
µL 35% HF/pyridine were added dropwise and the reaction mixture was stirred at room temperature 
for 24 hours. The reaction was poured on 20 mL 0.5M HCl solution and extracted four times with 
ethyl acetate. The combined organic layers were washed with brine dried over magnesium sulfate and 
concentrated in vacuo. Flash column chromatography (hexanes:ethyl acetate 1:2) gave 5 mg 78% yield 
of Penifulvin C. 139 
1H-NMR (400MHz, CDCl3): δ= 5.96 p.p.m., 3.49 (dd, J= 10.5, 4.2 Hz, 1H), 3.47 (dd, J= 10.5, 4.2 Hz 
1H), 2.98 (d, J= 6.3 Hz, 1H), 2.83 (d, J= 14.9 Hz, 1H), 2.50 (d, J= 14.9 Hz, 1H), 2.41 (dd, J= 9.8, 4.3 
Hz, 1H), 2.29-2.23 (m, 1H), 2.01-1.89 (m, 2H), 1.83-1.75 (m, 1H), 1.75 (d, J= 14.2 Hz, 1H), 1.68 (d, 
J= 14.2 Hz, 1H), 1.32 (s, 3H), 1.12 (s, 3H). 
13C-NMR (100MHz, CDCl3): δ= 177.72 p.p.m., 168.41, 103.74, 69.38, 66.61, 59.19, 50.89, 46.31, 
45.25, 44.37, 42.08, 30.31, 27.79, 27.54, 27.44. 
IR (film): cm-1 
HRMS (ESI) (m/z ): [M]+  calcd for C15H20O5 280.1311, found 280.1301. 
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[α]D= -72° (c 1.00g/100mL, CHCl3). 
((E)-5-Bromo-2-methyl-pent-2-enyloxy)-tert-butyl-dimethyl-silane 209 
 
 
To a suspension of selenium dioxide ( 0.832 g, 7.5 mmol, 0.5 eq.) in dry dichloromethane (20 mL) at 
0°C was added slowly anhydrous tert-butyl hydroperoxide (5-6 M, in decane, 5.45 mL ~30 mmol, 2.0 
eq.). The mixture was stirred at 0°C for 5 minutes and then the ice bath was removed. The resulting 
mixture was stirred at room temperature for 30 minutes and was then cooled to 0°C again. A solution 
of5-Bromo-2-methyl-2-pentene (2.45 g, 15 mmol, 1eq.) in dry dichloromethane (15 mL) was added 
slowly. The resulting suspension was then stirred at room temperature for 12 hours. The mixture was 
diluted with ether (100 mL) and filtered to remove solid compounds. The filtrate was washed with 
10% aq. KOH (100 mL) and brine (100 mL). The organic layer was dried over magnesium sulfate, 
filtered and concentrated under reduced pressure. Flash column chromatography (hexanes:ethyl 
acetate 4:1) gave 1.82g of the (E)-alcohol in 68% yield as a yellow oil with spectra identical to those 
reported in literature. 
Crude alcohol ( 1 g, 5.6 mmol, 1 eq.) was dissolved in dimethyl formamide (6 mL). Imidazole (920 
mg, 13.4 mmol, 2.4 eq.) was added and the mixture was stirred at room temperature. TBSCl ( 926 mg, 
6.1 mmol, 1.1 eq.) was added to this mixture and stirred over night. The reaction mixture was diluted 
with ether and water. The water phase was extracted two times with ether. The combined organic 
layers were dried over magnesium sulfate, and concentrated under reduced pressure. Flash column 
chromatography (hexanes:ethyl acetate 20:1) gave 1.6 g, 98% of compound 209. 
1H-NMR (400MHz, CDCl3): δ= 5.35 p.p.m., (ddt, J= 7.2, 2.9, 1.4 Hz, 1H), 3.95 (s, 2H), 3.29 (t, J= 
7.3 Hz, 2H), 2.55 (dd, J= 14.2, 7.0 Hz, 2H), 1.54 (s, 3H), 0.84 (s, 9H), 0.00 (s, 6H). 
13C-NMR (100MHz, CDCl3): δ= 177.72 p.p.m., 138.01, 120.85, 68.42, 32.87, 31.63, 26.10, 
18.81,14.00, -4.9. 
IR (film): 2956, 1472, 1253, 1072, 837, 776, 610 cm-1. 
HRMS (ESI) (m/z ): [M]+  calcd for C12H25BrOSi 292.0858, found 292.0864. 
(E)-(R)-7-(tert-Butyl-dimethyl-silanyloxy)-6-methyl-2-o-tolyl-hept-5-enoic acid ((1R,2R)-2-
hydroxy-1-methyl-2-phenyl-ethyl)-methyl-amide 209a 
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A solution of n-butyllithium (4.50 mL, 2.5M, 11.18 mmol, 2.05 eq.) was added to a suspension of 
LiCl (1.42 g, 33.54 mmol, 6 eq.) and diisopropylamine (1.6 mL, 11.18 mmol, 2.05 eq.) in THF. (5 mL) 
at -78°C. The resulting suspension was briefly warmed to 0°C and then cooled to -78°C. Amide 210 
(1.78 g, 6.0 mmol, 1.1 eq.) in THF ( 3 mL) was added to this mixture via cannula and stirred at that 
temperature for 1 h, then at 0°C for 15 min and at 23°C for 5 min. The mixture was cooled to 0°C and 
bromide xxx (1.6 g, 5.5 mmol, 1eq.) was added neat to this reaction mixture. After stirring at room 
temperature for 24 h the mixture was quenched with saturated aqueous ammonium chloride and 
extracted with dichloromethane (3x100 mL). The combined organic phases were dried over 
magnesium sulfate and concentrated in vacuo. Purification of the residue by flash column 
chromatography (hexane:ethylacetate=3:1) afforded 1.90 g (68%)of amide 209a. 
1H-NMR (400MHz, CDCl3): δ= 7.37-7.04 p.p.m., (m, 9H), 5.46-5.38 (m, 1H), 4.60-4.49 (m, 1H), 
4.47-4.34 (m, 1H), 4.00 (s, 2H), 3.76-3.65 (m, 1H), 2.92 (s, 1H), 2.55 (s, 2H), 2.38 (s, 1H), 2.30 (s, 
2H), 2.24-2.08 (m, 2H), 2.04-1.97 (m, 2H), 1.59 (s, 1H), 1.55 (s, 2H), 1.52-1.45 (m, 1H), 1.13 (s, 1H), 
1.12 (s, 2H), 0.9 (s, 9H), 0.06 (s, 6H). 
13C-NMR (100MHz, CDCl3): δ= 175.93 p.p.m., 142.73, 138.79, 135.90, 135.10, 131.00, 128.83, 
128.03, 127.38, 126.82, 124.09, 76.91, 75.94, 68.95, 60.83, 58.26, 45.56, 34.16, 26.44, 19.69, 14.38, 
13.90, -4.9. 
IR (film): 2927, 1623, 1457, 1252, 1113, 837, 775, 610 cm-1. 
HRMS (ESI) (m/z ): [M]+  calcd for C31H47NO3Si 509.3325, found 509.3317. 
[α]D= +103° (c 0.55g/100mL, CHCl3). 
(E)-(R)-7-(tert-Butyl-dimethyl-silanyloxy)-6-methyl-2-o-tolyl-hept-5-en-1-ol 211 
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A solution of n-butyllithium (3.4 mL, 2.5M, 8.4 mmol, 3.9 eq.) in hexanes was added to a solution of 
diisopropylamine (1.27 mL, 9.06 mmol, 4.2 eq.) in THF. (9 mL) at -78°C. The resulting solution was 
stirred at this temperature for 10 min, then warmed to 0°C and held at that temperature for 10 min. 
Borane-ammonia complex (266 mg, 8.6 mmol, 4 eq.) was added in one portion. The suspension was 
stirred at 0°C for 15 min, then at 23°C for 15 min, cooled again to 0°C and a solution of amide 209a 
(1.10 g, 2.1 mmol, 1 eq.) in THF.(6 mL ) was added via cannula. The reaction mixture was warmed to 
room temperature and stirred for 2 h before it was cooled to 0°C again and carefully quenched with 
1M hydrochloric acid (40 mL). The mixture was diluted with water (100 mL) and extracted with ether 
(3x 100 mL). The combined organic phases were dried over magnesium sulfate and the solvents were 
removed in vacuo to give 211 (692 mg, 92%) as a yellow oil which was directly used in the next step. 
An analytical sample was purified by chromatography (hexane:ethyl acetate 5:1). 
1H-NMR (400MHz, CDCl3): δ= 7.21-7.09 p.p.m., (m, 4H), 5.36 (ddt, J= 7.1, 2.4, 1.1 Hz, 1H), 3.97 (s, 
2H), 3.77-3.68 (m, 2H), 3.18 (ddd, J= 13.0, 9.3, 6.0 Hz, 1H), 2.33 (s, 3H), 1.94 (dd, J= 14.8, 7.5 Hz, 
2H), 1.83-1.75 (m, 1H), 1.72-1.63 (m, 1H), 1.44 (s, 3H), 0.90 (s, 9H), 0.05 (s, 6H). 
13C-NMR (100MHz, CDCl3): δ= 140.65 p.p.m., 137.69, 135.32, 130.91, 126.72, 126.62, 124.45, 
69.01, 67.72, 42.80, 32.33, 26.45, 25.52, 20.33, 13.65, -4.90. 
IR (film): 3356, 2941, 2865, 1458, 1383, 1063, 882, 610 cm-1. 
HRMS (ESI) (m/z ): [M]+  calcd for C21H36O2Si 348.2485, found 348.2492. 
[α]D= +11° (c 0.30g/100mL, CHCl3). 
[(1S,1aR,4R,4aR,6cS)-1-(tert-Butyl-dimethyl-silanyloxymethyl)-1,6c-dimethyl-
1,1a,2,3,4,6a,6b,6c-octahydro-cyclopenta[g]cyclopropa[cd]pentalen-4-yl]-methanol 218 
 
 
 
Compound 211 (428 mg, 1.23 mmol) in pentane (90 mL) was irradiated with a Hannovia 700W 
medium pressure mercury lamp with a quartz filter at room temperatur for 2 h. The reaction mixture 
was concentrated and the crude residue was submitted to flash column chromatography 
(hexane:ethylacetate = 10:1) yielding 90 mg 218 and 184 mg 219 total 64% yield) in a 1:2.0 ratio. 
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1H-NMR (400MHz, CDCl3): δ= 5.71 p.p.m., (dd, J= 5.3, 2.3 Hz, 1H), 5.46 (d, J= 5.1 Hz, 1H), 3.67-
3.61 (m, 1H), 3.57-3.50 (m, 1H), 3.50 (d, J= 8.8 Hz, 1H), 3.47 (d, J= 9.0 Hz, 1H), 2.48-2.39 (m, 1H), 
2.01-1.90 (m, 3H), 1.64-1.41 (m, 4H), 1.37 (s, 3H), 1.26 (s, 1H), 1.06 (s, 3H), 0.88 (s, 9H), -0.06 (s, 
3H), -0.03 (s, 3H). 
13C-NMR (100MHz, CDCl3): δ= 134.08 p.p.m., 129.58, 70.20, 65.74, 65.19, 47.89, 47.05, 46.72, 
42.48, 37.87, 31.44, 28.42, 25.95, 24.20, 18.78, 18.24, -5.33. 
IR (film): 3629, 2956, 2362, 1653, 1457, 1256, 1094, 738, 610 cm-1. 
HRMS (ESI) (m/z ): [M]+  calcd for C21H36O2Si 348.2485, found 348.2471. 
[α]D= -59° (c 0.45g/100mL, CHCl3). 
[(1R,3aR,4R,5aS,8aR)-4-(tert-Butyl-dimethyl-silanyloxymethyl)-4,5a-dimethyl-1,2,3,3a,4,5,5a,6-
octahydro-cyclopenta[c]pentalen-1-yl]-methanol 219a 
 
 
A solution of 219 (90 mg, 0.26 mmol, 1 eq.) in absolute THF (200µL) was cooled to -78°C and 
ethylamine (3 mL) was condensed in. Small pieces of lithium (11 mg, 1.55 mmol, 6 eq.) were added 
and the reaction mixture was stirred for 7 h until a deep blue color formed. The excess lithium was 
quenched with saturated ammonium chloride solution and the suspension was warmed to room 
temperature. Diethyl ether was added and the water phase was extracted with diethyl ether (3x 100 
mL). The combined organic layers were dried over magnesium sulfate and the solvents were removed 
in vacuo. Crude 219a was subjected to flash column chromatography (hexanes:ethyl acetate 10:1) to 
give 90 mg, in 96% yield as a yellow oil. 
1H-NMR (400MHz, CDCl3): δ= 5.76 p.p.m., (dt, J= 5.4, 2.1 Hz, 1H), 5.51 (dt, J= 5.3, 2.1 Hz, 1H), 
3.55-3.43 (m, 2H), 3.28 (d, J= 9.3 Hz, 1H), 3.17 (d, J= 9.3 Hz, 1H), 2.38 (dt, J= 17.2, 2.1 Hz, 1H), 
2.28-2.22 (m, 1H), 2.18 (dt, J= 17.2, 2.1 Hz, 1H), 2.03-1.96 (m, 1H), 1.92 (d, J= 13.4 Hz, 1H), 1.65-
1.61 (m, 1H), 1.48 (d, J= 13.2 Hz, 1H), 1.38-1.31 (m, 2H), 1.17 (s, 3H), 0.94 (s, 3H), 0.87 (s, 9H), -
0.01 (s, 6H). 
13C-NMR (100MHz, CDCl3): δ= 137.64 p.p.m., 127.23, 71.13, 65.09, 59.28, 53.48, 51.26, 50.32, 
49.08, 46.86, 45.09, 32.51, 28.04, 27.21, 25.85, 22.40, 18.29, -5.46. 
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IR (film): 3629, 2956, 2362, 1653, 1457, 1256, 1094, 738, 610 cm-1. 
HRMS (ESI) (m/z ): [M]+  calcd for C21H38O2Si 350.2641, found 350.2634. 
[α]D= -19° (c 0.30g/100mL, CHCl3). 
Compound 222 
OOO
OH
H
OTBS  
Alcohol 219a ( 90 mg, 0.26 mmol, 1 eq.) was dissolved in 3 mL dimethylsulfoxide. IBX ( 90mg, 0.32 
mmol, 1.5 eq.) was added to this stirred solution at room temperature. The mixture was stirred for one 
hour, diluted with diethyl ether and water and extracted two times with ether. The combined organic 
phases were dried over magnesium sulfate and concentrated in vacuo. The crude aldehyde was 
dissolved in3 mL tert-butanol and 1 mL 2,3-dimthyl-2-butene was added. Sodium chlorite (260 mg, 
2.6 mmol, 10 eq.) and 260 mg sodium dihydrogen phosphate were dissolved in 1.5 mL water. The 
solution was added dropwise to the aldehyde at room temperature, and the mixture was stirred for 
another 30 minutes. The reaction mixture was quenched with brine and extracted four times with 
dichloromethane. The combined organic layers were dried over magnesium sulfate and the solvents 
were removed in vacuo.  
Crude acid 220 (90 mg, 0.24mmol, 1 eq) was dissolved in dichloromethane (6 mL) in a three necked 
round bottom flask equipped with a gas outlet and a gas inlet-tube. The solution was cooled to -78°C 
and ozonized for 2 min (flow 100mL/min) until the solution was dark blue. The excess ozone was 
driven out with air until the solution became colorless again. Then thiourea (25 mg, 0.33 mmol, 1.37 
eq.) was added in one portion and the suspension was warmed to room temperature and stirred for 40 
min giving a cloudy solution. The solvent was removed in vacuo and the crude product was submitted 
to flash column chromatography (hexane:ethyl acetate=5:1) yielding 37 mg 36% of lactol 222 over 3 
steps. 
1H-NMR (400MHz, CDCl3): δ= 5.64 p.p.m., (s, 1H), 5.35 (ddd, J= 8.3, 5.5, 3.0 Hz, 1H), 3.36 (d, J= 
1.26 Hz, 2H), 2.94 (d, J= 7.6 Hz, 1H), 2.84 (d, J= 3.3 Hz, 1H), 2.29 (d, J= 8.6 Hz, 1H), 2.21-2.15 (m, 
1H), 2.07 (d, J= 14.4 Hz, 1H), 1.89-1.74 (m, 5H), 1.27 (d, J= 14.4 Hz, 1H), 1.10 (s, 3H), 0.95 (s, 3H), 
0.89 (s, 9H), 0.05 (s, 3H), 0.04 (s, 3H).  
13C-NMR (100MHz, CDCl3): δ= 179.80 p.p.m., 101.75, 96.67, 72.22, 66.18, 55.05, 52.71, 46.47, 
45.80, 41.64, 40.90, 31.51, 27.76, 26.48, 25.95, 23.00, 18.21, -5.30. 
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IR (film): 3629, 2956, 1791, 1464, 1251, 1094, 857, 739, 610 cm-1. 
HRMS (ESI) (m/z ): [M]+  calcd for C21H36O5Si 396.2332, found 396.2322. 
[α]D= -53° (c 0.90g/100mL, CHCl3). 
Compound 222a 
 
Lactol 222 (24 mg, 60 µmol, 1eq) was dissolved in dichloromethane (0.5 mL) at room temperature. 
PDC (136 mg, 0.36 mmol, 6 eq.) was added in one portion. After 20 min acetic acid (9 µL, 28 µmol, 
0.46 eq.) was added dropwise. The reaction mixture was stirred for another 24 hours and then diluted 
with diethyl ether. The suspension was filtered through a silica pad and concentrated in vacuo. Flash 
column chromatography (hexanes:ethyl acetate 5:1) gave 20 mg (83% yield) of acylal 222a. 
1H-NMR (400MHz, CDCl3): δ= 5.64 p.p.m., 5.88 (s, 1H), 3.37 (s, 2H), 2.99-2.95 (m, 3H), 2.49 (dd, 
J= 9.8, 2.3 Hz, 1H), 2.35 (d, J= 15.0 Hz, 1H), 2.30-2.25 (m, 1H), 2.09 (d, J= 14.4 Hz, 1H), 1.95-1.80 
(m, 2H), 1.66-1.57 (m, 1H), 1.54 (d, J= 14.4 Hz, 1H), 1.11 (s, 3H), 0.96 (s, 3H), 0.91 (s, 9H), 0.07 (s, 
6H). 
13C-NMR (100MHz, CDCl3): δ= 177.60 p.p.m., 168.79, 104.06, 72.39, 68.34, 56.18, 52.91, 46.36, 
46.25, 43.41, 42.03, 31.37, 27.42, 27.13, 25.98, 22.75, 18.38, -5.31, -5.41. 
IR (film): 2960, 1799, 1771, 1653, 1559, 1507, 1458, 1367, 1115, 1043, 995, 905, 738, 610 cm-1. 
HRMS (ESI) (m/z ): [M]+  calcd for C21H34O5Si 394.2176, found 394.2166. 
[α]D= -75° (c 0.85g/100mL, CHCl3). 
Penifulvin B 
 
 
173 
Acylal 222a ( 10 mg, 25 µmol, 1 eq.) was dissolved in 0.5 mL tetrahydrofuran. To this solution 200 
µL 35% HF/pyridine were added dropwise and the reaction mixture was stirred at room temperature 
for 24 hours. The reaction was poured on 20 mL 0.5M HCl solution and extracted four times with 
ethyl acetate. The combined organic layers were washed with brine dried over magnesium sulfate and 
concentrated in vacuo. Flash column chromatography (hexanes:ethyl acetate 1:2) gave 5.8 mg 82% 
yield of Penifulvin B 137. 
1H-NMR (400MHz, CDCl3): δ= 5.98 p.p.m., (s, 1H), 3.48 (s, 2H), 3.18 (dd, J= 14.9, 0.8 Hz, 1H), 2.98 
(d, J= 7.1 Hz, 1H), 2.61 (dd, J= 9.7, 2.7 Hz, 1H), 2.34 (d, J= 14.9 Hz, 1H), 2.28 (ddt, J= 13.1, 13.1, 
2.0 Hz, 1H), 2.09 (d, J= 14.4 Hz, 1H), 1.97-1.79 (m, 2H), 1.78 (s, 1H(OH)), 1.68-1.58 (m, 1H), 1.62 
(d, J= 14.6 Hz, 1H), 1.11 (s, 3H), 0.99 (s, 3H). 
13C-NMR (100MHz, CDCl3): δ= 177.88 p.p.m., 169.30, 103.88, 72.43, 66.65, 56.16, 53.77, 46.62, 
45.87, 43.38, 42.23, 31.33, 27.54, 27.48, 22.73. 
HRMS (ESI) (m/z ): [M]+  calcd for C15H20O5 280.1311, found 280.1304. 
[α]D= -84° (c 1.1g/100mL, CHCl3). 
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